ticker,rpa_date_utc,rpa_time_utc,rp_entity_id,entity_name,relevance,event_sentiment_score,group,sub_type,event_text,news_type,source_name,headline
WST,2021-01-28,11:02:36,2D84F1,Catena Group PLC,99,0.62,acquisitions-mergers,,Catena Group PLC: The acquisition of Insight by Catena,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Trading Update & Notice to Exercise Insight Option
WST,2021-01-28,11:02:36,2D84F1,Catena Group PLC,99,0.0,revenues,,"Catena Group PLC: Revenue of GBP883,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Trading Update & Notice to Exercise Insight Option
WST,2021-01-28,11:29:54,2D84F1,Catena Group PLC,100,0.0,earnings,,Catena Sees 2020 Loss in,FULL-ARTICLE,Dow Jones Newswires,Catena Sees 2020 Loss in Line With Expectations
WST,2021-03-08,15:20:41,2D84F1,Catena Group PLC,99,0.62,acquisitions-mergers,,Catena Group PLC: Acquisition of Insight,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Corporate Update
WST,2021-03-08,15:47:00,2D84F1,Catena Group PLC,100,0.53,labor-issues,,Catena Group Appoints New CFO,FULL-ARTICLE,Dow Jones Newswires,"Catena Group Appoints New CFO; Loans GBP400,000 to Insight"
WST,2021-03-22,07:00:21,2D84F1,Catena Group PLC,99,0.0,equity-actions,,Catena Group PLC: Proposed Name Change to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed Name Change to Insig AI Plc
WST,2021-03-22,08:46:01,2D84F1,Catena Group PLC,100,0.0,equity-actions,,Catena Group to Change Name to,FULL-ARTICLE,Dow Jones Newswires,Catena Group to Change Name to Insig AI After Reverse Takeover
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.65,earnings,negative,Catena Group PLC: we are reporting a total comprehensive loss of GBP0.5 million (31 December 2019: loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,0.0,equity-actions,,Catena raised GBP1.5 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,0.22,acquisitions-mergers,,"Catena Group PLC: In March 2020, Catena acquired a 9.1 per cent. interest in the issued share capital of Insight for GBP",PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.6,revenues,down,Catena Group PLC: SSL turnover fell by 48%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.51,assets,close,Catena Group PLC: The renewed school closures,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,0.0,equity-actions,,Catena Group PLC: the Company intends to change its name to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.63,earnings,negative,Catena Group PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.65,earnings,negative,Catena Group PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,95,-0.65,earnings,negative,Catena Group PLC: Loss per share (basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -2-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,0.0,earnings,,Catena Group PLC: our Interim Results for the six months ended 30 June 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,0.65,revenues,up,Catena Group PLC: While revenue recovered at the end of 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.51,assets,close,Catena Group PLC: The renewed school closures,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.65,earnings,negative,Catena Group PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.63,earnings,negative,Catena Group PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.62,earnings,negative,Catena Group PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.65,earnings,negative,Catena Group PLC: Loss after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,0.22,acquisitions-mergers,,"Catena Group PLC: In March 2020, the company acquired a 9.1% interest in the ordinary share capital of Insight for GBP",PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,NEWS-FLASH,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight Capital Partners
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.57,acquisitions-mergers,completed,Catena Group PLC: The completion of the Acquisition,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight Capital Partners
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,-0.51,labor-issues,,Directors of Catena will be resigning,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight Capital Partners
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight -2-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.0,products-services,,Catena Group PLC: The development of these products,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight -2-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.47,labor-issues,,Catena Group PLC: John was appointed as a Non-Executive Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight -2-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.62,acquisitions-mergers,,Catena Group PLC: The Company has also entered into a conditional share purchase agreement with each of the Minority Insight Sellers dated 20,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight -3-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.53,labor-issues,,Catena Group PLC: Ashley joined Catena as Chief Financial Officer in March 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight -3-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight -4-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,FULL-ARTICLE,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight Capital Partners
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,-0.51,labor-issues,,Directors of Catena will be resigning,FULL-ARTICLE,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight Capital Partners
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,FULL-ARTICLE,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight -2-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,FULL-ARTICLE,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight -3-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.53,labor-issues,,Ashley joined Catena as Chief Financial Officer in March 2021,FULL-ARTICLE,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight -3-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,FULL-ARTICLE,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight -4-
WST,2021-04-21,07:00:02,2D84F1,Catena Group PLC,99,0.0,equity-actions,,Catena Group plc - to be renamed,PRESS-RELEASE,LSE Regulatory News Service (RNS),AIM Schedule One - Catena Group PLC
WST,2021-04-21,07:00:02,2D84F1,Catena Group PLC,99,0.22,acquisitions-mergers,,Catena acquired a 9.1 per cent. interest in the ordinary share capital of Insight Capital Partners,PRESS-RELEASE,LSE Regulatory News Service (RNS),AIM Schedule One - Catena Group PLC
WST,2021-05-07,09:35:49,2D84F1,Catena Group PLC,99,0.0,investor-relations,,Catena Group PLC: the Company's next annual general meeting.,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Catena Group PLC Result of GM, Admission of Shares & Change of name"
WST,2021-08-13,06:30:06,2D84F1,Insig AI PLC,99,0.47,labor-issues,,Delighted to become Chairman of Insig AI,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Directorate changes
WST,2021-08-13,07:35:51,2D84F1,Insig AI PLC,100,-0.51,labor-issues,,Insig AI PLC said Friday that Executive Chairman Matthew Farnum-Schneider has resigned,FULL-ARTICLE,Dow Jones Newswires,Insig AI Chairman Matthew Farnum-Schneider Resigns
WST,2021-08-17,06:00:33,2D84F1,Insig AI PLC,99,0.49,partnerships,,Insig to partner with CarVal,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc CarVal HY and IG product lines partnership
WST,2021-08-17,06:00:33,2D84F1,Insig AI PLC,99,0.0,products-services,,Insig AI's and CarVal's jointly developed ESG technology,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc CarVal HY and IG product lines partnership
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: Final results for the 15 month period,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.52,revenues,down,Insig AI PLC: SSL turnover fell 38% in the 15-month period,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.47,equity-actions,,Insig AI PLC: Board restructure,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.53,labor-issues,,Insig AI PLC: Capital was appointed as Chief Executive of the Company,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.0,revenues,,"Insig AI PLC: Since 31 March 2021, SSL revenues",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.61,products-services,increase,Insig AI PLC: We are now seeing growing demand,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.61,earnings,positive,Insig AI PLC: Gross profit 245,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,"Insig AI PLC: Loss before taxation (1,062",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss per share (basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,90,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,90,-0.62,earnings,negative,Insig AI PLC: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,-0.62,earnings,negative,"Insig AI PLC: Loss before tax (1,050",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,0.0,revenues,,Insig AI PLC: Revenue arises,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,0.46,equity-actions,,Insig AI PLC: Investments in subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -5-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,0.0,revenues,,Insig AI PLC: All revenue was,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,-0.63,earnings,negative,Insig AI PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,-0.65,earnings,negative,Insig AI PLC: Loss on,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,-0.65,earnings,negative,Insig AI PLC: Basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: The consolidated loss for the 15-month period,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -7-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.0,equity-actions,,Insig AI PLC: Cost at 1 January 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -7-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.0,equity-actions,,Insig AI PLC: Cost at 31 March 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -7-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: In March 2020, the company acquired a 9.1% interest in the ordinary share capital of Insight for GBP",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -7-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,98,0.39,products-services,,Insig AI PLC: The Company entered into a loan agreement with Insig,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -8-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.0,equity-actions,,"Insig AI PLC: the company raised GBP1,000,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -9-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.0,assets,,Insig AI PLC: All financial assets are due within one year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -11-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,Insig AI PLC: the Company acquired a 9.1 per cent. interest (on a fully diluted basis) of the ordinary shares,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -11-"
WST,2021-09-15,06:00:13,2D84F1,Insig AI PLC,99,0.0,products-services,,Insig AI PLC: The Company has developed 15 individual machine learning models to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Launch of Insig ESG
WST,2021-09-15,06:00:13,2D84F1,Insig AI PLC,99,-0.54,products-services,,Insig AI PLC: Enable drill down,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Launch of Insig ESG
WST,2021-09-30,10:09:56,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Result of AGM
WST,2021-11-10,07:00:16,2D84F1,Insig AI PLC,99,0.53,labor-issues,,Insig AI PLC: has joined the Company as Chief Commercial Officer,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Colm McVeigh appointed as Chief Commercial Officer
WST,2021-11-10,07:00:16,2D84F1,Insig AI PLC,99,0.52,products-services,,Insig delivers ESG scoring solution to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc ESG scoring solution delivered to CarVal Investors
WST,2021-11-18,07:00:32,2D84F1,Insig AI PLC,99,0.34,products-services,,Insig AI PLC: Acquisition of FDB Systems,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Acquisition of FDB Systems Limited
WST,2021-11-18,07:00:32,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: Based on this revenue forecast for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Acquisition of FDB Systems Limited
WST,2021-11-19,07:00:33,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 50,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2021-11-19,11:36:23,2D84F1,Insig AI PLC,99,0.52,insider-trading,,"Insig AI PLC: Insig AI plc (AIM: INSG) has been notified that, Warren Pearson, Chief Technical Officer of the Company, has purchased 19,951 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2021-12-10,07:00:22,2D84F1,Insig AI PLC,99,0.47,labor-issues,,Insig AI PLC: Colm McVeigh appointment to the Board,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Colm McVeigh appointment to the Board
WST,2021-12-13,07:00:21,2D84F1,Insig AI PLC,99,0.39,products-services,,"Insig AI PLC: Insig AI commented: ""The agreement with 4BIO is our first contract win outside the financial services",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Contract win
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.57,acquisitions-mergers,completed,Insig AI PLC: Secured contract with Carval Investors,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.65,revenues,up,Insig AI PLC: Group revenue of GBP0.9 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: Group operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.53,labor-issues,,Insig AI PLC: Appointment of Colm McVeigh as Chief,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,Insig AI PLC: we invested heavily in our,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.72,revenues,up,Insig AI PLC: Having scalable offerings enables us to accelerate sales growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.37,equity-actions,increase,Insig AI PLC: see increasing interest in our,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Loss before taxation (844,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss per share (basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,Insig AI PLC: Acquisition of Insig,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -3-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,Insig AI PLC: The investment in Insig,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: The loss in the six months,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.0,equity-actions,,"Insig AI PLC: Non-recurring costs of GBP375,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2021-12-22,09:25:36,2D84F1,Insig AI PLC,100,-0.65,earnings,down,Insig AI 1H Pretax Loss Widened,FULL-ARTICLE,Dow Jones Newswires,"Insig AI 1H Pretax Loss Widened, Revenue Rose"
WST,2021-12-23,08:41:52,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 35,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2021-12-23,12:55:23,2D84F1,Insig AI PLC,99,0.52,insider-trading,,"Insig AI PLC: Insig AI plc (AIM: INSG) has been notified that, Colm McVeigh, Chief Commercial Officer of the Company, has purchased 29,550 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2021-12-30,07:00:01,2D84F1,Insig AI PLC,99,0.53,labor-issues,,Insig AI PLC: Directorate change,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Directorate change
WST,2021-01-28,11:02:36,2D84F1,Catena Group PLC,99,0.62,acquisitions-mergers,,Catena Group PLC: The acquisition of Insight by Catena,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Trading Update & Notice to Exercise Insight Option
WST,2021-01-28,11:02:36,2D84F1,Catena Group PLC,99,0.0,revenues,,"Catena Group PLC: Revenue of GBP883,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Trading Update & Notice to Exercise Insight Option
WST,2021-01-28,11:29:54,2D84F1,Catena Group PLC,100,0.0,earnings,,Catena Sees 2020 Loss in,FULL-ARTICLE,Dow Jones Newswires,Catena Sees 2020 Loss in Line With Expectations
WST,2021-03-08,15:20:41,2D84F1,Catena Group PLC,99,0.62,acquisitions-mergers,,Catena Group PLC: Acquisition of Insight,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Corporate Update
WST,2021-03-08,15:47:00,2D84F1,Catena Group PLC,100,0.53,labor-issues,,Catena Group Appoints New CFO,FULL-ARTICLE,Dow Jones Newswires,"Catena Group Appoints New CFO; Loans GBP400,000 to Insight"
WST,2021-03-22,07:00:21,2D84F1,Catena Group PLC,99,0.0,equity-actions,,Catena Group PLC: Proposed Name Change to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed Name Change to Insig AI Plc
WST,2021-03-22,08:46:01,2D84F1,Catena Group PLC,100,0.0,equity-actions,,Catena Group to Change Name to,FULL-ARTICLE,Dow Jones Newswires,Catena Group to Change Name to Insig AI After Reverse Takeover
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.65,earnings,negative,Catena Group PLC: we are reporting a total comprehensive loss of GBP0.5 million (31 December 2019: loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,0.0,equity-actions,,Catena raised GBP1.5 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,0.22,acquisitions-mergers,,"Catena Group PLC: In March 2020, Catena acquired a 9.1 per cent. interest in the issued share capital of Insight for GBP",PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.6,revenues,down,Catena Group PLC: SSL turnover fell by 48%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.51,assets,close,Catena Group PLC: The renewed school closures,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,0.0,equity-actions,,Catena Group PLC: the Company intends to change its name to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.63,earnings,negative,Catena Group PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.65,earnings,negative,Catena Group PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,95,-0.65,earnings,negative,Catena Group PLC: Loss per share (basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -2-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,0.0,earnings,,Catena Group PLC: our Interim Results for the six months ended 30 June 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,0.65,revenues,up,Catena Group PLC: While revenue recovered at the end of 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.51,assets,close,Catena Group PLC: The renewed school closures,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.65,earnings,negative,Catena Group PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.63,earnings,negative,Catena Group PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.62,earnings,negative,Catena Group PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,-0.65,earnings,negative,Catena Group PLC: Loss after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-03-31,06:00:10,2D84F1,Catena Group PLC,99,0.22,acquisitions-mergers,,"Catena Group PLC: In March 2020, the company acquired a 9.1% interest in the ordinary share capital of Insight for GBP",PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Interim Results -3-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,NEWS-FLASH,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight Capital Partners
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.57,acquisitions-mergers,completed,Catena Group PLC: The completion of the Acquisition,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight Capital Partners
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,-0.51,labor-issues,,Directors of Catena will be resigning,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight Capital Partners
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight -2-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.0,products-services,,Catena Group PLC: The development of these products,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight -2-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.47,labor-issues,,Catena Group PLC: John was appointed as a Non-Executive Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight -2-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.62,acquisitions-mergers,,Catena Group PLC: The Company has also entered into a conditional share purchase agreement with each of the Minority Insight Sellers dated 20,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight -3-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.53,labor-issues,,Catena Group PLC: Ashley joined Catena as Chief Financial Officer in March 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight -3-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,PRESS-RELEASE,LSE Regulatory News Service (RNS),Catena Group PLC Proposed acquisition of Insight -4-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,FULL-ARTICLE,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight Capital Partners
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,-0.51,labor-issues,,Directors of Catena will be resigning,FULL-ARTICLE,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight Capital Partners
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,FULL-ARTICLE,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight -2-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,FULL-ARTICLE,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight -3-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.53,labor-issues,,Ashley joined Catena as Chief Financial Officer in March 2021,FULL-ARTICLE,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight -3-
WST,2021-04-21,06:00:16,2D84F1,Catena Group PLC,100,0.55,acquisitions-mergers,interest,Catena Group PLC Proposed acquisition,FULL-ARTICLE,Dow Jones Newswires,Catena Group PLC Proposed acquisition of Insight -4-
WST,2021-04-21,07:00:02,2D84F1,Catena Group PLC,99,0.0,equity-actions,,Catena Group plc - to be renamed,PRESS-RELEASE,LSE Regulatory News Service (RNS),AIM Schedule One - Catena Group PLC
WST,2021-04-21,07:00:02,2D84F1,Catena Group PLC,99,0.22,acquisitions-mergers,,Catena acquired a 9.1 per cent. interest in the ordinary share capital of Insight Capital Partners,PRESS-RELEASE,LSE Regulatory News Service (RNS),AIM Schedule One - Catena Group PLC
WST,2021-05-07,09:35:49,2D84F1,Catena Group PLC,99,0.0,investor-relations,,Catena Group PLC: the Company's next annual general meeting.,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Catena Group PLC Result of GM, Admission of Shares & Change of name"
WST,2021-08-13,06:30:06,2D84F1,Insig AI PLC,99,0.47,labor-issues,,Delighted to become Chairman of Insig AI,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Directorate changes
WST,2021-08-13,07:35:51,2D84F1,Insig AI PLC,100,-0.51,labor-issues,,Insig AI PLC said Friday that Executive Chairman Matthew Farnum-Schneider has resigned,FULL-ARTICLE,Dow Jones Newswires,Insig AI Chairman Matthew Farnum-Schneider Resigns
WST,2021-08-17,06:00:33,2D84F1,Insig AI PLC,99,0.49,partnerships,,Insig to partner with CarVal,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc CarVal HY and IG product lines partnership
WST,2021-08-17,06:00:33,2D84F1,Insig AI PLC,99,0.0,products-services,,Insig AI's and CarVal's jointly developed ESG technology,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc CarVal HY and IG product lines partnership
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: Final results for the 15 month period,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.52,revenues,down,Insig AI PLC: SSL turnover fell 38% in the 15-month period,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.47,equity-actions,,Insig AI PLC: Board restructure,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.53,labor-issues,,Insig AI PLC: Capital was appointed as Chief Executive of the Company,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.0,revenues,,"Insig AI PLC: Since 31 March 2021, SSL revenues",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.61,products-services,increase,Insig AI PLC: We are now seeing growing demand,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.61,earnings,positive,Insig AI PLC: Gross profit 245,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,"Insig AI PLC: Loss before taxation (1,062",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss per share (basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,90,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,90,-0.62,earnings,negative,Insig AI PLC: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,-0.62,earnings,negative,"Insig AI PLC: Loss before tax (1,050",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,0.0,revenues,,Insig AI PLC: Revenue arises,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,0.46,equity-actions,,Insig AI PLC: Investments in subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -5-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,0.0,revenues,,Insig AI PLC: All revenue was,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,-0.63,earnings,negative,Insig AI PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,-0.65,earnings,negative,Insig AI PLC: Loss on,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,95,-0.65,earnings,negative,Insig AI PLC: Basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: The consolidated loss for the 15-month period,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -7-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.0,equity-actions,,Insig AI PLC: Cost at 1 January 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -7-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.0,equity-actions,,Insig AI PLC: Cost at 31 March 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -7-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: In March 2020, the company acquired a 9.1% interest in the ordinary share capital of Insight for GBP",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -7-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,98,0.39,products-services,,Insig AI PLC: The Company entered into a loan agreement with Insig,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -8-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.0,equity-actions,,"Insig AI PLC: the company raised GBP1,000,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -9-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.0,assets,,Insig AI PLC: All financial assets are due within one year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -11-"
WST,2021-09-06,06:00:16,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,Insig AI PLC: the Company acquired a 9.1 per cent. interest (on a fully diluted basis) of the ordinary shares,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -11-"
WST,2021-09-15,06:00:13,2D84F1,Insig AI PLC,99,0.0,products-services,,Insig AI PLC: The Company has developed 15 individual machine learning models to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Launch of Insig ESG
WST,2021-09-15,06:00:13,2D84F1,Insig AI PLC,99,-0.54,products-services,,Insig AI PLC: Enable drill down,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Launch of Insig ESG
WST,2021-09-30,10:09:56,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Result of AGM
WST,2021-11-10,07:00:16,2D84F1,Insig AI PLC,99,0.53,labor-issues,,Insig AI PLC: has joined the Company as Chief Commercial Officer,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Colm McVeigh appointed as Chief Commercial Officer
WST,2021-11-10,07:00:16,2D84F1,Insig AI PLC,99,0.52,products-services,,Insig delivers ESG scoring solution to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc ESG scoring solution delivered to CarVal Investors
WST,2021-11-18,07:00:32,2D84F1,Insig AI PLC,99,0.34,products-services,,Insig AI PLC: Acquisition of FDB Systems,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Acquisition of FDB Systems Limited
WST,2021-11-18,07:00:32,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: Based on this revenue forecast for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Acquisition of FDB Systems Limited
WST,2021-11-19,07:00:33,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 50,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2021-11-19,11:36:23,2D84F1,Insig AI PLC,99,0.52,insider-trading,,"Insig AI PLC: Insig AI plc (AIM: INSG) has been notified that, Warren Pearson, Chief Technical Officer of the Company, has purchased 19,951 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2021-12-10,07:00:22,2D84F1,Insig AI PLC,99,0.47,labor-issues,,Insig AI PLC: Colm McVeigh appointment to the Board,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Colm McVeigh appointment to the Board
WST,2021-12-13,07:00:21,2D84F1,Insig AI PLC,99,0.39,products-services,,"Insig AI PLC: Insig AI commented: ""The agreement with 4BIO is our first contract win outside the financial services",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Contract win
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.57,acquisitions-mergers,completed,Insig AI PLC: Secured contract with Carval Investors,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.65,revenues,up,Insig AI PLC: Group revenue of GBP0.9 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: Group operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.53,labor-issues,,Insig AI PLC: Appointment of Colm McVeigh as Chief,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,Insig AI PLC: we invested heavily in our,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.72,revenues,up,Insig AI PLC: Having scalable offerings enables us to accelerate sales growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.37,equity-actions,increase,Insig AI PLC: see increasing interest in our,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Loss before taxation (844,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss per share (basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,Insig AI PLC: Acquisition of Insig,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -3-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,Insig AI PLC: The investment in Insig,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: The loss in the six months,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2021-12-22,07:00:01,2D84F1,Insig AI PLC,99,0.0,equity-actions,,"Insig AI PLC: Non-recurring costs of GBP375,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2021-12-22,09:25:36,2D84F1,Insig AI PLC,100,-0.65,earnings,down,Insig AI 1H Pretax Loss Widened,FULL-ARTICLE,Dow Jones Newswires,"Insig AI 1H Pretax Loss Widened, Revenue Rose"
WST,2021-12-23,08:41:52,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 35,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2021-12-23,12:55:23,2D84F1,Insig AI PLC,99,0.52,insider-trading,,"Insig AI PLC: Insig AI plc (AIM: INSG) has been notified that, Colm McVeigh, Chief Commercial Officer of the Company, has purchased 29,550 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2021-12-30,07:00:01,2D84F1,Insig AI PLC,99,0.53,labor-issues,,Insig AI PLC: Directorate change,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Directorate change
WST,2024-04-02,06:00:19,2D84F1,Insig AI PLC,99,0.59,equity-actions,,Insig AI PLC: Equity funding facility proposal,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading update & equity funding facility proposal
WST,2024-04-17,06:00:13,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 100,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2024-05-30,06:00:20,2D84F1,Insig AI PLC,99,0.53,labor-issues,,"Insig AI PLC: Finally, Insig AI is pleased to announce the appointment of John Wilson as Independent Non-Executive Chairman",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Board changes
WST,2024-05-30,06:01:01,2D84F1,Insig AI PLC,99,0.49,partnerships,,"Insig AI PLC: At the same time, our partnership",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Strategic investment, revenue share and TVR"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: Final results for the year ended 31 March 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & Notice of AGM"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Reduced adjusted EBITDA loss of GBP0.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & Notice of AGM"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: we are reporting an operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & Notice of AGM"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: The equivalent loss for the previous year was GBP2.0 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & Notice of AGM"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: Revenues for the year were GBP0.4 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & Notice of AGM"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,"Insig AI PLC: the Company for the year ended 31 March 2024 was GBP17,185,547 (31 March 2023: loss",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -2-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,90,0.61,earnings,positive,"Insig AI PLC: Gross profit 369,860",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -3-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,90,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -3-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -4-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,93,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -5-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,93,0.0,earnings,,"Insig AI PLC: Therefore, operational results",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -5-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,93,0.0,assets,,Insig AI PLC: Technology assets - 7 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -5-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,90,0.0,earnings,,Insig AI PLC: The financial performance of,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -7-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,98,0.0,revenues,,"Insig AI PLC: For the year ended 31 March 2024, future sales forecasts",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -8-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,98,0.46,equity-actions,,Insig AI PLC: Investment in Subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -8-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,94,0.0,earnings,,Insig AI PLC: Other gains/(losses,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -9-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,94,0.0,earnings,,Insig AI PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -9-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,0.46,equity-actions,,Insig AI PLC: Investments in subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -11-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -12-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,94,0.44,labor-issues,,Insig AI PLC: Directors' remuneration,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -14-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,94,-0.49,labor-issues,,Insig AI PLC: Directors who retired,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -14-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,0.0,credit,,"Insig AI PLC: Loans totalling GBP678,402",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -15-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,-0.51,labor-issues,,"Insig AI PLC: On 30 May 2024, Colm McVeigh stepped down from the Board",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -15-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: On 30 May 2024, the Group acquired 5.45% equity interest in ImpactScope OU, an award-winning AI and blockchain",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -15-"
WST,2024-09-30,13:41:13,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Result of AGM
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Adjusted EBITDA loss of GBP0.4 million in H1-24,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: we have seen year on year revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,0.46,equity-actions,,Insig AI PLC: our investments in new technology,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,0.61,earnings,positive,"Insig AI PLC: Gross profit 165,780",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,91,-0.62,earnings,negative,Insig AI PLC: Loss before income tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,91,-0.65,earnings,negative,Insig AI PLC: Total comprehensive loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,91,0.0,earnings,,Insig AI PLC: Basic and diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,-0.65,dividends,suspended,Insig AI PLC: No dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: No diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2024-04-02,06:00:19,2D84F1,Insig AI PLC,99,0.59,equity-actions,,Insig AI PLC: Equity funding facility proposal,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading update & equity funding facility proposal
WST,2024-04-17,06:00:13,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 100,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2024-05-30,06:00:20,2D84F1,Insig AI PLC,99,0.53,labor-issues,,"Insig AI PLC: Finally, Insig AI is pleased to announce the appointment of John Wilson as Independent Non-Executive Chairman",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Board changes
WST,2024-05-30,06:01:01,2D84F1,Insig AI PLC,99,0.49,partnerships,,"Insig AI PLC: At the same time, our partnership",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Strategic investment, revenue share and TVR"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: Final results for the year ended 31 March 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & Notice of AGM"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Reduced adjusted EBITDA loss of GBP0.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & Notice of AGM"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: we are reporting an operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & Notice of AGM"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: The equivalent loss for the previous year was GBP2.0 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & Notice of AGM"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: Revenues for the year were GBP0.4 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & Notice of AGM"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,"Insig AI PLC: the Company for the year ended 31 March 2024 was GBP17,185,547 (31 March 2023: loss",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -2-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,90,0.61,earnings,positive,"Insig AI PLC: Gross profit 369,860",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -3-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,90,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -3-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -4-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,93,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -5-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,93,0.0,earnings,,"Insig AI PLC: Therefore, operational results",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -5-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,93,0.0,assets,,Insig AI PLC: Technology assets - 7 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -5-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,90,0.0,earnings,,Insig AI PLC: The financial performance of,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -7-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,98,0.0,revenues,,"Insig AI PLC: For the year ended 31 March 2024, future sales forecasts",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -8-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,98,0.46,equity-actions,,Insig AI PLC: Investment in Subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -8-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,94,0.0,earnings,,Insig AI PLC: Other gains/(losses,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -9-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,94,0.0,earnings,,Insig AI PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -9-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,0.46,equity-actions,,Insig AI PLC: Investments in subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -11-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -12-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,94,0.44,labor-issues,,Insig AI PLC: Directors' remuneration,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -14-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,94,-0.49,labor-issues,,Insig AI PLC: Directors who retired,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -14-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,0.0,credit,,"Insig AI PLC: Loans totalling GBP678,402",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -15-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,-0.51,labor-issues,,"Insig AI PLC: On 30 May 2024, Colm McVeigh stepped down from the Board",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -15-"
WST,2024-09-05,06:13:05,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: On 30 May 2024, the Group acquired 5.45% equity interest in ImpactScope OU, an award-winning AI and blockchain",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Accounts & -15-"
WST,2024-09-30,13:41:13,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Result of AGM
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Adjusted EBITDA loss of GBP0.4 million in H1-24,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: we have seen year on year revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,0.46,equity-actions,,Insig AI PLC: our investments in new technology,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,0.61,earnings,positive,"Insig AI PLC: Gross profit 165,780",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,91,-0.62,earnings,negative,Insig AI PLC: Loss before income tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,91,-0.65,earnings,negative,Insig AI PLC: Total comprehensive loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,91,0.0,earnings,,Insig AI PLC: Basic and diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,-0.65,dividends,suspended,Insig AI PLC: No dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: No diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2024-12-19,07:00:13,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2023-01-16,07:00:15,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 200,000 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-04-24,06:00:20,2D84F1,Insig AI PLC,99,0.72,revenues,up,Insig AI PLC: We are forecasting further sales growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading and operations update
WST,2023-04-24,06:00:20,2D84F1,Insig AI PLC,99,0.49,partnerships,,Insig AI PLC: CarVal partnership,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading and operations update
WST,2023-04-24,06:00:20,2D84F1,Insig AI PLC,99,0.39,products-services,,"Insig AI PLC: the Company announced a landmark agreement with CarVal Investors, L.P.",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading and operations update
WST,2023-04-24,06:00:20,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: The Company will be hosting an investor meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading and operations update
WST,2023-04-24,06:49:42,2D84F1,Insig AI PLC,100,0.65,revenues,up,Insig AI to Report Revenue Rise for FY 2023,FULL-ARTICLE,Dow Jones Newswires,"Insig AI to Report Revenue Rise for FY 2023; To Raise GBP900,000 via Subscription"
WST,2023-04-25,06:00:21,2D84F1,Insig AI PLC,100,-0.5,labor-issues,,Insig AI Plc Death of Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Death of Director
WST,2023-04-28,06:00:23,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 100,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding and Total Voting Rights
WST,2023-05-11,06:00:13,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 205,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-05-19,06:00:24,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 153,497 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: Final results for the year ended 31 March 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.42,revenues,up,Insig AI PLC: Revenue increase of 22% year on year to GBP2.1 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.47,labor-issues,,Insig AI PLC: Since Colm McVeigh was appointed to the board,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.42,revenues,up,Insig AI PLC: we are reporting a 22 per cent increase in consolidated revenue to GBP2.1 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: Combined operating loss was GBP4.8 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,"Insig AI PLC: the Company for the year ended 31 March 2023 was GBP21,180,437 (31 March 2022: loss",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.61,earnings,positive,"Insig AI PLC: Gross profit 1,359,195",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Loss before income tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Basic and Diluted Loss Per Share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,90,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,90,-0.65,earnings,negative,Insig AI PLC: Profit/(Loss) for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,94,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -5-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,94,0.0,assets,,Insig AI PLC: Technology assets - 7 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,94,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,93,0.46,equity-actions,,Insig AI PLC: Investment in Subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -9-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,93,0.0,earnings,,Insig AI PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -9-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.46,equity-actions,,Insig AI PLC: Investments in subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -11-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -12-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,97,0.44,labor-issues,,Insig AI PLC: Directors' remuneration,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -14-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.49,labor-issues,,Insig AI PLC: Directors who retired,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.0,credit,,"Insig AI PLC: Loans totalling GBP1,322,635",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2023-08-14,07:17:24,2D84F1,Insig AI PLC,92,-0.65,earnings,down,Insig AI reported a widened pretax loss for fiscal 2023,FULL-ARTICLE,Dow Jones Newswires,Insig AI Pretax Loss Widened on Higher Costs
WST,2023-08-15,06:00:20,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 150,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-08-21,06:00:17,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 116,944 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-08-24,06:00:20,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 50,050 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-08-30,06:00:16,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 100,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-09-15,06:00:18,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: At today's Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc AGM Statement
WST,2023-09-15,14:56:46,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Result of AGM
WST,2023-10-30,07:00:27,2D84F1,Insig AI PLC,100,0.52,products-services,,Insig AI Plc New Product Launch,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc New Product Launch
WST,2023-12-20,07:00:14,2D84F1,Insig AI PLC,99,-0.68,revenues,down,"Insig AI PLC: our first half revenues, with machine learning and data services revenue declining",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results
WST,2023-12-20,07:00:14,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: we are reporting a total comprehensive loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,99,0.0,earnings,,"Insig AI PLC: Gross profit 497,562",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -2-
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Loss before income tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -2-
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,91,-0.65,earnings,negative,Insig AI PLC: Total comprehensive loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -3-
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,99,0.0,dividends,,Insig AI PLC: No dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -4-
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: No diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -4-
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -5-
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,99,-0.44,assets,sale,Insig AI PLC: The subsidiaries were sold,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -5-
WST,2023-12-21,07:00:33,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 200,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-12-22,07:00:11,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 230,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-01-16,07:00:15,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 200,000 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-04-24,06:00:20,2D84F1,Insig AI PLC,99,0.72,revenues,up,Insig AI PLC: We are forecasting further sales growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading and operations update
WST,2023-04-24,06:00:20,2D84F1,Insig AI PLC,99,0.49,partnerships,,Insig AI PLC: CarVal partnership,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading and operations update
WST,2023-04-24,06:00:20,2D84F1,Insig AI PLC,99,0.39,products-services,,"Insig AI PLC: the Company announced a landmark agreement with CarVal Investors, L.P.",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading and operations update
WST,2023-04-24,06:00:20,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: The Company will be hosting an investor meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading and operations update
WST,2023-04-24,06:49:42,2D84F1,Insig AI PLC,100,0.65,revenues,up,Insig AI to Report Revenue Rise for FY 2023,FULL-ARTICLE,Dow Jones Newswires,"Insig AI to Report Revenue Rise for FY 2023; To Raise GBP900,000 via Subscription"
WST,2023-04-25,06:00:21,2D84F1,Insig AI PLC,100,-0.5,labor-issues,,Insig AI Plc Death of Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Death of Director
WST,2023-04-28,06:00:23,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 100,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding and Total Voting Rights
WST,2023-05-11,06:00:13,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 205,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-05-19,06:00:24,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 153,497 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: Final results for the year ended 31 March 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.42,revenues,up,Insig AI PLC: Revenue increase of 22% year on year to GBP2.1 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.47,labor-issues,,Insig AI PLC: Since Colm McVeigh was appointed to the board,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of AGM"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.42,revenues,up,Insig AI PLC: we are reporting a 22 per cent increase in consolidated revenue to GBP2.1 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: Combined operating loss was GBP4.8 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,"Insig AI PLC: the Company for the year ended 31 March 2023 was GBP21,180,437 (31 March 2022: loss",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.61,earnings,positive,"Insig AI PLC: Gross profit 1,359,195",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Loss before income tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Basic and Diluted Loss Per Share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,90,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,90,-0.65,earnings,negative,Insig AI PLC: Profit/(Loss) for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,94,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -5-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,94,0.0,assets,,Insig AI PLC: Technology assets - 7 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,94,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,93,0.46,equity-actions,,Insig AI PLC: Investment in Subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -9-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,93,0.0,earnings,,Insig AI PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -9-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.46,equity-actions,,Insig AI PLC: Investments in subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -11-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -12-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,97,0.44,labor-issues,,Insig AI PLC: Directors' remuneration,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -14-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.49,labor-issues,,Insig AI PLC: Directors who retired,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2023-08-14,06:00:20,2D84F1,Insig AI PLC,99,0.0,credit,,"Insig AI PLC: Loans totalling GBP1,322,635",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2023-08-14,07:17:24,2D84F1,Insig AI PLC,92,-0.65,earnings,down,Insig AI reported a widened pretax loss for fiscal 2023,FULL-ARTICLE,Dow Jones Newswires,Insig AI Pretax Loss Widened on Higher Costs
WST,2023-08-15,06:00:20,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 150,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-08-21,06:00:17,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 116,944 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-08-24,06:00:20,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 50,050 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-08-30,06:00:16,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 100,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-09-15,06:00:18,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: At today's Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc AGM Statement
WST,2023-09-15,14:56:46,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Result of AGM
WST,2023-10-30,07:00:27,2D84F1,Insig AI PLC,100,0.52,products-services,,Insig AI Plc New Product Launch,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc New Product Launch
WST,2023-12-20,07:00:14,2D84F1,Insig AI PLC,99,-0.68,revenues,down,"Insig AI PLC: our first half revenues, with machine learning and data services revenue declining",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results
WST,2023-12-20,07:00:14,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: we are reporting a total comprehensive loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,99,0.0,earnings,,"Insig AI PLC: Gross profit 497,562",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -2-
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Loss before income tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -2-
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,91,-0.65,earnings,negative,Insig AI PLC: Total comprehensive loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -3-
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,99,0.0,dividends,,Insig AI PLC: No dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -4-
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: No diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -4-
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -5-
WST,2023-12-20,07:00:15,2D84F1,Insig AI PLC,99,-0.44,assets,sale,Insig AI PLC: The subsidiaries were sold,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim results -5-
WST,2023-12-21,07:00:33,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 200,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2023-12-22,07:00:11,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 230,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-01-06,13:40:59,2D84F1,Insig AI PLC,99,0.52,insider-trading,,"Insig AI PLC: Insig AI plc (AIM: INSG) has been notified that, Steve Cracknell, Chief Executive Officer of the Company, has purchased 21,505 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-01-14,07:00:25,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 40,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-02-25,07:00:58,2D84F1,Insig AI PLC,100,0.39,products-services,,"Insig AI Plc Further agreement with CarVal Investors, L.P.",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Further agreement with CarVal Investors, L.P."
WST,2022-03-21,07:00:32,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI's revised business plan forecasts revenues of GBP2.4 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading and operations update
WST,2022-03-21,07:32:59,2D84F1,Insig AI PLC,100,0.65,revenues,up,Insig AI's Revenue Seen to Increase for FY2021,FULL-ARTICLE,Dow Jones Newswires,Insig AI's Revenue Seen to Increase for FY2021 and Keep Rising on Launch of ESG Fund
WST,2022-03-21,07:32:59,2D84F1,Insig AI PLC,100,0.0,revenues,,Insig AI's revised business plan forecasts revenues of GBP2.4 million,FULL-ARTICLE,Dow Jones Newswires,Insig AI's Revenue Seen to Increase for FY2021 and Keep Rising on Launch of ESG Fund
WST,2022-03-22,07:01:06,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 265,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-03-24,07:01:21,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 67,500 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-04-11,06:01:32,2D84F1,Insig AI PLC,99,0.47,labor-issues,,Insig AI appoints Richard Cooper as a non-executive director,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Directorate Change
WST,2022-04-25,06:00:56,2D84F1,Insig AI PLC,99,0.53,labor-issues,,Insig AI PLC: Directorate change,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Contract win, trading update and Board changes"
WST,2022-04-25,07:21:04,2D84F1,Insig AI PLC,100,0.53,labor-issues,,Insig AI Appoints New CEO,FULL-ARTICLE,Dow Jones Newswires,Insig AI Appoints New CEO; Confirms FY 2022 Revenue of GBP1.8 Mln
WST,2022-04-26,06:02:15,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 275,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-04-26,14:06:39,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 275,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-04-28,06:02:49,2D84F1,Insig AI PLC,100,0.39,products-services,,Insig AI Plc Update on agreement with CarVal Investors,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Update on agreement with CarVal Investors, L.P"
WST,2022-05-31,06:01:43,2D84F1,Insig AI PLC,99,0.39,products-services,,"Chief Executive of Insig AI commented: ""This agreement",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Data partnership and research agreement
WST,2022-05-31,06:01:43,2D84F1,Insig AI PLC,99,0.49,partnerships,,Be partnering with Insig AI to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Data partnership and research agreement
WST,2022-06-17,09:30:50,2D84F1,Insig AI PLC,100,0.38,credit,,Insig AI Plc Convertible loan agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Convertible loan agreement and drawdown
WST,2022-07-01,06:00:37,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 100,000 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-07-06,06:00:28,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 45,000 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-07-29,06:00:44,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 115,000 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-08-02,06:00:47,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 40,000 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-09-08,06:01:58,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: Notice of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Notice of AGM
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: Final results for the year ended 31 March 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of GM"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of GM"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.72,revenues,up,Insig AI PLC: Forecasting significant jump in second half revenues,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of GM"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.39,products-services,,"Insig AI PLC: we announced a landmark agreement with CarVal Investors, L.P.",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of GM"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,-0.57,labor-issues,,"Insig AI PLC: In June 2022, DWS's Chief Executive resigned",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of GM"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: we are reporting a total comprehensive loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.47,equity-actions,,Insig AI PLC: Board restructure,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.47,labor-issues,,Insig AI PLC: was appointed to the Company's board of directors,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,-0.57,labor-issues,,"Insig AI PLC: In August 2021, Matthew Farnum-Schneider resigned as Executive Chairman",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.34,products-services,,Insig AI PLC: Acquisition of FDB Systems,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.65,revenues,up,Insig AI PLC: the Company's sales growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,0.61,earnings,positive,"Insig AI PLC: Gross profit 989,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.62,earnings,negative,"Insig AI PLC: Loss before income tax (3,243,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,Insig AI PLC: Basic and Diluted Loss Per Share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,90,0.0,earnings,,Insig AI PLC: Total comprehensive loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,90,-0.65,earnings,negative,Insig AI PLC: Other comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,94,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -5-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,94,0.0,revenues,,Insig AI PLC: Revenue is,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -5-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,93,0.0,assets,,Insig AI PLC: Technology assets - 7 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,93,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,0.0,revenues,,Insig AI PLC: All revenue was,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -9-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,Insig AI PLC: Loss on,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -9-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,0.0,earnings,,Insig AI PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -9-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.0,equity-actions,,Insig AI PLC: Charge for the year 17,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -10-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.46,equity-actions,,Insig AI PLC: Investments in subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -10-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: Proceeds of,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -12-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,0.44,labor-issues,,Insig AI PLC: Directors' remuneration,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -14-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.57,labor-issues,,Insig AI PLC: Directors who resigned,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -14-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.62,earnings,negative,"Insig AI PLC: Loss before tax (3,243,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -14-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,Insig AI PLC: Loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -14-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.0,credit,,"Insig AI PLC: Loans totalling GBP3,113,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,Insig AI PLC: the Company acquired a 9.1 per cent interest (on a fully diluted basis) of the ordinary shares,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,"Insig AI PLC: The full year loss was GBP2,046,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,"Insig AI PLC: The full year loss was GBP363,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -16-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.47,labor-issues,,Insig AI PLC: the Company appointed Richard Cooper to the Board,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -16-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -16-"
WST,2022-09-09,06:54:02,2D84F1,Insig AI PLC,100,-0.65,earnings,down,Insig AI FY 2022 Pretax Loss Widened,FULL-ARTICLE,Dow Jones Newswires,"Insig AI FY 2022 Pretax Loss Widened, Sees Further Revenue Increase"
WST,2022-09-30,08:14:31,2D84F1,Insig AI PLC,100,0.51,products-services,,"Insig AI Gets GBP200,000 Contract",FULL-ARTICLE,Dow Jones Newswires,"Insig AI Gets GBP200,000 Contract"
WST,2022-09-30,11:13:16,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Result of Annual General Meeting & General Meeting
WST,2022-11-07,08:03:10,2D84F1,Insig AI PLC,100,0.51,products-services,,"Insig AI Gets GBP120,000 Contract",FULL-ARTICLE,Dow Jones Newswires,"Insig AI Gets GBP120,000 Contract"
WST,2022-11-08,07:00:15,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 132,500 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,0.72,revenues,up,Insig AI PLC: we anticipate growing revenues throughout 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: we published our full year results to 31 March,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,0.39,products-services,,"Insig AI PLC: we announced a landmark agreement with CarVal Investors, L.P.",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: we are reporting a total comprehensive loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,0.0,earnings,,"Insig AI PLC: Gross profit 594,152",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Loss before income tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,0.0,dividends,,Insig AI PLC: No dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: No diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2022-12-19,07:56:57,2D84F1,Insig AI PLC,100,-0.65,earnings,down,Insig AI 1H Pretax Loss Widened on,FULL-ARTICLE,Dow Jones Newswires,Insig AI 1H Pretax Loss Widened on Higher Costs
WST,2022-12-21,07:00:09,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: the Company's interim results to 30 September 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Directors gift shares to Company treasury & TVR
WST,2022-12-23,07:00:11,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 380,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director Dealing
WST,2022-12-28,07:00:43,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 70,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-01-06,13:40:59,2D84F1,Insig AI PLC,99,0.52,insider-trading,,"Insig AI PLC: Insig AI plc (AIM: INSG) has been notified that, Steve Cracknell, Chief Executive Officer of the Company, has purchased 21,505 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-01-14,07:00:25,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 40,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-02-25,07:00:58,2D84F1,Insig AI PLC,100,0.39,products-services,,"Insig AI Plc Further agreement with CarVal Investors, L.P.",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Further agreement with CarVal Investors, L.P."
WST,2022-03-21,07:00:32,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI's revised business plan forecasts revenues of GBP2.4 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading and operations update
WST,2022-03-21,07:32:59,2D84F1,Insig AI PLC,100,0.65,revenues,up,Insig AI's Revenue Seen to Increase for FY2021,FULL-ARTICLE,Dow Jones Newswires,Insig AI's Revenue Seen to Increase for FY2021 and Keep Rising on Launch of ESG Fund
WST,2022-03-21,07:32:59,2D84F1,Insig AI PLC,100,0.0,revenues,,Insig AI's revised business plan forecasts revenues of GBP2.4 million,FULL-ARTICLE,Dow Jones Newswires,Insig AI's Revenue Seen to Increase for FY2021 and Keep Rising on Launch of ESG Fund
WST,2022-03-22,07:01:06,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 265,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-03-24,07:01:21,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 67,500 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-04-11,06:01:32,2D84F1,Insig AI PLC,99,0.47,labor-issues,,Insig AI appoints Richard Cooper as a non-executive director,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Directorate Change
WST,2022-04-25,06:00:56,2D84F1,Insig AI PLC,99,0.53,labor-issues,,Insig AI PLC: Directorate change,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Contract win, trading update and Board changes"
WST,2022-04-25,07:21:04,2D84F1,Insig AI PLC,100,0.53,labor-issues,,Insig AI Appoints New CEO,FULL-ARTICLE,Dow Jones Newswires,Insig AI Appoints New CEO; Confirms FY 2022 Revenue of GBP1.8 Mln
WST,2022-04-26,06:02:15,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 275,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-04-26,14:06:39,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 275,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-04-28,06:02:49,2D84F1,Insig AI PLC,100,0.39,products-services,,Insig AI Plc Update on agreement with CarVal Investors,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Update on agreement with CarVal Investors, L.P"
WST,2022-05-31,06:01:43,2D84F1,Insig AI PLC,99,0.39,products-services,,"Chief Executive of Insig AI commented: ""This agreement",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Data partnership and research agreement
WST,2022-05-31,06:01:43,2D84F1,Insig AI PLC,99,0.49,partnerships,,Be partnering with Insig AI to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Data partnership and research agreement
WST,2022-06-17,09:30:50,2D84F1,Insig AI PLC,100,0.38,credit,,Insig AI Plc Convertible loan agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Convertible loan agreement and drawdown
WST,2022-07-01,06:00:37,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 100,000 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-07-06,06:00:28,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 45,000 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-07-29,06:00:44,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 115,000 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-08-02,06:00:47,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 40,000 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-09-08,06:01:58,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: Notice of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Notice of AGM
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: Final results for the year ended 31 March 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of GM"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of GM"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.72,revenues,up,Insig AI PLC: Forecasting significant jump in second half revenues,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of GM"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.39,products-services,,"Insig AI PLC: we announced a landmark agreement with CarVal Investors, L.P.",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of GM"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,-0.57,labor-issues,,"Insig AI PLC: In June 2022, DWS's Chief Executive resigned",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and Notice of GM"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: we are reporting a total comprehensive loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.47,equity-actions,,Insig AI PLC: Board restructure,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.47,labor-issues,,Insig AI PLC: was appointed to the Company's board of directors,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,-0.57,labor-issues,,"Insig AI PLC: In August 2021, Matthew Farnum-Schneider resigned as Executive Chairman",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.34,products-services,,Insig AI PLC: Acquisition of FDB Systems,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.65,revenues,up,Insig AI PLC: the Company's sales growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -2-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,0.61,earnings,positive,"Insig AI PLC: Gross profit 989,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.62,earnings,negative,"Insig AI PLC: Loss before income tax (3,243,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,Insig AI PLC: Basic and Diluted Loss Per Share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,Insig AI PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -3-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,90,0.0,earnings,,Insig AI PLC: Total comprehensive loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,90,-0.65,earnings,negative,Insig AI PLC: Other comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -4-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,94,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -5-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,94,0.0,revenues,,Insig AI PLC: Revenue is,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -5-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,93,0.0,assets,,Insig AI PLC: Technology assets - 7 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,93,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -6-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,0.0,revenues,,Insig AI PLC: All revenue was,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -9-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,Insig AI PLC: Loss on,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -9-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,0.0,earnings,,Insig AI PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -9-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.0,equity-actions,,Insig AI PLC: Charge for the year 17,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -10-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.46,equity-actions,,Insig AI PLC: Investments in subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -10-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: Proceeds of,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -12-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,0.44,labor-issues,,Insig AI PLC: Directors' remuneration,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -14-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.57,labor-issues,,Insig AI PLC: Directors who resigned,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -14-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.62,earnings,negative,"Insig AI PLC: Loss before tax (3,243,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -14-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,Insig AI PLC: Loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -14-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.0,credit,,"Insig AI PLC: Loans totalling GBP3,113,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,Insig AI PLC: the Company acquired a 9.1 per cent interest (on a fully diluted basis) of the ordinary shares,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,"Insig AI PLC: The full year loss was GBP2,046,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -15-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,"Insig AI PLC: The full year loss was GBP363,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -16-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.47,labor-issues,,Insig AI PLC: the Company appointed Richard Cooper to the Board,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -16-"
WST,2022-09-09,06:01:45,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of Report and -16-"
WST,2022-09-09,06:54:02,2D84F1,Insig AI PLC,100,-0.65,earnings,down,Insig AI FY 2022 Pretax Loss Widened,FULL-ARTICLE,Dow Jones Newswires,"Insig AI FY 2022 Pretax Loss Widened, Sees Further Revenue Increase"
WST,2022-09-30,08:14:31,2D84F1,Insig AI PLC,100,0.51,products-services,,"Insig AI Gets GBP200,000 Contract",FULL-ARTICLE,Dow Jones Newswires,"Insig AI Gets GBP200,000 Contract"
WST,2022-09-30,11:13:16,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Result of Annual General Meeting & General Meeting
WST,2022-11-07,08:03:10,2D84F1,Insig AI PLC,100,0.51,products-services,,"Insig AI Gets GBP120,000 Contract",FULL-ARTICLE,Dow Jones Newswires,"Insig AI Gets GBP120,000 Contract"
WST,2022-11-08,07:00:15,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 132,500 ordinary shares of 1 pence",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,0.72,revenues,up,Insig AI PLC: we anticipate growing revenues throughout 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: we published our full year results to 31 March,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,0.39,products-services,,"Insig AI PLC: we announced a landmark agreement with CarVal Investors, L.P.",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: we are reporting a total comprehensive loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,0.0,earnings,,"Insig AI PLC: Gross profit 594,152",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,-0.62,earnings,negative,Insig AI PLC: Loss before income tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -2-
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,0.0,dividends,,Insig AI PLC: No dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,-0.65,earnings,negative,Insig AI PLC: No diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2022-12-19,07:00:14,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Interim Results -4-
WST,2022-12-19,07:56:57,2D84F1,Insig AI PLC,100,-0.65,earnings,down,Insig AI 1H Pretax Loss Widened on,FULL-ARTICLE,Dow Jones Newswires,Insig AI 1H Pretax Loss Widened on Higher Costs
WST,2022-12-21,07:00:09,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: the Company's interim results to 30 September 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Directors gift shares to Company treasury & TVR
WST,2022-12-23,07:00:11,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 380,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director Dealing
WST,2022-12-28,07:00:43,2D84F1,Insig AI PLC,99,0.22,acquisitions-mergers,,"Insig AI PLC: the Company, has purchased 70,000 ordinary shares of 1 pence each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Director/PDMR Shareholding
WST,2024-05-24,16:24:47,651C38,Vienna Insurance Group AG,95,0.53,labor-issues,,Supervisory Board of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG) elected Rudolf Ertl as the new Chairman,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Eqs-Adhoc: Vienna Insurance Group Ag Wiener Versicherung Gruppe Reorganises The Chairmanship Of The Supervisory Board
WST,2024-05-24,16:24:47,651C38,Vienna Insurance Group AG,95,0.53,labor-issues,,Supervisory Board of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG) elected Rudolf Ertl as the new Chairman,PRESS-RELEASE,Dow Jones Newswires,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe reorganises the chairmanship of the Supervisory Board
WST,2024-05-24,16:24:47,651C38,Vienna Insurance Group AG,95,0.53,labor-issues,,Supervisory Board of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG) elected Rudolf Ertl as the new Chairman,PRESS-RELEASE,DGAP News,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe reorganises the chairmanship of the Supervisory Board
WST,2024-06-28,07:40:33,651C38,Vienna Insurance Group AG,99,-0.32,equity-actions,,Capital increase of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG),PRESS-RELEASE,DGAP News,"EQS-PVR: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Release according to Article 135, Section 2 BrseG with the objective of Europe-wide distribution"
WST,2024-06-28,07:40:33,651C38,Vienna Insurance Group AG,99,-0.32,equity-actions,,Capital increase of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG),PRESS-RELEASE,Dow Jones Newswires,"EQS-PVR: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Release according to Article 135, Section 2 BrseG with the objective of Europe-wide distribution"
WST,2024-06-28,07:41:24,651C38,Vienna Insurance Group AG,99,-0.32,equity-actions,,Capital increase of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG),PRESS-RELEASE,DGAP News,"EQS-PVR: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Release according to Article 135, Section 2 BrseG with the objective of Europe-wide distribution"
WST,2024-06-28,07:41:24,651C38,Vienna Insurance Group AG,99,-0.32,equity-actions,,Capital increase of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG),PRESS-RELEASE,Dow Jones Newswires,"EQS-PVR: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Release according to Article 135, Section 2 BrseG with the objective of Europe-wide distribution"
WST,2024-07-15,11:07:00,651C38,Vienna Insurance Group AG,100,0.27,credit-ratings,stable,S&PGR Afms Vienna Insurance Group Core Subs At 'A+'; Otlk Stbl,NEWS-FLASH,Dow Jones Newswires,S&PGR Afms Vienna Insurance Group Core Subs At 'A+'; Otlk Stbl
WST,2024-07-15,11:07:00,651C38,Vienna Insurance Group AG,100,0.27,credit-ratings,stable,S&PGR Afms Vienna Insurance Group Core Subs At 'A+'; Otlk Stbl,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Afms Vienna Insurance Group Core Subs At 'A+'; Otlk Stbl
WST,2024-07-15,11:07:10,651C38,Vienna Insurance Group AG,100,0.0,credit-ratings,affirmation,S&PGR Afms Vienna Insurance Group,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Afms Vienna Insurance Group -2-
WST,2024-05-24,16:24:47,651C38,Vienna Insurance Group AG,95,0.53,labor-issues,,Supervisory Board of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG) elected Rudolf Ertl as the new Chairman,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Eqs-Adhoc: Vienna Insurance Group Ag Wiener Versicherung Gruppe Reorganises The Chairmanship Of The Supervisory Board
WST,2024-05-24,16:24:47,651C38,Vienna Insurance Group AG,95,0.53,labor-issues,,Supervisory Board of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG) elected Rudolf Ertl as the new Chairman,PRESS-RELEASE,Dow Jones Newswires,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe reorganises the chairmanship of the Supervisory Board
WST,2024-05-24,16:24:47,651C38,Vienna Insurance Group AG,95,0.53,labor-issues,,Supervisory Board of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG) elected Rudolf Ertl as the new Chairman,PRESS-RELEASE,DGAP News,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe reorganises the chairmanship of the Supervisory Board
WST,2024-06-28,07:40:33,651C38,Vienna Insurance Group AG,99,-0.32,equity-actions,,Capital increase of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG),PRESS-RELEASE,DGAP News,"EQS-PVR: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Release according to Article 135, Section 2 BrseG with the objective of Europe-wide distribution"
WST,2024-06-28,07:40:33,651C38,Vienna Insurance Group AG,99,-0.32,equity-actions,,Capital increase of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG),PRESS-RELEASE,Dow Jones Newswires,"EQS-PVR: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Release according to Article 135, Section 2 BrseG with the objective of Europe-wide distribution"
WST,2024-06-28,07:41:24,651C38,Vienna Insurance Group AG,99,-0.32,equity-actions,,Capital increase of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG),PRESS-RELEASE,DGAP News,"EQS-PVR: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Release according to Article 135, Section 2 BrseG with the objective of Europe-wide distribution"
WST,2024-06-28,07:41:24,651C38,Vienna Insurance Group AG,99,-0.32,equity-actions,,Capital increase of VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG),PRESS-RELEASE,Dow Jones Newswires,"EQS-PVR: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Release according to Article 135, Section 2 BrseG with the objective of Europe-wide distribution"
WST,2024-07-15,11:07:00,651C38,Vienna Insurance Group AG,100,0.27,credit-ratings,stable,S&PGR Afms Vienna Insurance Group Core Subs At 'A+'; Otlk Stbl,NEWS-FLASH,Dow Jones Newswires,S&PGR Afms Vienna Insurance Group Core Subs At 'A+'; Otlk Stbl
WST,2024-07-15,11:07:00,651C38,Vienna Insurance Group AG,100,0.27,credit-ratings,stable,S&PGR Afms Vienna Insurance Group Core Subs At 'A+'; Otlk Stbl,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Afms Vienna Insurance Group Core Subs At 'A+'; Otlk Stbl
WST,2024-07-15,11:07:10,651C38,Vienna Insurance Group AG,100,0.0,credit-ratings,affirmation,S&PGR Afms Vienna Insurance Group,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Afms Vienna Insurance Group -2-
WST,2021-03-18,17:47:45,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.0,credit-ratings,set,S&PGR Rates Austrian Insurer VIG,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Austrian Insurer VIG's Sr Unsec Debt 'A'
WST,2021-04-07,01:00:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.55,acquisitions-mergers,,Aegon's sale of its Central and Eastern European business to VIG,PRESS-RELEASE,Business Wire,An update of Aegon's sale of its Central and Eastern European business to VIG
WST,2021-04-07,01:00:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.55,acquisitions-mergers,,Aegon's sale of its Central and Eastern European business to VIG,PRESS-RELEASE,Dow Jones Newswires,Press Release: An update of Aegon's sale of its Central and Eastern European business to VIG
WST,2021-04-07,01:10:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.55,acquisitions-mergers,,Aegon's sale of its Central and Eastern European business to VIG,PRESS-RELEASE,Business Wire,An update of Aegon's sale of its Central and Eastern European business to VIG
WST,2021-04-07,01:10:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.55,acquisitions-mergers,,Aegon's sale of its Central and Eastern European business to VIG,PRESS-RELEASE,Dow Jones Newswires,Press Release: An update of Aegon's sale of its Central and Eastern European business to VIG
WST,2021-04-20,09:35:06,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,99,0.0,investor-relations,,Vienna Insurance Group AG Wiener Versicherung Gruppe: CONVOCATION to the 30th Annual General Meeting,PRESS-RELEASE,Dow Jones Newswires,EANS-General Meeting: Vienna Insurance Group AG Wiener Versicherung Gruppe / Invitation to the General Meeting according to art. 107 para. 3 Companies Act - ATTACHMENT
WST,2021-04-20,09:35:06,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,99,0.0,investor-relations,,Vienna Insurance Group AG Wiener Versicherung Gruppe: CONVOCATION to the 30th Annual General Meeting,PRESS-RELEASE,News Aktuell,EANS-General Meeting: Vienna Insurance Group AG Wiener Versicherung Gruppe / Invitation to the General Meeting according to art. 107 para. 3 Companies Act - ATTACHMENT
WST,2021-08-13,08:48:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.6,acquisitions-mergers,approval,European Commission gives green light to Vienna Insurance Group for acquisition of Aegon,PRESS-RELEASE,Business Wire,European Commission gives green light to Vienna Insurance Group for acquisition of Aegon's CEE business
WST,2021-08-13,08:48:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.6,acquisitions-mergers,approval,European Commission gives green light to Vienna Insurance Group for acquisition of Aegon,PRESS-RELEASE,Business Wire,European Commission gives green light to Vienna Insurance Group for acquisition of Aegon's CEE business
WST,2021-08-13,08:48:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.6,acquisitions-mergers,approval,European Commission gives green light to Vienna Insurance Group for acquisition of Aegon,PRESS-RELEASE,Dow Jones Newswires,Press Release: European Commission gives green light to Vienna Insurance Group for acquisition of Aegon's CEE business
WST,2021-08-13,08:48:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.6,acquisitions-mergers,approval,European Commission gives green light to Vienna Insurance Group for acquisition of Aegon,PRESS-RELEASE,Dow Jones Newswires,Press Release: European Commission gives green light to Vienna Insurance Group for acquisition of Aegon's CEE business
WST,2021-09-21,06:10:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.55,acquisitions-mergers,,Aegon's sale of its Central and Eastern European business to VIG,PRESS-RELEASE,Business Wire,An update on Aegon's sale of its Central and Eastern European business to VIG
WST,2021-09-21,06:10:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.55,acquisitions-mergers,,Aegon's sale of its Central and Eastern European business to VIG,PRESS-RELEASE,Business Wire,An update on Aegon's sale of its Central and Eastern European business to VIG
WST,2021-12-22,18:04:07,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,94,0.39,products-services,,Vienna INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG) and the Hungarian government have reached an agreement on,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Vienna Insurance Group and Hungary reach an agreement on the outlines of a cooperation and the further procedure regarding the Hungarian insurance companies AEGON and UNION
WST,2021-12-22,18:04:07,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,94,0.39,products-services,,Vienna INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG) and the Hungarian government have reached an agreement on,PRESS-RELEASE,News Aktuell,PRESS RELEASE: Vienna Insurance Group and Hungary reach an agreement on the outlines of a cooperation and the further procedure regarding the Hungarian insurance companies AEGON and UNION
WST,2021-12-22,21:15:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,96,0.39,products-services,,Vienna Insurance Group and Hungary reach an agreement on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aegon takes note of VIG's announcement regarding Aegon's business in Central and Eastern Europe
WST,2021-12-22,21:15:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,96,0.39,products-services,,Vienna Insurance Group and Hungary reach an agreement on,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Aegon takes note of VIG's announcement regarding Aegon's business in Central and Eastern Europe
WST,2021-12-22,21:15:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,96,0.39,products-services,,Vienna Insurance Group and Hungary reach an agreement on,PRESS-RELEASE,GlobeNewswire,Aegon takes note of VIG's announcement regarding Aegon's business in Central and Eastern Europe
WST,2021-12-22,21:15:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,96,0.39,products-services,,Vienna Insurance Group and Hungary reach an agreement on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aegon takes note of VIG's announcement regarding Aegon's business in Central and Eastern Europe
WST,2021-03-18,17:47:45,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.0,credit-ratings,set,S&PGR Rates Austrian Insurer VIG,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Austrian Insurer VIG's Sr Unsec Debt 'A'
WST,2021-04-07,01:00:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.55,acquisitions-mergers,,Aegon's sale of its Central and Eastern European business to VIG,PRESS-RELEASE,Business Wire,An update of Aegon's sale of its Central and Eastern European business to VIG
WST,2021-04-07,01:00:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.55,acquisitions-mergers,,Aegon's sale of its Central and Eastern European business to VIG,PRESS-RELEASE,Dow Jones Newswires,Press Release: An update of Aegon's sale of its Central and Eastern European business to VIG
WST,2021-04-07,01:10:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.55,acquisitions-mergers,,Aegon's sale of its Central and Eastern European business to VIG,PRESS-RELEASE,Business Wire,An update of Aegon's sale of its Central and Eastern European business to VIG
WST,2021-04-07,01:10:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.55,acquisitions-mergers,,Aegon's sale of its Central and Eastern European business to VIG,PRESS-RELEASE,Dow Jones Newswires,Press Release: An update of Aegon's sale of its Central and Eastern European business to VIG
WST,2021-04-20,09:35:06,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,99,0.0,investor-relations,,Vienna Insurance Group AG Wiener Versicherung Gruppe: CONVOCATION to the 30th Annual General Meeting,PRESS-RELEASE,Dow Jones Newswires,EANS-General Meeting: Vienna Insurance Group AG Wiener Versicherung Gruppe / Invitation to the General Meeting according to art. 107 para. 3 Companies Act - ATTACHMENT
WST,2021-04-20,09:35:06,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,99,0.0,investor-relations,,Vienna Insurance Group AG Wiener Versicherung Gruppe: CONVOCATION to the 30th Annual General Meeting,PRESS-RELEASE,News Aktuell,EANS-General Meeting: Vienna Insurance Group AG Wiener Versicherung Gruppe / Invitation to the General Meeting according to art. 107 para. 3 Companies Act - ATTACHMENT
WST,2021-08-13,08:48:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.6,acquisitions-mergers,approval,European Commission gives green light to Vienna Insurance Group for acquisition of Aegon,PRESS-RELEASE,Business Wire,European Commission gives green light to Vienna Insurance Group for acquisition of Aegon's CEE business
WST,2021-08-13,08:48:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.6,acquisitions-mergers,approval,European Commission gives green light to Vienna Insurance Group for acquisition of Aegon,PRESS-RELEASE,Business Wire,European Commission gives green light to Vienna Insurance Group for acquisition of Aegon's CEE business
WST,2021-08-13,08:48:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.6,acquisitions-mergers,approval,European Commission gives green light to Vienna Insurance Group for acquisition of Aegon,PRESS-RELEASE,Dow Jones Newswires,Press Release: European Commission gives green light to Vienna Insurance Group for acquisition of Aegon's CEE business
WST,2021-08-13,08:48:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.6,acquisitions-mergers,approval,European Commission gives green light to Vienna Insurance Group for acquisition of Aegon,PRESS-RELEASE,Dow Jones Newswires,Press Release: European Commission gives green light to Vienna Insurance Group for acquisition of Aegon's CEE business
WST,2021-09-21,06:10:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.55,acquisitions-mergers,,Aegon's sale of its Central and Eastern European business to VIG,PRESS-RELEASE,Business Wire,An update on Aegon's sale of its Central and Eastern European business to VIG
WST,2021-09-21,06:10:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.55,acquisitions-mergers,,Aegon's sale of its Central and Eastern European business to VIG,PRESS-RELEASE,Business Wire,An update on Aegon's sale of its Central and Eastern European business to VIG
WST,2021-12-22,18:04:07,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,94,0.39,products-services,,Vienna INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG) and the Hungarian government have reached an agreement on,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Vienna Insurance Group and Hungary reach an agreement on the outlines of a cooperation and the further procedure regarding the Hungarian insurance companies AEGON and UNION
WST,2021-12-22,18:04:07,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,94,0.39,products-services,,Vienna INSURANCE GROUP AG Wiener Versicherung Gruppe (VIG) and the Hungarian government have reached an agreement on,PRESS-RELEASE,News Aktuell,PRESS RELEASE: Vienna Insurance Group and Hungary reach an agreement on the outlines of a cooperation and the further procedure regarding the Hungarian insurance companies AEGON and UNION
WST,2021-12-22,21:15:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,96,0.39,products-services,,Vienna Insurance Group and Hungary reach an agreement on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aegon takes note of VIG's announcement regarding Aegon's business in Central and Eastern Europe
WST,2021-12-22,21:15:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,96,0.39,products-services,,Vienna Insurance Group and Hungary reach an agreement on,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Aegon takes note of VIG's announcement regarding Aegon's business in Central and Eastern Europe
WST,2021-12-22,21:15:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,96,0.39,products-services,,Vienna Insurance Group and Hungary reach an agreement on,PRESS-RELEASE,GlobeNewswire,Aegon takes note of VIG's announcement regarding Aegon's business in Central and Eastern Europe
WST,2021-12-22,21:15:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,96,0.39,products-services,,Vienna Insurance Group and Hungary reach an agreement on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aegon takes note of VIG's announcement regarding Aegon's business in Central and Eastern Europe
WST,2021-02-26,22:00:27,7045FB,Westridge Resources Inc.,100,0.53,labor-issues,,Harrys Manufacturing Inc. Appoints New President and CEO,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New President and CEO
WST,2021-02-26,22:00:27,7045FB,Westridge Resources Inc.,100,0.53,labor-issues,,Harrys Manufacturing Inc. Appoints New President and CEO,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New President and CEO
WST,2021-02-26,22:00:27,7045FB,Westridge Resources Inc.,100,0.53,labor-issues,,Harrys Manufacturing Inc. Appoints New President and CEO,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New President and CEO
WST,2021-02-26,22:00:27,7045FB,Westridge Resources Inc.,100,0.53,labor-issues,,Harrys Manufacturing Inc. Appoints New President and CEO,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New President and CEO
WST,2021-02-26,22:00:27,7045FB,Westridge Resources Inc.,100,0.53,labor-issues,,Harrys Manufacturing Inc. Appoints New President and CEO,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New President and CEO
WST,2021-02-26,22:00:27,7045FB,Westridge Resources Inc.,100,0.53,labor-issues,,Harrys Manufacturing Inc. Appoints New President and CEO,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New President and CEO
WST,2022-02-16,17:20:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.58,products-services,,Vig reaches agreement with Hungarian,PRESS-RELEASE,Dow Jones Newswires,Press Release: VIG reaches agreement with Hungarian state holding Corvinus
WST,2022-02-16,17:20:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.58,products-services,,Vig reaches agreement with Hungarian,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: VIG reaches agreement with Hungarian state holding Corvinus
WST,2022-02-16,17:20:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.58,products-services,,Vig reaches agreement with Hungarian,PRESS-RELEASE,GlobeNewswire,VIG reaches agreement with Hungarian state holding Corvinus
WST,2022-02-16,17:20:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.58,products-services,,Vig reaches agreement with Hungarian,PRESS-RELEASE,Dow Jones Newswires,Press Release: VIG reaches agreement with Hungarian state holding Corvinus
WST,2022-02-17,13:36:03,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.7,earnings,above-expectations,Vienna Insurance Group Clearly Exceeds Earnings Expectations,NEWS-FLASH,Dow Jones Newswires,Eqs-Adhoc: Vienna Insurance Group Clearly Exceeds Earnings Expectations For 2021
WST,2022-02-17,13:36:03,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.7,earnings,above-expectations,Vienna Insurance Group Clearly Exceeds Earnings Expectations,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Eqs-Adhoc: Vienna Insurance Group Clearly Exceeds Earnings Expectations For 2021
WST,2022-02-17,13:36:04,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.7,earnings,above-expectations,Vienna Insurance Group clearly exceeds earnings expectations,PRESS-RELEASE,Dow Jones Newswires,EQS-Adhoc: Vienna Insurance Group clearly exceeds earnings expectations for 2021
WST,2022-02-17,13:36:04,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.7,earnings,above-expectations,Vienna Insurance Group clearly exceeds earnings expectations,PRESS-RELEASE,DGAP News,EQS-Adhoc: Vienna Insurance Group clearly exceeds earnings expectations for 2021
WST,2022-06-06,10:59:42,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.16,credit-ratings,set,S&PGR Rates VIG's Junior Subordinated Notes 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates VIG's Junior Subordinated Notes 'A-'
WST,2022-02-16,17:20:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.58,products-services,,Vig reaches agreement with Hungarian,PRESS-RELEASE,Dow Jones Newswires,Press Release: VIG reaches agreement with Hungarian state holding Corvinus
WST,2022-02-16,17:20:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.58,products-services,,Vig reaches agreement with Hungarian,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: VIG reaches agreement with Hungarian state holding Corvinus
WST,2022-02-16,17:20:00,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.58,products-services,,Vig reaches agreement with Hungarian,PRESS-RELEASE,GlobeNewswire,VIG reaches agreement with Hungarian state holding Corvinus
WST,2022-02-16,17:20:01,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.58,products-services,,Vig reaches agreement with Hungarian,PRESS-RELEASE,Dow Jones Newswires,Press Release: VIG reaches agreement with Hungarian state holding Corvinus
WST,2022-02-17,13:36:03,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.7,earnings,above-expectations,Vienna Insurance Group Clearly Exceeds Earnings Expectations,NEWS-FLASH,Dow Jones Newswires,Eqs-Adhoc: Vienna Insurance Group Clearly Exceeds Earnings Expectations For 2021
WST,2022-02-17,13:36:03,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.7,earnings,above-expectations,Vienna Insurance Group Clearly Exceeds Earnings Expectations,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Eqs-Adhoc: Vienna Insurance Group Clearly Exceeds Earnings Expectations For 2021
WST,2022-02-17,13:36:04,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.7,earnings,above-expectations,Vienna Insurance Group clearly exceeds earnings expectations,PRESS-RELEASE,Dow Jones Newswires,EQS-Adhoc: Vienna Insurance Group clearly exceeds earnings expectations for 2021
WST,2022-02-17,13:36:04,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.7,earnings,above-expectations,Vienna Insurance Group clearly exceeds earnings expectations,PRESS-RELEASE,DGAP News,EQS-Adhoc: Vienna Insurance Group clearly exceeds earnings expectations for 2021
WST,2022-06-06,10:59:42,651C38,Vienna Insurance Group AG Wiener Versicherung Gruppe,100,0.16,credit-ratings,set,S&PGR Rates VIG's Junior Subordinated Notes 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates VIG's Junior Subordinated Notes 'A-'
WST,2022-03-04,01:00:21,7045FB,Westridge Resources Inc.,100,0.38,credit,,Harrys Enters into Convertible Loan Agreement,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Enters into Convertible Loan Agreement
WST,2022-03-04,01:00:21,7045FB,Westridge Resources Inc.,100,0.38,credit,,Harrys Enters into Convertible Loan Agreement,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Enters into Convertible Loan Agreement
WST,2022-03-04,01:00:21,7045FB,Westridge Resources Inc.,100,0.38,credit,,Harrys Enters into Convertible Loan Agreement,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Enters into Convertible Loan Agreement
WST,2023-02-22,15:10:23,651C38,Vienna Insurance Group AG,97,0.0,earnings,,Vienna Insurance Group will publish the preliminary results for 2022,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Vienna Insurance: Eqs-Adhoc: Preliminary Vig Group Net Results In A Range Of Eur 460 - 470 Million Significantly Above Expectations
WST,2023-02-22,15:10:23,651C38,Vienna Insurance Group AG,98,0.0,earnings,,Vienna Insurance Group will publish the preliminary results for 2022,PRESS-RELEASE,Dow Jones Newswires,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Preliminary VIG Group net results in a range of EUR 460 - 470 million significantly above expectations
WST,2023-02-22,15:10:23,651C38,Vienna Insurance Group AG,98,0.0,earnings,,Vienna Insurance Group will publish the preliminary results for 2022,PRESS-RELEASE,DGAP News,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Preliminary VIG Group net results in a range of EUR 460 - 470 million significantly above expectations
WST,2023-04-13,09:34:12,651C38,Vienna Insurance Group Wiener Versicherung Gruppe AG,100,0.09,credit-ratings,affirmation,S&PGR Affirms VIG Insurance Group's Jr. Sub. Notes At 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms VIG Insurance Group's Jr. Sub. Notes At 'A-'
WST,2023-06-01,06:00:00,651C38,Vienna Insurance Group AG,100,0.5,acquisitions-mergers,completed,Aegon completes sale of Central and Eastern European Businesses to VIG,PRESS-RELEASE,GlobeNewswire,Aegon completes sale of Central and Eastern European Businesses to VIG
WST,2023-06-01,06:00:01,651C38,Vienna Insurance Group AG,100,0.5,acquisitions-mergers,completed,Aegon completes sale of Central and Eastern European Businesses to VIG,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aegon completes sale of Central and Eastern European Businesses to VIG
WST,2023-06-01,06:00:02,651C38,Vienna Insurance Group AG,100,0.5,acquisitions-mergers,completed,Aegon completes sale of Central and Eastern European Businesses to VIG,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Aegon completes sale of Central and Eastern European Businesses to VIG
WST,2023-06-01,06:00:02,651C38,Vienna Insurance Group AG,100,0.5,acquisitions-mergers,completed,Aegon completes sale of Central and Eastern European Businesses to VIG,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aegon completes sale of Central and Eastern European Businesses to VIG
WST,2023-07-27,14:01:04,651C38,Vienna Insurance Group AG,100,0.27,credit-ratings,stable,S&PGR Affirms Vienna Insurance Group At 'A+'; Outlook Stable,NEWS-FLASH,Dow Jones Newswires,S&PGR Affirms Vienna Insurance Group At 'A+'; Outlook Stable
WST,2023-07-27,14:01:04,651C38,Vienna Insurance Group AG,100,0.27,credit-ratings,stable,S&PGR Affirms Vienna Insurance Group At 'A+'; Outlook Stable,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms Vienna Insurance Group At 'A+'; Outlook Stable
WST,2023-07-27,14:01:14,651C38,Vienna Insurance Group AG,100,0.0,credit-ratings,affirmation,S&PGR Affirms Vienna Insurance,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms Vienna Insurance -2-
WST,2023-11-27,15:29:00,651C38,Vienna Insurance Group AG,100,0.0,dividends,,Vienna Insurance Group Sets New Dividend,NEWS-FLASH,Dow Jones Newswires,Eqs-Adhoc: Vienna Insurance Group Sets New Dividend Policy
WST,2023-11-27,15:29:06,651C38,Vienna Insurance Group AG,100,0.0,dividends,,Vienna Insurance Group Sets New Dividend,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Eqs-Adhoc: Vienna Insurance Group Sets New Dividend Policy
WST,2023-11-27,15:29:09,651C38,Vienna Insurance Group AG,100,0.0,dividends,,Vienna Insurance Group sets new dividend,PRESS-RELEASE,Dow Jones Newswires,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Vienna Insurance Group sets new dividend policy
WST,2023-11-27,15:29:09,651C38,Vienna Insurance Group AG,100,0.0,dividends,,Vienna Insurance Group sets new dividend,PRESS-RELEASE,DGAP News,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Vienna Insurance Group sets new dividend policy
WST,2023-02-22,15:10:23,651C38,Vienna Insurance Group AG,97,0.0,earnings,,Vienna Insurance Group will publish the preliminary results for 2022,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Vienna Insurance: Eqs-Adhoc: Preliminary Vig Group Net Results In A Range Of Eur 460 - 470 Million Significantly Above Expectations
WST,2023-02-22,15:10:23,651C38,Vienna Insurance Group AG,98,0.0,earnings,,Vienna Insurance Group will publish the preliminary results for 2022,PRESS-RELEASE,Dow Jones Newswires,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Preliminary VIG Group net results in a range of EUR 460 - 470 million significantly above expectations
WST,2023-02-22,15:10:23,651C38,Vienna Insurance Group AG,98,0.0,earnings,,Vienna Insurance Group will publish the preliminary results for 2022,PRESS-RELEASE,DGAP News,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Preliminary VIG Group net results in a range of EUR 460 - 470 million significantly above expectations
WST,2023-04-13,09:34:12,651C38,Vienna Insurance Group Wiener Versicherung Gruppe AG,100,0.09,credit-ratings,affirmation,S&PGR Affirms VIG Insurance Group's Jr. Sub. Notes At 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms VIG Insurance Group's Jr. Sub. Notes At 'A-'
WST,2023-06-01,06:00:00,651C38,Vienna Insurance Group AG,100,0.5,acquisitions-mergers,completed,Aegon completes sale of Central and Eastern European Businesses to VIG,PRESS-RELEASE,GlobeNewswire,Aegon completes sale of Central and Eastern European Businesses to VIG
WST,2023-06-01,06:00:01,651C38,Vienna Insurance Group AG,100,0.5,acquisitions-mergers,completed,Aegon completes sale of Central and Eastern European Businesses to VIG,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aegon completes sale of Central and Eastern European Businesses to VIG
WST,2023-06-01,06:00:02,651C38,Vienna Insurance Group AG,100,0.5,acquisitions-mergers,completed,Aegon completes sale of Central and Eastern European Businesses to VIG,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Aegon completes sale of Central and Eastern European Businesses to VIG
WST,2023-06-01,06:00:02,651C38,Vienna Insurance Group AG,100,0.5,acquisitions-mergers,completed,Aegon completes sale of Central and Eastern European Businesses to VIG,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aegon completes sale of Central and Eastern European Businesses to VIG
WST,2023-07-27,14:01:04,651C38,Vienna Insurance Group AG,100,0.27,credit-ratings,stable,S&PGR Affirms Vienna Insurance Group At 'A+'; Outlook Stable,NEWS-FLASH,Dow Jones Newswires,S&PGR Affirms Vienna Insurance Group At 'A+'; Outlook Stable
WST,2023-07-27,14:01:04,651C38,Vienna Insurance Group AG,100,0.27,credit-ratings,stable,S&PGR Affirms Vienna Insurance Group At 'A+'; Outlook Stable,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms Vienna Insurance Group At 'A+'; Outlook Stable
WST,2023-07-27,14:01:14,651C38,Vienna Insurance Group AG,100,0.0,credit-ratings,affirmation,S&PGR Affirms Vienna Insurance,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms Vienna Insurance -2-
WST,2023-11-27,15:29:00,651C38,Vienna Insurance Group AG,100,0.0,dividends,,Vienna Insurance Group Sets New Dividend,NEWS-FLASH,Dow Jones Newswires,Eqs-Adhoc: Vienna Insurance Group Sets New Dividend Policy
WST,2023-11-27,15:29:06,651C38,Vienna Insurance Group AG,100,0.0,dividends,,Vienna Insurance Group Sets New Dividend,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Eqs-Adhoc: Vienna Insurance Group Sets New Dividend Policy
WST,2023-11-27,15:29:09,651C38,Vienna Insurance Group AG,100,0.0,dividends,,Vienna Insurance Group sets new dividend,PRESS-RELEASE,Dow Jones Newswires,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Vienna Insurance Group sets new dividend policy
WST,2023-11-27,15:29:09,651C38,Vienna Insurance Group AG,100,0.0,dividends,,Vienna Insurance Group sets new dividend,PRESS-RELEASE,DGAP News,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: Vienna Insurance Group sets new dividend policy
WST,2023-07-28,15:45:57,7045FB,Westridge Resources Inc.,100,0.53,labor-issues,,Harrys Manufacturing Inc. Appoints New President & CEO,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New President & CEO
WST,2023-07-28,15:45:57,7045FB,Westridge Resources Inc.,100,0.53,labor-issues,,Harrys Manufacturing Inc. Appoints New President & CEO,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New President & CEO
WST,2023-07-31,20:31:01,7045FB,Westridge Resources Inc.,100,0.47,labor-issues,,Harrys Manufacturing Inc. Appoints New Board Member,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New Board Member and Secretary/ Update
WST,2023-07-28,15:45:57,7045FB,Westridge Resources Inc.,100,0.53,labor-issues,,Harrys Manufacturing Inc. Appoints New President & CEO,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New President & CEO
WST,2023-07-28,15:45:57,7045FB,Westridge Resources Inc.,100,0.53,labor-issues,,Harrys Manufacturing Inc. Appoints New President & CEO,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New President & CEO
WST,2023-07-31,20:31:01,7045FB,Westridge Resources Inc.,100,0.47,labor-issues,,Harrys Manufacturing Inc. Appoints New Board Member,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New Board Member and Secretary/ Update
WST,2023-07-28,15:45:57,7045FB,Westridge Resources Inc.,100,0.53,labor-issues,,Harrys Manufacturing Inc. Appoints New President & CEO,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New President & CEO
WST,2023-07-28,15:45:57,7045FB,Westridge Resources Inc.,100,0.53,labor-issues,,Harrys Manufacturing Inc. Appoints New President & CEO,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New President & CEO
WST,2023-07-31,20:31:01,7045FB,Westridge Resources Inc.,100,0.47,labor-issues,,Harrys Manufacturing Inc. Appoints New Board Member,PRESS-RELEASE,DJ Global Press Release Wire,Harrys Manufacturing Inc. Appoints New Board Member and Secretary/ Update
WST,2024-02-01,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2023 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2023 Conference Call
WST,2024-02-01,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2023 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2023 Conference Call
WST,2024-02-01,11:00:34,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2023 Conference Call
WST,2024-02-01,11:00:34,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2023 Conference Call
WST,2024-02-07,11:36:14,BF79F5,West Pharmaceutical Services Inc.,100,0.94,analyst-ratings,positive,West Pharma Raised to Buy From Hold by Jefferies,NEWS-FLASH,Dow Jones Newswires,West Pharma Raised to Buy From Hold by Jefferies
WST,2024-02-07,11:36:14,BF79F5,West Pharmaceutical Services Inc.,100,0.88,price-targets,upgrade,West Pharma Price Target Raised to $536.00/Share From $323.00 by Jefferies,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $536.00/Share From $323.00 by Jefferies
WST,2024-02-13,10:43:08,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2024-02-13,10:43:08,BF79F5,West Pharmaceutical Services Inc.,100,0.66,price-targets,upgrade,West Pharma Price Target Raised to $470.00/Share From $440.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $470.00/Share From $440.00 by Keybanc
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $3B-$3.03B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $3B-$3.03B >WST
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2023",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2023",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Conference Call Scheduled for 9 a.m. EST Today,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Fourth-quarter 2023 net sales of $732.0 million grew 3.3%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.02,revenues,,West Pharmaceutical Services Inc.: Full-year 2023 net sales of $2.950 billion grew 2.2%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2023 reported-diluted EPS of $1.83,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 reported-diluted EPS of $7.88,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2023 adjusted-diluted EPS of $1.83,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS of $8.08,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,-0.75,revenues,down,West Pharmaceutical Services Inc.: Full-year 2024 net sales are expected to be in a range of $3.000 billion to $3.025 billion,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,"West Pharmaceutical Services Inc.: In the full-year 2023, net sales grew by 15.0% to $552.5 million",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.7,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $362.0 million, compared with $284.6 million in 2022",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.22,acquisitions-mergers,,"West Pharmaceutical Services Inc.: we purchased 1,265,661 shares of our",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2024 adjusted-diluted EPS is expected to be in a range of $7.50 to $7.75,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending is expected to be $350 million,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Fourth-Quarter 2023 Conference Call,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 4Q Sales $732M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Sales $732M >WST
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $732.0,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -2-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 278.2,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -2-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.85 $1.38,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -2-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -2-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $7.50,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $7.50-Adj EPS $7.75 >WST
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q EPS $1.83,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q EPS $1.83 >WST
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: Restructuring,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -3-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: The twelve-month charge,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -3-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -3-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -3-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -3-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Adj EPS $1.83,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Adj EPS $1.83 >WST
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,98,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -4-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $7.46,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $7.46-EPS $7.71 >WST
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Net $137M,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Net $137M >WST
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Conference Call Scheduled for 9 a.m. EST Today,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Fourth-quarter 2023 net sales of $732.0 million grew 3.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.02,revenues,,West Pharmaceutical Services Inc.: Full-year 2023 net sales of $2.950 billion grew 2.2%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2023 reported-diluted EPS of $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 reported-diluted EPS of $7.88,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2023 adjusted-diluted EPS of $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS of $8.08,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,-0.75,revenues,down,West Pharmaceutical Services Inc.: Full-year 2024 net sales are expected to be in a range of $3.000 billion to $3.025 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,"West Pharmaceutical Services Inc.: In the full-year 2023, net sales grew by 15.0% to $552.5 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.7,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $362.0 million, compared with $284.6 million in 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.22,acquisitions-mergers,,"West Pharmaceutical Services Inc.: we purchased 1,265,661 shares of our",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2024 adjusted-diluted EPS is expected to be in a range of $7.50 to $7.75,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending is expected to be $350 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Fourth-Quarter 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $732.0,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 278.2,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.85 $1.38,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: The twelve-month charge,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,98,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -4-
WST,2024-02-15,12:52:37,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: the ""Company"") issued a press release announcing its fourth-quarter and full year 2023 financial results",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2024-02-15,15:08:22,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West said Thursday morning it expects adjusted diluted earnings,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Stock Tumbles on Weak 2024 Outlook -- Barrons.com
WST,2024-02-15,15:08:22,BF79F5,West Pharmaceutical Services Inc.,100,-0.68,revenues,down,"West Pharmaceutical Services Inc.: The company said 2024 would bring ""moderated organic sales",FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Stock Tumbles on Weak 2024 Outlook -- Barrons.com
WST,2024-02-16,18:45:25,BF79F5,West Pharmaceutical Services Inc.,100,0.0,analyst-ratings,neutral,West Pharma Is Maintained at Neutral by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Neutral by UBS
WST,2024-02-16,18:45:25,BF79F5,West Pharmaceutical Services Inc.,100,-0.66,price-targets,downgrade,West Pharma Price Target Cut to $375.00/Share From $400.00 by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $375.00/Share From $400.00 by UBS
WST,2024-02-20,11:00:06,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces Second-Quarter 2024 Dividend,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Dividend
WST,2024-02-20,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces Second-Quarter 2024 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Dividend
WST,2024-02-21,08:13:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 4Q 2023 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 4Q 2023 (WST)"
WST,2024-02-27,16:39:26,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Abraham Sells 7,012 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Abraham Sells 7,012 Of West Pharmaceutical Services >WST"
WST,2024-02-27,21:36:50,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Chmn Green Registers 64,132 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"Chmn Green Registers 64,132 Of West Pharmaceutical Services >WST"
WST,2024-02-28,21:30:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,"West Pharmaceutical Services Inc.: It will also present at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 9:00 AM ET",PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2024-02-28,21:48:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,"West Pharmaceutical Services Inc.: It will also present at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 9:00 AM ET",PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2024-02-29,21:41:45,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Chmn Green Sells 64,132 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"Chmn Green Sells 64,132 Of West Pharmaceutical Services >WST"
WST,2024-03-01,18:08:54,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Treas Witherspoon Sells 2,019 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"Treas Witherspoon Sells 2,019 Of West Pharmaceutical Services >WST"
WST,2024-03-12,15:48:21,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,Vp Winters Sells 815 Of West Pharmaceutical Services,TABULAR-MATERIAL,Dow Jones Newswires,VP Winters Sells 815 Of West Pharmaceutical Services >WST
WST,2024-04-11,10:00:06,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,West to Host First-Quarter 2024 Conference Call
WST,2024-04-11,10:00:06,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host First-Quarter 2024 Conference Call
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 1Q Sales $695.4M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Sales $695.4M >WST
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: First-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2024",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Net sales of $695.4 million declined 3.0%,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.55,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2024 net sales guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2024 financial guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $90.6 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 729,679 shares for $267.0 million",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is raising full-year 2024 financial guidance of,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2024 financial guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $7.63,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $7.63-Adj EPS $7.88 >WST
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.65,revenues,up,West Pharmaceutical Services Inc.: Net sales $695.4,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 230.2,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.57 $1.88,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q EPS $1.55,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q EPS $1.55 >WST
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -3-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Adj EPS $1.56,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Adj EPS $1.56 >WST
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $7.59,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $7.59-EPS $7.84 >WST
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Net $115.3M,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Net $115.3M >WST
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: First-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Net sales of $695.4 million declined 3.0%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2024 net sales guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2024 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $90.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 729,679 shares for $267.0 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is raising full-year 2024 financial guidance of,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2024 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Net sales $695.4,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 230.2,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.57 $1.88,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:35:42,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,above-expectations,"West Pharma 1Q EPS, Sales Top Views",FULL-ARTICLE,Dow Jones Newswires,"West Pharma 1Q EPS, Sales Top Views as Inventory Issues Ease"
WST,2024-04-25,10:35:42,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services said its first-quarter earnings,FULL-ARTICLE,Dow Jones Newswires,"West Pharma 1Q EPS, Sales Top Views as Inventory Issues Ease"
WST,2024-04-25,10:35:42,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West posted earnings of $1.56 a share,FULL-ARTICLE,Dow Jones Newswires,"West Pharma 1Q EPS, Sales Top Views as Inventory Issues Ease"
WST,2024-04-25,11:43:34,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: West Pharmaceutical Services, Inc. (the ""Company"") issued a press release announcing its first-quarter 2024 financial results.",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2024-04-30,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2024-04-30,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2024-05-07,19:42:32,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Chmn Green Registers 66,000 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"Chmn Green Registers 66,000 Of West Pharmaceutical Services >WST"
WST,2024-05-09,19:39:46,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Chmn Green Sells 66,000 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"Chmn Green Sells 66,000 Of West Pharmaceutical Services >WST"
WST,2024-05-10,17:39:27,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,Dir Hofmann Registers 617 Of West Pharmaceutical Services >WST,RNS-SEC144,Dow Jones Newswires,Dir Hofmann Registers 617 Of West Pharmaceutical Services >WST
WST,2024-05-21,07:11:55,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 1Q 2024 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 1Q 2024 (WST)"
WST,2024-05-28,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2024-05-28,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2024-06-13,20:47:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Abraham Sells 1,800 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Abraham Sells 1,800 Of West Pharmaceutical Services >WST"
WST,2024-07-11,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Second-Quarter 2024 Conference Call
WST,2024-07-11,10:00:06,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Second-Quarter 2024 Conference Call
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.87B-$2.9B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.87B-$2.9B >WST
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Second-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Net sales of $702.1 million declined 6.9%,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.44,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.51, compared to $2.06 in the same period last year",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: The Company is updating full-year 2024 net sales guidance to a range of $2.870 billion to $2.900 billion,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: The Company is updating full-year 2024 adjusted-diluted EPS guidance to a range of $6.35 to $6.65,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: our second-quarter revenues increase sequentially.,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.34,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $190.8 million, an increase of 21.1%",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 1,239,015 shares for $454.1 million",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2024 Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending is expected to be $375 million,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Adj EPS $1.52,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Adj EPS $1.52 >WST
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -2-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 702.1,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -2-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 230.0,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -2-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -2-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.52 $ 2.08 $,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -2-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $6.35,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $6.35-Adj EPS $6.65 >WST
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -3-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -3-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -3-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -3-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $6.31,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $6.31-EPS $6.61 >WST
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q EPS $1.51,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q EPS $1.51 >WST
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Net $111.3M,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Net $111.3M >WST
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 2Q Sales $702.1M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Sales $702.1M >WST
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Second-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Net sales of $702.1 million declined 6.9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.44,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.51, compared to $2.06 in the same period last year",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -3-
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: The Company is updating full-year 2024 net sales guidance to a range of $2.870 billion to $2.900 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: The Company is updating full-year 2024 adjusted-diluted EPS guidance to a range of $6.35 to $6.65,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: our second-quarter revenues increase sequentially.,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.34,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $190.8 million, an increase of 21.1%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 1,239,015 shares for $454.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2024 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending is expected to be $375 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,96,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 702.1,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -2-
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,96,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 230.0,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -2-
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,96,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -2-
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,96,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.52 $ 2.08 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -2-
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -3-
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -3-
WST,2024-07-25,10:25:49,BF79F5,West Pharmaceutical Services Inc.,100,-0.74,earnings,down,West Pharmaceutical Services Cuts Full-Year Outlook After,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Services Cuts Full-Year Outlook After Fall in 2Q Earnings
WST,2024-07-25,10:25:49,BF79F5,West Pharmaceutical Services Inc.,100,-0.74,earnings,down,West Pharmaceutical Services cut its guidance for 2024,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Services Cuts Full-Year Outlook After Fall in 2Q Earnings
WST,2024-07-25,12:05:54,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: the ""Company"") issued a press release announcing its second-quarter 2024 financial results",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2024-07-25,12:12:48,BF79F5,West Pharmaceutical Services Inc.,100,-0.74,earnings,down,West Pharmaceutical Services Inc.: the company cut its guidance for 2024,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Shares Fall on Reduced Full-Year Outlook
WST,2024-08-06,20:51:52,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Chmn Green Registers 30,732 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"Chmn Green Registers 30,732 Of West Pharmaceutical Services >WST"
WST,2024-08-08,20:18:24,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Chmn Green Sells 30,732 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"Chmn Green Sells 30,732 Of West Pharmaceutical Services >WST"
WST,2024-08-21,07:10:16,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 2Q 2024 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 2Q 2024 (WST)"
WST,2024-08-21,20:52:37,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,Dir Hofmann Sells 617 Of West Pharmaceutical Services,TABULAR-MATERIAL,Dow Jones Newswires,Dir Hofmann Sells 617 Of West Pharmaceutical Services >WST
WST,2024-08-21,21:03:51,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Treas Witherspoon Sells 1,029 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"Treas Witherspoon Sells 1,029 Of West Pharmaceutical Services >WST"
WST,2024-09-05,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2024-09-05,10:02:32,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2024-10-09,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.4,products-services,,West Wins Heart of Pharma Award,PRESS-RELEASE,PR Newswire,West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards
WST,2024-10-09,10:08:02,BF79F5,West Pharmaceutical Services Inc.,100,0.4,products-services,,West Wins Heart of Pharma Award,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards
WST,2024-10-10,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Third-Quarter 2024 Conference Call
WST,2024-10-10,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Third-Quarter 2024 Conference Call
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 3Q Sales $746.9M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Sales $746.9M >WST
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $6.55,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $6.55-Adj EPS $6.75 >WST
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2024",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Third-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharmaceutical Services Inc.: Net sales of $746.9 million declined 0.1%,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.28,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.85, compared to $2.14 in the same period last year",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: the Company increased its full year 2024 net sales guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2024 dividend of $0.21,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.13,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $272.1 million, an increase of 7.4%",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 1,409,786 shares for $506.5 million",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2024 Updated Financial Guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2024 adjusted-diluted EPS is expected to be in a range of $6.55 to $6.75,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Our updated adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For the fourth-quarter 2024, our EPS guidance",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q EPS $1.85,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q EPS $1.85 >WST
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -2-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 746.9,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -2-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 264.7,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -2-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -2-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.87 $ 2.17 $,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -2-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Adj EPS $1.85,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Adj EPS $1.85 >WST
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -3-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2022 restructuring plan,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -3-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -3-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -3-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -3-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -3-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $6.52,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $6.52-EPS $6.72 >WST
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Net $136M,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Net $136M >WST
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Third-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharmaceutical Services Inc.: Net sales of $746.9 million declined 0.1%,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.28,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.85, compared to $2.14 in the same period last year",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: the Company increased its full year 2024 net sales guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2024 dividend of $0.21,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.13,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $272.1 million, an increase of 7.4%",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 1,409,786 shares for $506.5 million",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2024 Updated Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2024 adjusted-diluted EPS is expected to be in a range of $6.55 to $6.75,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Our updated adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For the fourth-quarter 2024, our EPS guidance",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2022 restructuring plan,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2024 -3-
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2024 -3-
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2024 -3-
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2024 -3-
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2024 -3-
WST,2024-10-24,11:51:23,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: West Pharmaceutical Services, Inc. (the ""Company"") issued a press release announcing its third-quarter 2024 financial results.",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2024-10-24,15:07:14,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,above-expectations,West Pharmaceutical Services Inc.: The company also reported better-than-expected sales in its third quarter,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Services Shares Rise 19% after Raising 2024 Outlook
WST,2024-10-29,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2024-10-29,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2024-10-31,15:51:20,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Vp Abraham Acquires 278 Of West Pharmaceutical Services >WST,TABULAR-MATERIAL,Dow Jones Newswires,VP Abraham Acquires 278 Of West Pharmaceutical Services >WST
WST,2024-10-31,16:06:32,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,Treas Witherspoon Sells 703 Of West Pharmaceutical Services,TABULAR-MATERIAL,Dow Jones Newswires,Treas Witherspoon Sells 703 Of West Pharmaceutical Services >WST
WST,2024-11-21,08:09:16,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 3Q 2024 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 3Q 2024 (WST)"
WST,2024-12-11,11:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,PRESS-RELEASE,PR Newswire,West Elects New Director to the Board
WST,2024-12-11,11:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Elects New Director to the Board
WST,2024-12-11,21:12:15,BF79F5,West Pharmaceutical Services Inc.,99,0.47,labor-issues,,"West Pharmaceutical Services Inc.: the ""Company"") elected Janet Haugen, to its Board of Directors (the ""Board"")",RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2024-12-11,21:12:15,BF79F5,West Pharmaceutical Services Inc.,93,0.47,labor-issues,,West Pharmaceutical Services Inc.: the Company issued a press release announcing the appointment of Ms. Haugen to the Board,RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Regulation FD >WST
WST,2024-12-12,16:20:52,BF79F5,West Pharmaceutical Services Inc.,100,0.94,analyst-ratings,positive,West Pharma Raised to Buy From Neutral by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Raised to Buy From Neutral by UBS
WST,2024-12-12,16:20:52,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $390.00/Share From $350.00 by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $390.00/Share From $350.00 by UBS
WST,2024-12-13,14:21:45,BF79F5,West Pharmaceutical Services Inc.,100,0.01,analyst-ratings,neutral,West Pharma Initiated at Peer Perform by Wolfe Research,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Peer Perform by Wolfe Research
WST,2024-12-13,16:15:05,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Buy by B of A Securities
WST,2024-12-13,16:15:05,BF79F5,West Pharmaceutical Services Inc.,100,0.3,price-targets,upgrade,West Pharma Price Target Raised to $355.00/Share From $350.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $355.00/Share From $350.00 by B of A Securities
WST,2024-12-13,21:08:07,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharmaceutical Services Authorizes Repurchase,RNS-SEC8K,Dow Jones Newswires,"West Pharmaceutical Services Authorizes Repurchase of Up to 550,000 Shares"
WST,2024-12-13,21:23:36,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services to Buy Back Up To 550,000 Shares",FULL-ARTICLE,Dow Jones Newswires,"West Pharmaceutical Services to Buy Back Up To 550,000 Shares"
WST,2024-02-01,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2023 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2023 Conference Call
WST,2024-02-01,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2023 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2023 Conference Call
WST,2024-02-01,11:00:34,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2023 Conference Call
WST,2024-02-01,11:00:34,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2023 Conference Call
WST,2024-02-07,11:36:14,BF79F5,West Pharmaceutical Services Inc.,100,0.94,analyst-ratings,positive,West Pharma Raised to Buy From Hold by Jefferies,NEWS-FLASH,Dow Jones Newswires,West Pharma Raised to Buy From Hold by Jefferies
WST,2024-02-07,11:36:14,BF79F5,West Pharmaceutical Services Inc.,100,0.88,price-targets,upgrade,West Pharma Price Target Raised to $536.00/Share From $323.00 by Jefferies,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $536.00/Share From $323.00 by Jefferies
WST,2024-02-13,10:43:08,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2024-02-13,10:43:08,BF79F5,West Pharmaceutical Services Inc.,100,0.66,price-targets,upgrade,West Pharma Price Target Raised to $470.00/Share From $440.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $470.00/Share From $440.00 by Keybanc
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $3B-$3.03B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $3B-$3.03B >WST
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2023",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2023",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Conference Call Scheduled for 9 a.m. EST Today,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Fourth-quarter 2023 net sales of $732.0 million grew 3.3%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.02,revenues,,West Pharmaceutical Services Inc.: Full-year 2023 net sales of $2.950 billion grew 2.2%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2023 reported-diluted EPS of $1.83,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 reported-diluted EPS of $7.88,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2023 adjusted-diluted EPS of $1.83,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS of $8.08,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,-0.75,revenues,down,West Pharmaceutical Services Inc.: Full-year 2024 net sales are expected to be in a range of $3.000 billion to $3.025 billion,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,"West Pharmaceutical Services Inc.: In the full-year 2023, net sales grew by 15.0% to $552.5 million",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.7,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $362.0 million, compared with $284.6 million in 2022",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.22,acquisitions-mergers,,"West Pharmaceutical Services Inc.: we purchased 1,265,661 shares of our",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2024 adjusted-diluted EPS is expected to be in a range of $7.50 to $7.75,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending is expected to be $350 million,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Fourth-Quarter 2023 Conference Call,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 4Q Sales $732M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Sales $732M >WST
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $732.0,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -2-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 278.2,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -2-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.85 $1.38,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -2-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -2-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $7.50,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $7.50-Adj EPS $7.75 >WST
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q EPS $1.83,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q EPS $1.83 >WST
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: Restructuring,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -3-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: The twelve-month charge,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -3-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -3-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -3-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -3-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Adj EPS $1.83,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Adj EPS $1.83 >WST
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,98,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2023 -4-
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $7.46,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $7.46-EPS $7.71 >WST
WST,2024-02-15,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Net $137M,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Net $137M >WST
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Conference Call Scheduled for 9 a.m. EST Today,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Fourth-quarter 2023 net sales of $732.0 million grew 3.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.02,revenues,,West Pharmaceutical Services Inc.: Full-year 2023 net sales of $2.950 billion grew 2.2%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2023 reported-diluted EPS of $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 reported-diluted EPS of $7.88,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2023 adjusted-diluted EPS of $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS of $8.08,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,-0.75,revenues,down,West Pharmaceutical Services Inc.: Full-year 2024 net sales are expected to be in a range of $3.000 billion to $3.025 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,"West Pharmaceutical Services Inc.: In the full-year 2023, net sales grew by 15.0% to $552.5 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.7,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $362.0 million, compared with $284.6 million in 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.22,acquisitions-mergers,,"West Pharmaceutical Services Inc.: we purchased 1,265,661 shares of our",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2024 adjusted-diluted EPS is expected to be in a range of $7.50 to $7.75,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending is expected to be $350 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Fourth-Quarter 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2023 Results
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $732.0,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 278.2,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.85 $1.38,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: The twelve-month charge,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2024-02-15,11:00:41,BF79F5,West Pharmaceutical Services Inc.,98,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -4-
WST,2024-02-15,12:52:37,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: the ""Company"") issued a press release announcing its fourth-quarter and full year 2023 financial results",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2024-02-15,15:08:22,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West said Thursday morning it expects adjusted diluted earnings,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Stock Tumbles on Weak 2024 Outlook -- Barrons.com
WST,2024-02-15,15:08:22,BF79F5,West Pharmaceutical Services Inc.,100,-0.68,revenues,down,"West Pharmaceutical Services Inc.: The company said 2024 would bring ""moderated organic sales",FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Stock Tumbles on Weak 2024 Outlook -- Barrons.com
WST,2024-02-16,18:45:25,BF79F5,West Pharmaceutical Services Inc.,100,0.0,analyst-ratings,neutral,West Pharma Is Maintained at Neutral by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Neutral by UBS
WST,2024-02-16,18:45:25,BF79F5,West Pharmaceutical Services Inc.,100,-0.66,price-targets,downgrade,West Pharma Price Target Cut to $375.00/Share From $400.00 by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $375.00/Share From $400.00 by UBS
WST,2024-02-20,11:00:06,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces Second-Quarter 2024 Dividend,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Dividend
WST,2024-02-20,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces Second-Quarter 2024 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Dividend
WST,2024-02-21,08:13:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 4Q 2023 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 4Q 2023 (WST)"
WST,2024-02-27,16:39:26,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Abraham Sells 7,012 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Abraham Sells 7,012 Of West Pharmaceutical Services >WST"
WST,2024-02-27,21:36:50,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Chmn Green Registers 64,132 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"Chmn Green Registers 64,132 Of West Pharmaceutical Services >WST"
WST,2024-02-28,21:30:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,"West Pharmaceutical Services Inc.: It will also present at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 9:00 AM ET",PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2024-02-28,21:48:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,"West Pharmaceutical Services Inc.: It will also present at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 9:00 AM ET",PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2024-02-29,21:41:45,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Chmn Green Sells 64,132 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"Chmn Green Sells 64,132 Of West Pharmaceutical Services >WST"
WST,2024-03-01,18:08:54,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Treas Witherspoon Sells 2,019 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"Treas Witherspoon Sells 2,019 Of West Pharmaceutical Services >WST"
WST,2024-03-12,15:48:21,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,Vp Winters Sells 815 Of West Pharmaceutical Services,TABULAR-MATERIAL,Dow Jones Newswires,VP Winters Sells 815 Of West Pharmaceutical Services >WST
WST,2024-04-11,10:00:06,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,West to Host First-Quarter 2024 Conference Call
WST,2024-04-11,10:00:06,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host First-Quarter 2024 Conference Call
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 1Q Sales $695.4M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Sales $695.4M >WST
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: First-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2024",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Net sales of $695.4 million declined 3.0%,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.55,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2024 net sales guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2024 financial guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $90.6 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 729,679 shares for $267.0 million",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is raising full-year 2024 financial guidance of,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2024 financial guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $7.63,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $7.63-Adj EPS $7.88 >WST
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.65,revenues,up,West Pharmaceutical Services Inc.: Net sales $695.4,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 230.2,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.57 $1.88,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q EPS $1.55,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q EPS $1.55 >WST
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Results and -3-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Adj EPS $1.56,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Adj EPS $1.56 >WST
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $7.59,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $7.59-EPS $7.84 >WST
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Net $115.3M,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Net $115.3M >WST
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: First-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Net sales of $695.4 million declined 3.0%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2024 net sales guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2024 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $90.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 729,679 shares for $267.0 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is raising full-year 2024 financial guidance of,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2024 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Net sales $695.4,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 230.2,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.57 $1.88,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 -2-
WST,2024-04-25,10:35:42,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,above-expectations,"West Pharma 1Q EPS, Sales Top Views",FULL-ARTICLE,Dow Jones Newswires,"West Pharma 1Q EPS, Sales Top Views as Inventory Issues Ease"
WST,2024-04-25,10:35:42,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services said its first-quarter earnings,FULL-ARTICLE,Dow Jones Newswires,"West Pharma 1Q EPS, Sales Top Views as Inventory Issues Ease"
WST,2024-04-25,10:35:42,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West posted earnings of $1.56 a share,FULL-ARTICLE,Dow Jones Newswires,"West Pharma 1Q EPS, Sales Top Views as Inventory Issues Ease"
WST,2024-04-25,11:43:34,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: West Pharmaceutical Services, Inc. (the ""Company"") issued a press release announcing its first-quarter 2024 financial results.",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2024-04-30,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2024-04-30,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2024-05-07,19:42:32,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Chmn Green Registers 66,000 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"Chmn Green Registers 66,000 Of West Pharmaceutical Services >WST"
WST,2024-05-09,19:39:46,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Chmn Green Sells 66,000 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"Chmn Green Sells 66,000 Of West Pharmaceutical Services >WST"
WST,2024-05-10,17:39:27,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,Dir Hofmann Registers 617 Of West Pharmaceutical Services >WST,RNS-SEC144,Dow Jones Newswires,Dir Hofmann Registers 617 Of West Pharmaceutical Services >WST
WST,2024-05-21,07:11:55,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 1Q 2024 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 1Q 2024 (WST)"
WST,2024-05-28,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2024-05-28,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2024-06-13,20:47:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Abraham Sells 1,800 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Abraham Sells 1,800 Of West Pharmaceutical Services >WST"
WST,2024-07-11,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Second-Quarter 2024 Conference Call
WST,2024-07-11,10:00:06,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Second-Quarter 2024 Conference Call
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.87B-$2.9B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.87B-$2.9B >WST
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Second-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Net sales of $702.1 million declined 6.9%,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.44,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.51, compared to $2.06 in the same period last year",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: The Company is updating full-year 2024 net sales guidance to a range of $2.870 billion to $2.900 billion,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: The Company is updating full-year 2024 adjusted-diluted EPS guidance to a range of $6.35 to $6.65,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: our second-quarter revenues increase sequentially.,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.34,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $190.8 million, an increase of 21.1%",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 1,239,015 shares for $454.1 million",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2024 Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending is expected to be $375 million,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Adj EPS $1.52,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Adj EPS $1.52 >WST
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -2-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 702.1,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -2-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 230.0,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -2-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -2-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.52 $ 2.08 $,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -2-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $6.35,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $6.35-Adj EPS $6.65 >WST
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -3-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -3-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -3-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2024 Results -3-
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $6.31,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $6.31-EPS $6.61 >WST
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q EPS $1.51,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q EPS $1.51 >WST
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Net $111.3M,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Net $111.3M >WST
WST,2024-07-25,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 2Q Sales $702.1M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Sales $702.1M >WST
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Second-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Net sales of $702.1 million declined 6.9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.44,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.51, compared to $2.06 in the same period last year",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -3-
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: The Company is updating full-year 2024 net sales guidance to a range of $2.870 billion to $2.900 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: The Company is updating full-year 2024 adjusted-diluted EPS guidance to a range of $6.35 to $6.65,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: our second-quarter revenues increase sequentially.,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.34,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $190.8 million, an increase of 21.1%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 1,239,015 shares for $454.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2024 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending is expected to be $375 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 Results
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,96,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 702.1,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -2-
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,96,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 230.0,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -2-
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,96,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -2-
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,96,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.52 $ 2.08 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -2-
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -3-
WST,2024-07-25,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2024 -3-
WST,2024-07-25,10:25:49,BF79F5,West Pharmaceutical Services Inc.,100,-0.74,earnings,down,West Pharmaceutical Services Cuts Full-Year Outlook After,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Services Cuts Full-Year Outlook After Fall in 2Q Earnings
WST,2024-07-25,10:25:49,BF79F5,West Pharmaceutical Services Inc.,100,-0.74,earnings,down,West Pharmaceutical Services cut its guidance for 2024,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Services Cuts Full-Year Outlook After Fall in 2Q Earnings
WST,2024-07-25,12:05:54,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: the ""Company"") issued a press release announcing its second-quarter 2024 financial results",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2024-07-25,12:12:48,BF79F5,West Pharmaceutical Services Inc.,100,-0.74,earnings,down,West Pharmaceutical Services Inc.: the company cut its guidance for 2024,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Shares Fall on Reduced Full-Year Outlook
WST,2024-08-06,20:51:52,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Chmn Green Registers 30,732 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"Chmn Green Registers 30,732 Of West Pharmaceutical Services >WST"
WST,2024-08-08,20:18:24,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Chmn Green Sells 30,732 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"Chmn Green Sells 30,732 Of West Pharmaceutical Services >WST"
WST,2024-08-21,07:10:16,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 2Q 2024 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 2Q 2024 (WST)"
WST,2024-08-21,20:52:37,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,Dir Hofmann Sells 617 Of West Pharmaceutical Services,TABULAR-MATERIAL,Dow Jones Newswires,Dir Hofmann Sells 617 Of West Pharmaceutical Services >WST
WST,2024-08-21,21:03:51,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Treas Witherspoon Sells 1,029 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"Treas Witherspoon Sells 1,029 Of West Pharmaceutical Services >WST"
WST,2024-09-05,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2024-09-05,10:02:32,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2024-10-09,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.4,products-services,,West Wins Heart of Pharma Award,PRESS-RELEASE,PR Newswire,West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards
WST,2024-10-09,10:08:02,BF79F5,West Pharmaceutical Services Inc.,100,0.4,products-services,,West Wins Heart of Pharma Award,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards
WST,2024-10-10,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Third-Quarter 2024 Conference Call
WST,2024-10-10,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Third-Quarter 2024 Conference Call
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 3Q Sales $746.9M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Sales $746.9M >WST
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $6.55,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $6.55-Adj EPS $6.75 >WST
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2024",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Third-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharmaceutical Services Inc.: Net sales of $746.9 million declined 0.1%,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.28,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.85, compared to $2.14 in the same period last year",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: the Company increased its full year 2024 net sales guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2024 dividend of $0.21,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.13,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $272.1 million, an increase of 7.4%",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 1,409,786 shares for $506.5 million",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2024 Updated Financial Guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2024 adjusted-diluted EPS is expected to be in a range of $6.55 to $6.75,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Our updated adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For the fourth-quarter 2024, our EPS guidance",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q EPS $1.85,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q EPS $1.85 >WST
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -2-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 746.9,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -2-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 264.7,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -2-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -2-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.87 $ 2.17 $,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -2-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Adj EPS $1.85,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Adj EPS $1.85 >WST
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2024 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -3-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2022 restructuring plan,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -3-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -3-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -3-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -3-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2024 Results, -3-"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $6.52,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $6.52-EPS $6.72 >WST
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Net $136M,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Net $136M >WST
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Third-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharmaceutical Services Inc.: Net sales of $746.9 million declined 0.1%,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.28,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.85, compared to $2.14 in the same period last year",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: the Company increased its full year 2024 net sales guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2024 dividend of $0.21,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.13,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $272.1 million, an increase of 7.4%",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 1,409,786 shares for $506.5 million",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2024 Updated Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2024 adjusted-diluted EPS is expected to be in a range of $6.55 to $6.75,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Our updated adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For the fourth-quarter 2024, our EPS guidance",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2024 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend"
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2022 restructuring plan,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2024 -3-
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2024 -3-
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2024 -3-
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2024 -3-
WST,2024-10-24,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2024 -3-
WST,2024-10-24,11:51:23,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: West Pharmaceutical Services, Inc. (the ""Company"") issued a press release announcing its third-quarter 2024 financial results.",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2024-10-24,15:07:14,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,above-expectations,West Pharmaceutical Services Inc.: The company also reported better-than-expected sales in its third quarter,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Services Shares Rise 19% after Raising 2024 Outlook
WST,2024-10-29,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2024-10-29,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2024-10-31,15:51:20,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Vp Abraham Acquires 278 Of West Pharmaceutical Services >WST,TABULAR-MATERIAL,Dow Jones Newswires,VP Abraham Acquires 278 Of West Pharmaceutical Services >WST
WST,2024-10-31,16:06:32,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,Treas Witherspoon Sells 703 Of West Pharmaceutical Services,TABULAR-MATERIAL,Dow Jones Newswires,Treas Witherspoon Sells 703 Of West Pharmaceutical Services >WST
WST,2024-11-21,08:09:16,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 3Q 2024 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 3Q 2024 (WST)"
WST,2024-12-11,11:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,PRESS-RELEASE,PR Newswire,West Elects New Director to the Board
WST,2024-12-11,11:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Elects New Director to the Board
WST,2024-12-11,21:12:15,BF79F5,West Pharmaceutical Services Inc.,99,0.47,labor-issues,,"West Pharmaceutical Services Inc.: the ""Company"") elected Janet Haugen, to its Board of Directors (the ""Board"")",RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2024-12-11,21:12:15,BF79F5,West Pharmaceutical Services Inc.,93,0.47,labor-issues,,West Pharmaceutical Services Inc.: the Company issued a press release announcing the appointment of Ms. Haugen to the Board,RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Regulation FD >WST
WST,2024-12-12,16:20:52,BF79F5,West Pharmaceutical Services Inc.,100,0.94,analyst-ratings,positive,West Pharma Raised to Buy From Neutral by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Raised to Buy From Neutral by UBS
WST,2024-12-12,16:20:52,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $390.00/Share From $350.00 by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $390.00/Share From $350.00 by UBS
WST,2024-12-13,14:21:45,BF79F5,West Pharmaceutical Services Inc.,100,0.01,analyst-ratings,neutral,West Pharma Initiated at Peer Perform by Wolfe Research,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Peer Perform by Wolfe Research
WST,2024-12-13,16:15:05,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Buy by B of A Securities
WST,2024-12-13,16:15:05,BF79F5,West Pharmaceutical Services Inc.,100,0.3,price-targets,upgrade,West Pharma Price Target Raised to $355.00/Share From $350.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $355.00/Share From $350.00 by B of A Securities
WST,2024-12-13,21:08:07,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharmaceutical Services Authorizes Repurchase,RNS-SEC8K,Dow Jones Newswires,"West Pharmaceutical Services Authorizes Repurchase of Up to 550,000 Shares"
WST,2024-12-13,21:23:36,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services to Buy Back Up To 550,000 Shares",FULL-ARTICLE,Dow Jones Newswires,"West Pharmaceutical Services to Buy Back Up To 550,000 Shares"
WST,2021-01-20,09:33:30,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 4Q 2020 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 4Q 2020 (WST)"
WST,2021-01-21,17:45:12,BF79F5,West Pharmaceutical Services Inc.,94,0.49,partnerships,,West Pharmaceutical Services Inc.: has cooperated with the company throughout,FULL-ARTICLE,Dow Jones Newswires,Race-West Identifies Farm in Connection With Butternut Squash Recalls
WST,2021-02-04,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2020 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2020 Conference Call
WST,2021-02-04,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2020 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2020 Conference Call
WST,2021-02-04,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2020 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2020 Conference Call
WST,2021-02-04,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2020 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2020 Conference Call
WST,2021-02-17,17:28:18,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Ceo Green Surrenders 92 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,CEO Green Surrenders 92 Of West Pharmaceutical Services >WST
WST,2021-02-17,17:28:42,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Montecalvo Surrenders 9 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Montecalvo Surrenders 9 Of West Pharmaceutical Services >WST
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.32,earnings,,West Announces Fourth-Quarter and Full-Year 2020 Results,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Fourth-Quarter and Full-Year 2020 Results,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.42,revenues,up,West Pharmaceutical Services Inc.: Fourth-quarter 2020 net sales of $580.2 million grew 23.3%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Full-year 2020 net sales of $2.147 billion grew 16.7%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2020 reported-diluted EPS of $1.29,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2020 reported-diluted EPS of $4.57,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2020 adjusted-diluted EPS of $1.34,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2020 adjusted-diluted EPS of $4.76,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,products-services,,West Pharmaceutical Services Inc.: Contract-Manufactured Products,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,"West Pharmaceutical Services Inc.: In the full-year 2020, net sales grew by 12.9% to $498.6 million",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures were $174.4 million,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2021 Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.500 billion to $2.525 billion,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 reported-diluted EPS is expected to be in a range of $6.00 to $6.15,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2021 capital spending is expected,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.33 $0.86,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Twelve Months Ended December 31, December 31, Net Sales",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,assets,sale,West Pharmaceutical Services Inc.: the Company recorded a net gain on the sale of fixed assets,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q EPS $1.29,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q EPS $1.29 >WST
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Adj EPS $1.34,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Adj EPS $1.34 >WST
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Net $98.4M,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Net $98.4M >WST
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 4Q Sales $580.2M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Sales $580.2M >WST
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.32,earnings,,West Announces Fourth-Quarter and Full-Year 2020 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Fourth-Quarter and Full-Year 2020 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.42,revenues,up,West Pharmaceutical Services Inc.: Fourth-quarter 2020 net sales of $580.2 million grew 23.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Full-year 2020 net sales of $2.147 billion grew 16.7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2020 reported-diluted EPS of $1.29,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2020 reported-diluted EPS of $4.57,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2020 adjusted-diluted EPS of $1.34,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2020 adjusted-diluted EPS of $4.76,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,products-services,,West Pharmaceutical Services Inc.: Contract-Manufactured Products,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,"West Pharmaceutical Services Inc.: In the full-year 2020, net sales grew by 12.9% to $498.6 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures were $174.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2021 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.500 billion to $2.525 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 reported-diluted EPS is expected to be in a range of $6.00 to $6.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2021 capital spending is expected,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $580.2,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.33 $0.86,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,assets,sale,West Pharmaceutical Services Inc.: the Company recorded a net gain on the sale of fixed assets,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2021-02-18,11:02:23,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $6.00,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $6.00-EPS $6.15 >WST
WST,2021-02-18,11:02:23,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.5B-$2.53B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.5B-$2.53B >WST
WST,2021-02-18,11:16:18,BF79F5,West Pharmaceutical Services Inc.,100,0.64,earnings,up,"West Pharmaceuticals Services 4Q Profit, Sales Rise",FULL-ARTICLE,Dow Jones Newswires,"West Pharmaceuticals Services 4Q Profit, Sales Rise on Pandemic-Associated Sales"
WST,2021-02-18,11:23:47,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceuticals Services Inc. said it expects 2021 sales to grow,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceuticals Services Expects Sales to Grow Up to About 18% in 2021
WST,2021-02-18,11:23:47,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: The company said it expects full-year earnings,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceuticals Services Expects Sales to Grow Up to About 18% in 2021
WST,2021-02-18,18:28:36,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services, Inc. CEO Eric Green on Q4 2020 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q4 2020 Results -- Earnings Call Transcript >WST"
WST,2021-02-18,18:28:36,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West-pharmaceutical-services-inc-wst-ceo-eric-green-on-q4-2020-results-earnings,NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q4 2020 Results -- Earnings Call Transcript >WST"
WST,2021-02-24,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a second-quarter 2021 dividend of $0.17,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Dividend
WST,2021-02-24,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on May 5, 2021",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Dividend
WST,2021-02-24,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a second-quarter 2021 dividend of $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Dividend
WST,2021-02-24,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on May 5, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Dividend
WST,2021-03-01,21:55:57,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Officer Abraham Surrenders 677 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,Officer Abraham Surrenders 677 Of West Pharmaceutical Services >WST
WST,2021-03-17,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.0,marketing,,"West Pharmaceutical Services, Inc. (NYSE: WST) announced that management will present virtually at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum",PRESS-RELEASE,PR Newswire,West Announces Participation in Upcoming Investor Conference
WST,2021-03-17,10:01:05,BF79F5,West Pharmaceutical Services Inc.,99,0.0,marketing,,"West Pharmaceutical Services, Inc. (NYSE: WST) announced that management will present virtually at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Participation in Upcoming Investor Conference
WST,2021-04-15,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2021 Conference Call,PRESS-RELEASE,PR Newswire,West to Host First-Quarter 2021 Conference Call
WST,2021-04-15,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2021 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host First-Quarter 2021 Conference Call
WST,2021-04-20,08:28:43,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 1Q 2021 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 1Q 2021 (WST)"
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.5,revenues,up,West Pharmaceutical Services Inc.: Net sales of $670.7 million grew 36.5%,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.99,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.630 billion to $2.655 billion,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: increased demand for our products,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: we are raising our full-year financial guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $54.7 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 479,000 shares for $137.1 million",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2021 Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS is expected to be in a range of $6.95 to $7.10,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, 2021 2020 Net sales $670.7",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.04 $1.01,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, Net Sales",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 1Q Sales $670.7M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Sales $670.7M >WST
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q EPS $1.99,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q EPS $1.99 >WST
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Adj EPS $2.05,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Adj EPS $2.05 >WST
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $6.95,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $6.95-Adj EPS $7.10 >WST
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.63B-$2.66B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.63B-$2.66B >WST
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Net $151.2M,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Net $151.2M >WST
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.5,revenues,up,West Pharmaceutical Services Inc.: Net sales of $670.7 million grew 36.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.99,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.630 billion to $2.655 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: increased demand for our products,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: we are raising our full-year financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $54.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 479,000 shares for $137.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2021 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS is expected to be in a range of $6.95 to $7.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, 2021 2020 Net sales $670.7",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.04 $1.01,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, Net Sales",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 -2-
WST,2021-04-29,10:04:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Had Seen 2021 Adjusted EPS $6.00-$6.15,NEWS-FLASH,Dow Jones Newswires,West Pharma Had Seen 2021 Adjusted EPS $6.00-$6.15 >WST
WST,2021-04-29,10:26:45,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,above-expectations,"West Pharmaceutical 1Q Profit, Sales Beat Expectations",FULL-ARTICLE,Dow Jones Newswires,"West Pharmaceutical 1Q Profit, Sales Beat Expectations"
WST,2021-04-29,10:26:45,BF79F5,West Pharmaceutical Services Inc.,100,0.64,earnings,up,West Pharmaceutical Services Inc. posted a rise in first-quarter profit,FULL-ARTICLE,Dow Jones Newswires,"West Pharmaceutical 1Q Profit, Sales Beat Expectations"
WST,2021-04-30,23:08:53,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services, Inc. CEO Eric Green on Q1 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q1 2021 Results -- Earnings Call Transcript >WST"
WST,2021-04-30,23:08:53,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West-pharmaceutical-services-inc-wst-ceo-eric-green-on-q1-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q1 2021 Results -- Earnings Call Transcript >WST"
WST,2021-05-05,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a third-quarter 2021 dividend of $0.17,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conference
WST,2021-05-05,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on August 4, 2021",PRESS-RELEASE,PR Newswire,West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conference
WST,2021-05-05,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a third-quarter 2021 dividend of $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conference
WST,2021-05-05,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on August 4, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conference
WST,2021-05-07,18:28:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Winters Surrenders 10 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Winters Surrenders 10 Of West Pharmaceutical Services >WST
WST,2021-05-10,20:50:52,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Officer Abraham Sells 2,171 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"Officer Abraham Sells 2,171 Of West Pharmaceutical Services >WST"
WST,2021-06-22,14:15:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,"Cfo Birkett Surrenders 1,090 Of West Pharmaceutical Services >WST",FULL-ARTICLE,Dow Jones Newswires,"CFO Birkett Surrenders 1,090 Of West Pharmaceutical Services >WST"
WST,2021-07-15,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2021 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Second-Quarter 2021 Conference Call
WST,2021-07-15,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2021 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Second-Quarter 2021 Conference Call
WST,2021-07-21,07:21:31,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 2Q 2021 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 2Q 2021 (WST)"
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q EPS $2.47,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q EPS $2.47 >WST
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 2Q Sales $723.6M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Sales $723.6M >WST
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $8.05,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $8.05-Adj EPS $8.20 >WST
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.52,revenues,up,West Pharmaceutical Services Inc.: Net sales of $723.6 million grew 37.3%,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.47,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Company is raising full-year 2021 net sales,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: increased demand for our products,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: increased demand for our high-value product,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: we are raising our full-year financial guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,-0.56,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $111.6 million, an increase of 61%",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 479,000 shares for $137.1 million",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.760 billion to $2.785 billion,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS is expected to be in a range of $8.05 to $8.20,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Adj EPS $2.46,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Adj EPS $2.46 >WST
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 315.1,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.53 $1.24,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Six Months Ended June 30, June 30, Net Sales",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -3-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -3-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.76B-$2.79B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.76B-$2.79B >WST
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Net $187.3M,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Net $187.3M >WST
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.52,revenues,up,West Pharmaceutical Services Inc.: Net sales of $723.6 million grew 37.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Company is raising full-year 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: increased demand for our products,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: increased demand for our high-value product,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: we are raising our full-year financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,-0.56,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $111.6 million, an increase of 61%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 479,000 shares for $137.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.760 billion to $2.785 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS is expected to be in a range of $8.05 to $8.20,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.53 $1.24,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Six Months Ended June 30, June 30, Net Sales",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 -3-
WST,2021-07-29,10:17:58,BF79F5,West Pharmaceutical Services Inc.,100,0.64,earnings,up,West Pharmaceutical 2Q Earnings Rise,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical 2Q Earnings Rise on Stronger Demand
WST,2021-07-29,10:17:58,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc. Thursday posted sales and earnings growth in the latest quarter,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical 2Q Earnings Rise on Stronger Demand
WST,2021-07-29,10:23:18,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Raises Full-Year Outlook,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Raises Full-Year Outlook
WST,2021-07-29,18:38:44,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services, Inc. CEO Eric Green on Q2 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q2 2021 Results -- Earnings Call Transcript >WST"
WST,2021-07-29,18:38:44,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West-pharmaceutical-services-inc-wst-ceo-eric-green-on-q2-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q2 2021 Results -- Earnings Call Transcript >WST"
WST,2021-07-30,10:05:14,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2021-07-30,10:05:14,BF79F5,West Pharmaceutical Services Inc.,100,0.82,price-targets,upgrade,West Pharma Price Target Raised to $475.00/Share From $350.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $475.00/Share From $350.00 by Keybanc
WST,2021-08-23,20:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,PRESS-RELEASE,PR Newswire,West Elects New Director to the Board
WST,2021-08-23,20:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Pharmaceutical Services Inc.: As CEO,PRESS-RELEASE,PR Newswire,West Elects New Director to the Board
WST,2021-08-23,20:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Elects New Director to the Board
WST,2021-08-23,20:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Pharmaceutical Services Inc.: As CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Elects New Director to the Board
WST,2021-08-23,20:30:52,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,NEWS-FLASH,Dow Jones Newswires,West Elects New Director to the Bd
WST,2021-09-13,14:51:51,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,"Dir Zenner Gifts 11,827 Of West Pharmaceutical Services >WST",FULL-ARTICLE,Dow Jones Newswires,"Dir Zenner Gifts 11,827 Of West Pharmaceutical Services >WST"
WST,2021-09-14,14:46:05,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Lai Sells 9,672 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"VP Lai Sells 9,672 Of West Pharmaceutical Services >WST"
WST,2021-09-27,21:01:20,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Montecalvo Surrenders 620 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Montecalvo Surrenders 620 Of West Pharmaceutical Services >WST
WST,2021-10-14,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2021 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Third-Quarter 2021 Conference Call
WST,2021-10-14,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2021 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Third-Quarter 2021 Conference Call
WST,2021-10-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.56,products-services,,West Pharmaceutical Services Inc.: has won the INTERPHEX Best Technologies Innovation Award,PRESS-RELEASE,PR Newswire,West's NovaGuard(R) SA Pro Safety System Recognized for Best Technologies Innovation at INTERPHEX
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2021",PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.46,revenues,up,West Pharmaceutical Services Inc.: Net sales of $706.5 million grew 28.9%,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.31,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Company is raising full-year 2021 net sales,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2021 dividend of $0.18,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on November 17, 2021",PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $176.9 million, an increase of 51.6%",PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 479,000 shares for $137.1 million",PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2021 Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.800 billion to $2.810 billion,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS is expected to be in a range of $8.40 to $8.50,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 3Q Sales $706.5M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Sales $706.5M >WST
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $8.40,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $8.40-Adj EPS $8.50 >WST
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.37 $1.11,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Nine Months Ended September 30, September 30, Net Sales",PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q EPS $2.31,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q EPS $2.31 >WST
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Adj EPS $2.06,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Adj EPS $2.06 >WST
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.8B-$2.81B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.8B-$2.81B >WST
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and -3-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and -3-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Net $175.6M,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Net $175.6M >WST
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.46,revenues,up,West Pharmaceutical Services Inc.: Net sales of $706.5 million grew 28.9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Company is raising full-year 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2021 dividend of $0.18,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on November 17, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $176.9 million, an increase of 51.6%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 479,000 shares for $137.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2021 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.800 billion to $2.810 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS is expected to be in a range of $8.40 to $8.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.37 $1.11,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Nine Months Ended September 30, September 30, Net Sales",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 -3-
WST,2021-10-28,10:04:42,BF79F5,West Pharmaceutical Services Inc.,100,0.62,dividends,up,West Pharma Raises Dividend to 18c,NEWS-FLASH,Dow Jones Newswires,West Pharma Raises Dividend to 18c >WST
WST,2021-10-28,17:45:33,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West-pharmaceutical-services-wst-ceo-eric-green-on-q3-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,West Pharmaceutical Services' CEO Eric Green on Q3 2021 Results -- Earnings Call Transcript >WST
WST,2021-10-28,17:45:33,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services' CEO Eric Green on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,West Pharmaceutical Services' CEO Eric Green on Q3 2021 Results -- Earnings Call Transcript >WST
WST,2021-11-01,19:06:36,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Winters Surrenders 47 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Winters Surrenders 47 Of West Pharmaceutical Services >WST
WST,2021-11-11,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2021-11-11,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2021-11-17,21:42:05,BF79F5,West Pharmaceutical Services Inc.,100,0.46,credit-ratings,set,Moody's Assigns Aa1 To West Co.,NEWS-FLASH,Dow Jones Newswires,"Moody's Assigns Aa1 To West Co. Ems & Fire Protection District, Mo's Go Refunding Bonds"
WST,2021-12-27,21:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2021-01-20,09:33:30,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 4Q 2020 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 4Q 2020 (WST)"
WST,2021-01-21,17:45:12,BF79F5,West Pharmaceutical Services Inc.,94,0.49,partnerships,,West Pharmaceutical Services Inc.: has cooperated with the company throughout,FULL-ARTICLE,Dow Jones Newswires,Race-West Identifies Farm in Connection With Butternut Squash Recalls
WST,2021-02-04,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2020 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2020 Conference Call
WST,2021-02-04,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2020 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2020 Conference Call
WST,2021-02-04,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2020 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2020 Conference Call
WST,2021-02-04,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2020 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2020 Conference Call
WST,2021-02-17,17:28:18,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Ceo Green Surrenders 92 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,CEO Green Surrenders 92 Of West Pharmaceutical Services >WST
WST,2021-02-17,17:28:42,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Montecalvo Surrenders 9 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Montecalvo Surrenders 9 Of West Pharmaceutical Services >WST
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.32,earnings,,West Announces Fourth-Quarter and Full-Year 2020 Results,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Fourth-Quarter and Full-Year 2020 Results,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.42,revenues,up,West Pharmaceutical Services Inc.: Fourth-quarter 2020 net sales of $580.2 million grew 23.3%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Full-year 2020 net sales of $2.147 billion grew 16.7%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2020 reported-diluted EPS of $1.29,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2020 reported-diluted EPS of $4.57,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2020 adjusted-diluted EPS of $1.34,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2020 adjusted-diluted EPS of $4.76,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,products-services,,West Pharmaceutical Services Inc.: Contract-Manufactured Products,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,"West Pharmaceutical Services Inc.: In the full-year 2020, net sales grew by 12.9% to $498.6 million",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures were $174.4 million,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2021 Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.500 billion to $2.525 billion,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 reported-diluted EPS is expected to be in a range of $6.00 to $6.15,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2021 capital spending is expected,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.33 $0.86,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Twelve Months Ended December 31, December 31, Net Sales",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,assets,sale,West Pharmaceutical Services Inc.: the Company recorded a net gain on the sale of fixed assets,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2020 -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q EPS $1.29,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q EPS $1.29 >WST
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Adj EPS $1.34,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Adj EPS $1.34 >WST
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Net $98.4M,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Net $98.4M >WST
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 4Q Sales $580.2M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Sales $580.2M >WST
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.32,earnings,,West Announces Fourth-Quarter and Full-Year 2020 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Fourth-Quarter and Full-Year 2020 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.42,revenues,up,West Pharmaceutical Services Inc.: Fourth-quarter 2020 net sales of $580.2 million grew 23.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Full-year 2020 net sales of $2.147 billion grew 16.7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2020 reported-diluted EPS of $1.29,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2020 reported-diluted EPS of $4.57,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2020 adjusted-diluted EPS of $1.34,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2020 adjusted-diluted EPS of $4.76,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,products-services,,West Pharmaceutical Services Inc.: Contract-Manufactured Products,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,"West Pharmaceutical Services Inc.: In the full-year 2020, net sales grew by 12.9% to $498.6 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures were $174.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2021 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.500 billion to $2.525 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 reported-diluted EPS is expected to be in a range of $6.00 to $6.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2021 capital spending is expected,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2020 Results
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $580.2,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.33 $0.86,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2021-02-18,11:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,assets,sale,West Pharmaceutical Services Inc.: the Company recorded a net gain on the sale of fixed assets,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2021-02-18,11:02:23,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $6.00,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $6.00-EPS $6.15 >WST
WST,2021-02-18,11:02:23,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.5B-$2.53B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.5B-$2.53B >WST
WST,2021-02-18,11:16:18,BF79F5,West Pharmaceutical Services Inc.,100,0.64,earnings,up,"West Pharmaceuticals Services 4Q Profit, Sales Rise",FULL-ARTICLE,Dow Jones Newswires,"West Pharmaceuticals Services 4Q Profit, Sales Rise on Pandemic-Associated Sales"
WST,2021-02-18,11:23:47,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceuticals Services Inc. said it expects 2021 sales to grow,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceuticals Services Expects Sales to Grow Up to About 18% in 2021
WST,2021-02-18,11:23:47,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: The company said it expects full-year earnings,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceuticals Services Expects Sales to Grow Up to About 18% in 2021
WST,2021-02-18,18:28:36,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services, Inc. CEO Eric Green on Q4 2020 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q4 2020 Results -- Earnings Call Transcript >WST"
WST,2021-02-18,18:28:36,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West-pharmaceutical-services-inc-wst-ceo-eric-green-on-q4-2020-results-earnings,NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q4 2020 Results -- Earnings Call Transcript >WST"
WST,2021-02-24,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a second-quarter 2021 dividend of $0.17,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Dividend
WST,2021-02-24,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on May 5, 2021",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Dividend
WST,2021-02-24,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a second-quarter 2021 dividend of $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Dividend
WST,2021-02-24,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on May 5, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Dividend
WST,2021-03-01,21:55:57,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Officer Abraham Surrenders 677 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,Officer Abraham Surrenders 677 Of West Pharmaceutical Services >WST
WST,2021-03-17,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.0,marketing,,"West Pharmaceutical Services, Inc. (NYSE: WST) announced that management will present virtually at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum",PRESS-RELEASE,PR Newswire,West Announces Participation in Upcoming Investor Conference
WST,2021-03-17,10:01:05,BF79F5,West Pharmaceutical Services Inc.,99,0.0,marketing,,"West Pharmaceutical Services, Inc. (NYSE: WST) announced that management will present virtually at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Participation in Upcoming Investor Conference
WST,2021-04-15,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2021 Conference Call,PRESS-RELEASE,PR Newswire,West to Host First-Quarter 2021 Conference Call
WST,2021-04-15,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2021 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host First-Quarter 2021 Conference Call
WST,2021-04-20,08:28:43,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 1Q 2021 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 1Q 2021 (WST)"
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.5,revenues,up,West Pharmaceutical Services Inc.: Net sales of $670.7 million grew 36.5%,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.99,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.630 billion to $2.655 billion,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: increased demand for our products,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: we are raising our full-year financial guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $54.7 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 479,000 shares for $137.1 million",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2021 Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS is expected to be in a range of $6.95 to $7.10,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, 2021 2020 Net sales $670.7",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.04 $1.01,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, Net Sales",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2021 Results -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 1Q Sales $670.7M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Sales $670.7M >WST
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q EPS $1.99,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q EPS $1.99 >WST
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Adj EPS $2.05,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Adj EPS $2.05 >WST
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $6.95,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $6.95-Adj EPS $7.10 >WST
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.63B-$2.66B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.63B-$2.66B >WST
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Net $151.2M,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Net $151.2M >WST
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.5,revenues,up,West Pharmaceutical Services Inc.: Net sales of $670.7 million grew 36.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.99,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.630 billion to $2.655 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: increased demand for our products,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: we are raising our full-year financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $54.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 479,000 shares for $137.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2021 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS is expected to be in a range of $6.95 to $7.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, 2021 2020 Net sales $670.7",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 Results
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.04 $1.01,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, Net Sales",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 -2-
WST,2021-04-29,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2021 -2-
WST,2021-04-29,10:04:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Had Seen 2021 Adjusted EPS $6.00-$6.15,NEWS-FLASH,Dow Jones Newswires,West Pharma Had Seen 2021 Adjusted EPS $6.00-$6.15 >WST
WST,2021-04-29,10:26:45,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,above-expectations,"West Pharmaceutical 1Q Profit, Sales Beat Expectations",FULL-ARTICLE,Dow Jones Newswires,"West Pharmaceutical 1Q Profit, Sales Beat Expectations"
WST,2021-04-29,10:26:45,BF79F5,West Pharmaceutical Services Inc.,100,0.64,earnings,up,West Pharmaceutical Services Inc. posted a rise in first-quarter profit,FULL-ARTICLE,Dow Jones Newswires,"West Pharmaceutical 1Q Profit, Sales Beat Expectations"
WST,2021-04-30,23:08:53,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services, Inc. CEO Eric Green on Q1 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q1 2021 Results -- Earnings Call Transcript >WST"
WST,2021-04-30,23:08:53,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West-pharmaceutical-services-inc-wst-ceo-eric-green-on-q1-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q1 2021 Results -- Earnings Call Transcript >WST"
WST,2021-05-05,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a third-quarter 2021 dividend of $0.17,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conference
WST,2021-05-05,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on August 4, 2021",PRESS-RELEASE,PR Newswire,West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conference
WST,2021-05-05,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a third-quarter 2021 dividend of $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conference
WST,2021-05-05,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on August 4, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conference
WST,2021-05-07,18:28:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Winters Surrenders 10 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Winters Surrenders 10 Of West Pharmaceutical Services >WST
WST,2021-05-10,20:50:52,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Officer Abraham Sells 2,171 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"Officer Abraham Sells 2,171 Of West Pharmaceutical Services >WST"
WST,2021-06-22,14:15:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,"Cfo Birkett Surrenders 1,090 Of West Pharmaceutical Services >WST",FULL-ARTICLE,Dow Jones Newswires,"CFO Birkett Surrenders 1,090 Of West Pharmaceutical Services >WST"
WST,2021-07-15,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2021 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Second-Quarter 2021 Conference Call
WST,2021-07-15,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2021 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Second-Quarter 2021 Conference Call
WST,2021-07-21,07:21:31,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 2Q 2021 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 2Q 2021 (WST)"
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q EPS $2.47,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q EPS $2.47 >WST
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 2Q Sales $723.6M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Sales $723.6M >WST
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $8.05,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $8.05-Adj EPS $8.20 >WST
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.52,revenues,up,West Pharmaceutical Services Inc.: Net sales of $723.6 million grew 37.3%,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.47,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Company is raising full-year 2021 net sales,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: increased demand for our products,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: increased demand for our high-value product,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: we are raising our full-year financial guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,-0.56,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $111.6 million, an increase of 61%",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 479,000 shares for $137.1 million",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.760 billion to $2.785 billion,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS is expected to be in a range of $8.05 to $8.20,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Adj EPS $2.46,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Adj EPS $2.46 >WST
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 315.1,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.53 $1.24,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Six Months Ended June 30, June 30, Net Sales",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -3-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2021 Results -3-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.76B-$2.79B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.76B-$2.79B >WST
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Net $187.3M,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Net $187.3M >WST
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.52,revenues,up,West Pharmaceutical Services Inc.: Net sales of $723.6 million grew 37.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Company is raising full-year 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: increased demand for our products,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: increased demand for our high-value product,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: we are raising our full-year financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,-0.56,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $111.6 million, an increase of 61%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 479,000 shares for $137.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.760 billion to $2.785 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS is expected to be in a range of $8.05 to $8.20,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 Results
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.53 $1.24,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Six Months Ended June 30, June 30, Net Sales",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 -2-
WST,2021-07-29,10:00:26,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2021 -3-
WST,2021-07-29,10:17:58,BF79F5,West Pharmaceutical Services Inc.,100,0.64,earnings,up,West Pharmaceutical 2Q Earnings Rise,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical 2Q Earnings Rise on Stronger Demand
WST,2021-07-29,10:17:58,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc. Thursday posted sales and earnings growth in the latest quarter,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical 2Q Earnings Rise on Stronger Demand
WST,2021-07-29,10:23:18,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Raises Full-Year Outlook,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Raises Full-Year Outlook
WST,2021-07-29,18:38:44,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services, Inc. CEO Eric Green on Q2 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q2 2021 Results -- Earnings Call Transcript >WST"
WST,2021-07-29,18:38:44,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West-pharmaceutical-services-inc-wst-ceo-eric-green-on-q2-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q2 2021 Results -- Earnings Call Transcript >WST"
WST,2021-07-30,10:05:14,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2021-07-30,10:05:14,BF79F5,West Pharmaceutical Services Inc.,100,0.82,price-targets,upgrade,West Pharma Price Target Raised to $475.00/Share From $350.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $475.00/Share From $350.00 by Keybanc
WST,2021-08-23,20:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,PRESS-RELEASE,PR Newswire,West Elects New Director to the Board
WST,2021-08-23,20:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Pharmaceutical Services Inc.: As CEO,PRESS-RELEASE,PR Newswire,West Elects New Director to the Board
WST,2021-08-23,20:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Elects New Director to the Board
WST,2021-08-23,20:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Pharmaceutical Services Inc.: As CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Elects New Director to the Board
WST,2021-08-23,20:30:52,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,NEWS-FLASH,Dow Jones Newswires,West Elects New Director to the Bd
WST,2021-09-13,14:51:51,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,"Dir Zenner Gifts 11,827 Of West Pharmaceutical Services >WST",FULL-ARTICLE,Dow Jones Newswires,"Dir Zenner Gifts 11,827 Of West Pharmaceutical Services >WST"
WST,2021-09-14,14:46:05,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Lai Sells 9,672 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"VP Lai Sells 9,672 Of West Pharmaceutical Services >WST"
WST,2021-09-27,21:01:20,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Montecalvo Surrenders 620 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Montecalvo Surrenders 620 Of West Pharmaceutical Services >WST
WST,2021-10-14,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2021 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Third-Quarter 2021 Conference Call
WST,2021-10-14,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2021 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Third-Quarter 2021 Conference Call
WST,2021-10-25,10:00:04,BF79F5,West Pharmaceutical Services Inc.,99,0.56,products-services,,West Pharmaceutical Services Inc.: has won the INTERPHEX Best Technologies Innovation Award,PRESS-RELEASE,PR Newswire,West's NovaGuard(R) SA Pro Safety System Recognized for Best Technologies Innovation at INTERPHEX
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2021",PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.46,revenues,up,West Pharmaceutical Services Inc.: Net sales of $706.5 million grew 28.9%,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.31,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Company is raising full-year 2021 net sales,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2021 dividend of $0.18,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on November 17, 2021",PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $176.9 million, an increase of 51.6%",PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 479,000 shares for $137.1 million",PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2021 Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.800 billion to $2.810 billion,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS is expected to be in a range of $8.40 to $8.50,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 3Q Sales $706.5M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Sales $706.5M >WST
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $8.40,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $8.40-Adj EPS $8.50 >WST
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.37 $1.11,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Nine Months Ended September 30, September 30, Net Sales",PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q EPS $2.31,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q EPS $2.31 >WST
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Adj EPS $2.06,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Adj EPS $2.06 >WST
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.8B-$2.81B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.8B-$2.81B >WST
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2021 Results,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and -3-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Third-Quarter 2021 Results and -3-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Net $175.6M,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Net $175.6M >WST
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.46,revenues,up,West Pharmaceutical Services Inc.: Net sales of $706.5 million grew 28.9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Company is raising full-year 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2021 dividend of $0.18,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on November 17, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $176.9 million, an increase of 51.6%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 479,000 shares for $137.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2021 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2021 net sales are expected to be in a range of $2.800 billion to $2.810 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS is expected to be in a range of $8.40 to $8.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.37 $1.11,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Nine Months Ended September 30, September 30, Net Sales",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 -2-
WST,2021-10-28,10:00:14,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2021 -3-
WST,2021-10-28,10:04:42,BF79F5,West Pharmaceutical Services Inc.,100,0.62,dividends,up,West Pharma Raises Dividend to 18c,NEWS-FLASH,Dow Jones Newswires,West Pharma Raises Dividend to 18c >WST
WST,2021-10-28,17:45:33,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West-pharmaceutical-services-wst-ceo-eric-green-on-q3-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,West Pharmaceutical Services' CEO Eric Green on Q3 2021 Results -- Earnings Call Transcript >WST
WST,2021-10-28,17:45:33,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services' CEO Eric Green on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,West Pharmaceutical Services' CEO Eric Green on Q3 2021 Results -- Earnings Call Transcript >WST
WST,2021-11-01,19:06:36,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Winters Surrenders 47 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Winters Surrenders 47 Of West Pharmaceutical Services >WST
WST,2021-11-11,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2021-11-11,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2021-11-17,21:42:05,BF79F5,West Pharmaceutical Services Inc.,100,0.46,credit-ratings,set,Moody's Assigns Aa1 To West Co.,NEWS-FLASH,Dow Jones Newswires,"Moody's Assigns Aa1 To West Co. Ems & Fire Protection District, Mo's Go Refunding Bonds"
WST,2021-12-27,21:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2022-01-05,13:15:03,BF79F5,West Pharmaceutical Services Inc.,99,0.44,products-services,,"West Expands Operations in Juarez, Mexico",PRESS-RELEASE,PR Newswire,East West Manufacturing Acquires Texas and Mexico-based Operations of Compass Electronics Solutions
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors have approved a first-quarter 2022 dividend of $0.18,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on February 2, 2022",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharmaceutical Services Inc.: The Company's Board of Directors authorized a share repurchase program,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2022 Dividend,NEWS-FLASH,Dow Jones Newswires,West Announces First-Quarter 2022 Dividend And 2022 Share Repurchase Program >WST
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors have approved a first-quarter 2022 dividend of $0.18,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on February 2, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharmaceutical Services Inc.: The Company's Board of Directors authorized a share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program
WST,2022-01-05,21:33:36,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharma Says Board Authorized Share-Repurchase Program for 2022,NEWS-FLASH,Dow Jones Newswires,"West Pharma Says Board Authorized Share-Repurchase Program for 2022 of Up to 650,000 Shares of Its Common Stock >WST"
WST,2022-01-21,09:16:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 4Q 2021 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 4Q 2021 (WST)"
WST,2022-01-25,11:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.49,partnerships,,West and Corning have developed this exceptional collaboration to,PRESS-RELEASE,PR Newswire,West Announces Landmark Collaboration with Corning in Pharmaceutical Injectable Drug Delivery
WST,2022-01-25,11:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.49,partnerships,,West and Corning have developed this exceptional collaboration to,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Landmark Collaboration with Corning in Pharmaceutical Injectable Drug Delivery
WST,2022-01-25,11:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.49,partnerships,,West Announces Landmark Collaboration With Corning in,NEWS-FLASH,Dow Jones Newswires,West Announces Landmark Collaboration With Corning in Pharmaceutical Injectable Drug Delivery
WST,2022-02-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2021 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2021 Conference Call
WST,2022-02-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2021 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2021 Conference Call
WST,2022-02-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2021 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2021 Conference Call
WST,2022-02-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2021 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2021 Conference Call
WST,2022-02-11,12:56:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,"Ceo Green Gifts 3,150 Of West Pharmaceutical Services >WST",FULL-ARTICLE,Dow Jones Newswires,"CEO Green Gifts 3,150 Of West Pharmaceutical Services >WST"
WST,2022-02-14,22:47:53,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Ceo Green Surrenders 85 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,CEO Green Surrenders 85 Of West Pharmaceutical Services >WST
WST,2022-02-14,22:55:52,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Montecalvo Surrenders 27 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Montecalvo Surrenders 27 Of West Pharmaceutical Services >WST
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 4Q Sales $730.8M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Sales $730.8M >WST
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2021",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2021",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.44,revenues,up,West Pharmaceutical Services Inc.: Fourth-quarter 2021 net sales of $730.8 million grew 26.0%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.48,revenues,up,West Pharmaceutical Services Inc.: Full-year 2021 net sales of $2.832 billion grew 31.9%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2021 reported-diluted EPS of $1.93,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 reported-diluted EPS of $8.67,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2021 adjusted-diluted EPS of $2.04,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS of $8.58,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Organic sales declined by 2.1%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,"West Pharmaceutical Services Inc.: In the full-year 2021, net sales grew by 3.2% to $514.7 million",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.72,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $253.4 million, compared with $174.4 million in 2020",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2022 Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2022 net sales are expected to be in a range of $3.050 billion to $3.075 billion,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 reported-diluted EPS is expected to be in a range of $9.20 to $9.35,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected to be $380 million,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $3.05B-$3.08B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $3.05B-$3.08B >WST
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.98 $1.33,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 -2-
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Twelve Months Ended December 31, December 31, Net Sales",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 -2-
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 -2-
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q EPS $1.93,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q EPS $1.93 >WST
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,95,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 -3-
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Adj EPS $2.04,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Adj EPS $2.04 >WST
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Net $147.7M,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Net $147.7M >WST
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.44,revenues,up,West Pharmaceutical Services Inc.: Fourth-quarter 2021 net sales of $730.8 million grew 26.0%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.48,revenues,up,West Pharmaceutical Services Inc.: Full-year 2021 net sales of $2.832 billion grew 31.9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2021 reported-diluted EPS of $1.93,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 reported-diluted EPS of $8.67,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2021 adjusted-diluted EPS of $2.04,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS of $8.58,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Organic sales declined by 2.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,"West Pharmaceutical Services Inc.: In the full-year 2021, net sales grew by 3.2% to $514.7 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.72,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $253.4 million, compared with $174.4 million in 2020",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2022 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2022 net sales are expected to be in a range of $3.050 billion to $3.075 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 reported-diluted EPS is expected to be in a range of $9.20 to $9.35,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected to be $380 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.98 $1.33,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Twelve Months Ended December 31, December 31, Net Sales",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2022-02-17,11:04:53,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $9.20,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $9.20-EPS $9.35 >WST
WST,2022-02-17,11:19:43,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Sees 2022 Sales Growth,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Sees 2022 Sales Growth
WST,2022-02-17,20:19:29,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services, Inc. CEO Eric Green on Q4 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q4 2021 Results -- Earnings Call Transcript >WST"
WST,2022-02-17,20:19:29,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West-pharmaceutical-services-inc-wst-ceo-eric-green-on-q4-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q4 2021 Results -- Earnings Call Transcript >WST"
WST,2022-02-23,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a second-quarter 2022 dividend of $0.18,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Dividend
WST,2022-02-23,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on May 4, 2022",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Dividend
WST,2022-02-23,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a second-quarter 2022 dividend of $0.18,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Dividend
WST,2022-02-23,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on May 4, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Dividend
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Names President,PRESS-RELEASE,PR Newswire,West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,-0.43,labor-issues,,Zenner Retires from West Board,PRESS-RELEASE,PR Newswire,West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services Inc.: the Company's Board of Directors, effective as of West's next Annual Shareholders' Meeting",PRESS-RELEASE,PR Newswire,West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Names President,NEWS-FLASH,Dow Jones Newswires,West Names President And CEO Eric M. Green As Chair Of The Board >WST
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Names President and CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Names President,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,-0.43,labor-issues,,Zenner Retires from West Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services Inc.: the Company's Board of Directors, effective as of West's next Annual Shareholders' Meeting",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-03-09,11:00:06,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2022-03-09,11:01:47,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2022-03-16,15:17:28,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Lai Sells 8,016 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"VP Lai Sells 8,016 Of West Pharmaceutical Services >WST"
WST,2022-04-01,21:54:41,BF79F5,West Pharmaceutical Services Inc.,100,0.38,credit,,West Pharmaceutical Services Amends Credit Facility,RNS-SEC8K,Dow Jones Newswires,"West Pharmaceutical Services Amends Credit Facility, Including Increase From $300M to $500M >WST"
WST,2022-04-07,13:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.49,partnerships,,"Systems collaborates with West Pharmaceutical Services, Inc. to",PRESS-RELEASE,PR Newswire,"Pneuma Systems collaborates with West Pharmaceutical Services, Inc. to improve the patient experience"
WST,2022-04-07,13:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.49,partnerships,,"Systems collaborates with West Pharmaceutical Services, Inc. to",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Pneuma Systems collaborates with West Pharmaceutical Services, Inc. to improve the patient experience"
WST,2022-04-07,13:01:58,BF79F5,West Pharmaceutical Services Inc.,100,0.49,partnerships,,"Systems Collaborates With West Pharmaceutical Services, Inc. to",NEWS-FLASH,Dow Jones Newswires,"Pneuma Systems Collaborates With West Pharmaceutical Services, Inc. to Improve the Patient Experience"
WST,2022-04-14,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2022 Conference Call,PRESS-RELEASE,PR Newswire,West to Host First-Quarter 2022 Conference Call
WST,2022-04-14,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2022 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host First-Quarter 2022 Conference Call
WST,2022-04-14,13:08:59,BF79F5,West Pharmaceutical Services Inc.,100,0.44,labor-issues,,West Pharmaceutical CEO Eric Green Received Total Compensation of $9.47M,NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical CEO Eric Green Received Total Compensation of $9.47M in 2021, Up From $7.64M in 2020"
WST,2022-04-21,08:15:30,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 1Q 2022 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 1Q 2022 (WST)"
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2022",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales of $720.0 million grew 7.4%,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.29,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2022 financial guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2022 financial guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is raising full-year 2022 financial guidance of,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a third-quarter 2022 dividend of $0.18,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on August 3, 2022",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: growing demand for our high-value products,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,"West Pharmaceutical Services Inc.: our full-year 2022 net sales guidance, raising",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Net sales declined by 6.6% to $118.7 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $65.8 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 390,000 shares for $147.1 million",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected to be $380 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, 2022 2021 Net sales $720.0",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2022 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.34 $2.04,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, Net Sales",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q EPS $2.29,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q EPS $2.29 >WST
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 1Q Sales $720M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Sales $720M >WST
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Adj EPS $2.30,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Adj EPS $2.30 >WST
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Net $173.8M,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Net $173.8M >WST
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales of $720.0 million grew 7.4%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.29,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is raising full-year 2022 financial guidance of,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a third-quarter 2022 dividend of $0.18,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on August 3, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: growing demand for our high-value products,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,"West Pharmaceutical Services Inc.: our full-year 2022 net sales guidance, raising",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Net sales declined by 6.6% to $118.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $65.8 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 390,000 shares for $147.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected to be $380 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, 2022 2021 Net sales $720.0",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.34 $2.04,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, Net Sales",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 -2-
WST,2022-04-28,10:06:53,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharma Backs FY Sales $3.05B-$3.075B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Backs FY Sales $3.05B-$3.075B >WST
WST,2022-04-28,10:07:08,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharma Raises FY View To Adj EPS $9.30,NEWS-FLASH,Dow Jones Newswires,West Pharma Raises FY View To Adj EPS $9.30-Adj EPS $9.45 >WST
WST,2022-04-28,10:07:20,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharma Declares Dividend of 18,NEWS-FLASH,Dow Jones Newswires,West Pharma Declares Dividend of 18c >WST
WST,2022-04-28,20:07:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services, Inc. CEO Eric Green on Q1 2022 Earnings Call",NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q1 2022 Earnings Call Transcript >WST"
WST,2022-04-29,09:01:12,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2022-04-29,09:01:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.82,price-targets,downgrade,West Pharma Price Target Cut to $400.00/Share From $475.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $400.00/Share From $475.00 by Keybanc
WST,2022-05-03,20:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2022-05-03,20:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2022-05-06,15:31:38,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Winters Surrenders 10 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Winters Surrenders 10 Of West Pharmaceutical Services >WST
WST,2022-05-12,20:30:05,BF79F5,West Pharmaceutical Services Inc.,99,0.53,labor-issues,,West Pharmaceutical Services Inc.: The Company also announced the hiring of Kathy dePadua as Vice President and Chief,PRESS-RELEASE,PR Newswire,West Announces Executive Leadership Appointments
WST,2022-05-12,20:30:06,BF79F5,West Pharmaceutical Services Inc.,99,0.53,labor-issues,,West Announces Executive Leadership Appointments,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Executive Leadership Appointments
WST,2022-05-12,20:48:01,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Pharma Names CFO Bernard J. Birkett to Newly Combined Position of Chief,NEWS-FLASH,Dow Jones Newswires,West Pharma Names CFO Bernard J. Birkett to Newly Combined Position of Chief Fincl and Operations Officer >WST
WST,2022-05-12,20:48:58,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,Appointed Chief Comml Officer >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Names Cindy Reiss-Clark Has Been Appointed Chief Comml Officer >WST
WST,2022-06-13,10:00:06,BF79F5,West Pharmaceutical Services Inc.,99,0.49,partnerships,,West has partnered with Daikyo in,PRESS-RELEASE,PR Newswire,West Introduces Daikyo Crystal Zenith(R) 2.25mL Insert Needle Syringe System at BIO International Convention
WST,2022-06-23,14:13:48,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Cfo Birkett Surrenders 946 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,CFO Birkett Surrenders 946 Of West Pharmaceutical Services >WST
WST,2022-07-14,21:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2022 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Second-Quarter 2022 Conference Call
WST,2022-07-14,21:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2022 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Second-Quarter 2022 Conference Call
WST,2022-07-21,08:27:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 2Q 2022 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 2Q 2022 (WST)"
WST,2022-07-27,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,PRESS-RELEASE,PR Newswire,West Elects New Director to the Board
WST,2022-07-27,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Elects New Director to the Board
WST,2022-07-27,10:00:29,BF79F5,West Pharmaceutical Services Inc.,100,0.47,labor-issues,,West Pharma Names Stephen Lockhart to Board,NEWS-FLASH,Dow Jones Newswires,West Pharma Names Stephen Lockhart to Board >WST
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.32,earnings,,West Announces Second-Quarter 2022 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.1,revenues,,West Pharmaceutical Services Inc.: Net sales of $771.3 million grew 6.6%,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.48,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: The Company is updating full-year 2022 net sales guidance to a range of $2.950 billion to $2.975 billion,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: The Company is updating full-year 2022 adjusted-diluted EPS guidance to a new range of $9.00 to $9.15,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.68,revenues,down,West Pharmaceutical Services Inc.: Segment sales declined,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.3,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $131.9 million, an increase of 18.2%",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 476,667 shares for $175.7 million",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2022 Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For second-half 2022, our EPS guidance",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected to be $380 million,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2022 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 321.5,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.53 $2.53,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Six Months Ended June 30, June 30, Net Sales",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2022 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -3-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -3-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 2Q Sales $771.3M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Sales $771.3M >WST
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q EPS $2.48,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q EPS $2.48 >WST
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Adj EPS $2.47,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Adj EPS $2.47 >WST
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Net $188.5M,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Net $188.5M >WST
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.32,earnings,,West Pharmaceutical Services Inc.: We delivered excellent second-quarter results,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.1,revenues,,West Pharmaceutical Services Inc.: Net sales of $771.3 million grew 6.6%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: The Company is updating full-year 2022 net sales guidance to a range of $2.950 billion to $2.975 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: The Company is updating full-year 2022 adjusted-diluted EPS guidance to a new range of $9.00 to $9.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.68,revenues,down,West Pharmaceutical Services Inc.: Segment sales declined,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.3,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $131.9 million, an increase of 18.2%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 476,667 shares for $175.7 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2022 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For second-half 2022, our EPS guidance",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected to be $380 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.53 $2.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Six Months Ended June 30, June 30, Net Sales",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 -3-
WST,2022-07-28,10:06:49,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.95B-$2.975B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.95B-$2.975B >WST
WST,2022-07-28,10:07:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $9,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $9-Adj EPS $9.15 >WST
WST,2022-07-28,18:26:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services, Inc.'s CEO Eric Green on Q2 2022 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc.'s CEO Eric Green on Q2 2022 Results -- Earnings Call Transcript >WST"
WST,2022-07-28,18:26:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West-pharmaceutical-services-inc-s-wst-ceo-eric-green-on-q2-2022-results-earnings,NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc.'s CEO Eric Green on Q2 2022 Results -- Earnings Call Transcript >WST"
WST,2022-08-03,16:26:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Officer Abraham Sells 5,374 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"Officer Abraham Sells 5,374 Of West Pharmaceutical Services >WST"
WST,2022-08-03,19:25:28,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Coo Birkett Sells 14,174 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"COO Birkett Sells 14,174 Of West Pharmaceutical Services >WST"
WST,2022-08-11,10:00:05,BF79F5,West Pharmaceutical Services Inc.,99,0.22,acquisitions-mergers,,West Pharmaceutical Services Inc.: West's investment in Latch Medical advances our,PRESS-RELEASE,PR Newswire,"West Makes Minority Investment in Dublin-Based Latch Medical, a Developer of Vaccine and Biologics Delivery Platforms"
WST,2022-08-11,10:00:24,BF79F5,West Pharmaceutical Services Inc.,99,0.22,acquisitions-mergers,,West Pharmaceutical Services Inc.: West's investment in Latch Medical advances our,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Makes Minority Investment in Dublin-Based Latch Medical, a Developer of Vaccine and Biologics Delivery Platforms"
WST,2022-09-08,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2022-09-08,10:02:40,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2022-10-13,10:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2022 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Third-Quarter 2022 Conference Call
WST,2022-10-13,10:00:25,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2022 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Third-Quarter 2022 Conference Call
WST,2022-10-21,07:43:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 3Q 2022 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 3Q 2022 (WST)"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q EPS $1.59,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q EPS $1.59 >WST
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2022",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Net sales of $686.9 million declined 2.8%,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.59,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2022 dividend of $0.19,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on November 16, 2022",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.13,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $189.7 million, an increase of 7.2%",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 563,334 shares for $202.9 million",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2022 Financial Guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2022 net sales are expected to be in the range of $2.830 billion to $2.840 billion,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 adjusted-diluted EPS is expected to be in the range of $8.15 to $8.20,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For the fourth-quarter 2022, our EPS guidance",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $8.15,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $8.15-Adj EPS $8.20 >WST
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Adj EPS $2.03,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Adj EPS $2.03 >WST
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.83B-$2.84B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.83B-$2.84B >WST
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2022 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -2-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $686.9,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -2-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 268.0,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -2-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.62 $2.37,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -2-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Reported Operating Profit,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -2-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 3Q Sales $686.9M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Sales $686.9M >WST
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2022 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -3-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -3-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -3-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -3-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Net $120.6M,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Net $120.6M >WST
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Net sales of $686.9 million declined 2.8%,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.59,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2022 dividend of $0.19,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on November 16, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,-0.13,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $189.7 million, an increase of 7.2%",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 563,334 shares for $202.9 million",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2022 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2022 net sales are expected to be in the range of $2.830 billion to $2.840 billion,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 adjusted-diluted EPS is expected to be in the range of $8.15 to $8.20,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For the fourth-quarter 2022, our EPS guidance",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,97,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $686.9,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -2-
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,97,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 268.0,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -2-
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,97,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.62 $2.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -2-
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,97,0.6,earnings,positive,West Pharmaceutical Services Inc.: Reported Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -2-
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -3-
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -3-
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -3-
WST,2022-10-27,10:08:25,BF79F5,West Pharmaceutical Services Inc.,100,0.38,dividends,up,West Pharma Raises Dividend to 19c Vs. 18c,NEWS-FLASH,Dow Jones Newswires,West Pharma Raises Dividend to 19c Vs. 18c >WST
WST,2022-10-28,09:02:23,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2022-10-28,09:02:23,BF79F5,West Pharmaceutical Services Inc.,100,-0.8,price-targets,downgrade,West Pharma Price Target Cut to $350.00/Share From $400.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $350.00/Share From $400.00 by Keybanc
WST,2022-10-28,11:12:53,BF79F5,West Pharmaceutical Services Inc.,100,-0.58,analyst-ratings,negative,West Pharma Cut to Neutral From Buy,NEWS-FLASH,Dow Jones Newswires,West Pharma Cut to Neutral From Buy by B of A Securities
WST,2022-10-28,11:12:53,BF79F5,West Pharmaceutical Services Inc.,100,-0.86,price-targets,downgrade,West Pharma Price Target Cut to $250.00/Share From $385.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $250.00/Share From $385.00 by B of A Securities
WST,2022-11-01,19:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Winters Surrenders 47 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Winters Surrenders 47 Of West Pharmaceutical Services >WST
WST,2022-11-04,20:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,"West Pharmaceutical Services Inc.: The Company will also present at the Stephens Annual Investment Conference in Nashville, TN on Thursday",PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2022-11-04,20:37:31,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,"West Pharmaceutical Services Inc.: The Company will also present at the Stephens Annual Investment Conference in Nashville, TN on Thursday",PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2022-11-30,14:07:18,BF79F5,West Pharmaceutical Services Inc.,100,0.01,analyst-ratings,neutral,West Pharma Initiated at Neutral by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Neutral by UBS
WST,2022-11-30,14:07:18,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $250.00/Share by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $250.00/Share by UBS
WST,2022-12-02,10:03:59,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2022-12-02,10:03:59,BF79F5,West Pharmaceutical Services Inc.,100,-0.8,price-targets,downgrade,West Pharma Price Target Cut to $315.00/Share From $350.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $315.00/Share From $350.00 by Keybanc
WST,2022-12-02,11:04:30,BF79F5,West Pharmaceutical Services Inc.,100,-0.8,price-targets,downgrade,West Pharmaceutical Services stock price target cut to $315 from $350 at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW West Pharmaceutical Services stock price target cut to $315 from $350 at KeyBanc Capital
WST,2022-12-06,23:09:41,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Ceo Green Registers 44,000 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"CEO Green Registers 44,000 Of West Pharmaceutical Services >WST"
WST,2022-12-08,13:39:30,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Ceo Green Sells 44,000 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"CEO Green Sells 44,000 Of West Pharmaceutical Services >WST"
WST,2022-12-13,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a first-quarter 2023 dividend of $0.19,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference
WST,2022-12-13,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on February 1, 2023",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference
WST,2022-12-13,11:00:36,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a first-quarter 2023 dividend of $0.19,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference
WST,2022-12-13,11:00:36,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on February 1, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference
WST,2022-12-14,10:09:04,BF79F5,West Pharmaceutical Services Inc.,100,0.01,analyst-ratings,neutral,West Pharma Initiated at Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Hold by Deutsche Bank
WST,2022-12-14,10:09:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $250.00/Share by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $250.00/Share by Deutsche Bank
WST,2022-01-05,13:15:03,BF79F5,West Pharmaceutical Services Inc.,99,0.44,products-services,,"West Expands Operations in Juarez, Mexico",PRESS-RELEASE,PR Newswire,East West Manufacturing Acquires Texas and Mexico-based Operations of Compass Electronics Solutions
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors have approved a first-quarter 2022 dividend of $0.18,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on February 2, 2022",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharmaceutical Services Inc.: The Company's Board of Directors authorized a share repurchase program,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2022 Dividend,NEWS-FLASH,Dow Jones Newswires,West Announces First-Quarter 2022 Dividend And 2022 Share Repurchase Program >WST
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors have approved a first-quarter 2022 dividend of $0.18,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on February 2, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program
WST,2022-01-05,21:30:03,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharmaceutical Services Inc.: The Company's Board of Directors authorized a share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program
WST,2022-01-05,21:33:36,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharma Says Board Authorized Share-Repurchase Program for 2022,NEWS-FLASH,Dow Jones Newswires,"West Pharma Says Board Authorized Share-Repurchase Program for 2022 of Up to 650,000 Shares of Its Common Stock >WST"
WST,2022-01-21,09:16:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 4Q 2021 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 4Q 2021 (WST)"
WST,2022-01-25,11:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.49,partnerships,,West and Corning have developed this exceptional collaboration to,PRESS-RELEASE,PR Newswire,West Announces Landmark Collaboration with Corning in Pharmaceutical Injectable Drug Delivery
WST,2022-01-25,11:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.49,partnerships,,West and Corning have developed this exceptional collaboration to,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Landmark Collaboration with Corning in Pharmaceutical Injectable Drug Delivery
WST,2022-01-25,11:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.49,partnerships,,West Announces Landmark Collaboration With Corning in,NEWS-FLASH,Dow Jones Newswires,West Announces Landmark Collaboration With Corning in Pharmaceutical Injectable Drug Delivery
WST,2022-02-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2021 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2021 Conference Call
WST,2022-02-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2021 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2021 Conference Call
WST,2022-02-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2021 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2021 Conference Call
WST,2022-02-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2021 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2021 Conference Call
WST,2022-02-11,12:56:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,"Ceo Green Gifts 3,150 Of West Pharmaceutical Services >WST",FULL-ARTICLE,Dow Jones Newswires,"CEO Green Gifts 3,150 Of West Pharmaceutical Services >WST"
WST,2022-02-14,22:47:53,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Ceo Green Surrenders 85 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,CEO Green Surrenders 85 Of West Pharmaceutical Services >WST
WST,2022-02-14,22:55:52,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Montecalvo Surrenders 27 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Montecalvo Surrenders 27 Of West Pharmaceutical Services >WST
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 4Q Sales $730.8M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Sales $730.8M >WST
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2021",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2021",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.44,revenues,up,West Pharmaceutical Services Inc.: Fourth-quarter 2021 net sales of $730.8 million grew 26.0%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.48,revenues,up,West Pharmaceutical Services Inc.: Full-year 2021 net sales of $2.832 billion grew 31.9%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2021 reported-diluted EPS of $1.93,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 reported-diluted EPS of $8.67,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2021 adjusted-diluted EPS of $2.04,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS of $8.58,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Organic sales declined by 2.1%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,"West Pharmaceutical Services Inc.: In the full-year 2021, net sales grew by 3.2% to $514.7 million",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.72,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $253.4 million, compared with $174.4 million in 2020",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2022 Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2022 net sales are expected to be in a range of $3.050 billion to $3.075 billion,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 reported-diluted EPS is expected to be in a range of $9.20 to $9.35,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected to be $380 million,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $3.05B-$3.08B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $3.05B-$3.08B >WST
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.98 $1.33,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 -2-
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Twelve Months Ended December 31, December 31, Net Sales",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 -2-
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 -2-
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q EPS $1.93,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q EPS $1.93 >WST
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,95,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2021 -3-
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Adj EPS $2.04,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Adj EPS $2.04 >WST
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Net $147.7M,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Net $147.7M >WST
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m.,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.44,revenues,up,West Pharmaceutical Services Inc.: Fourth-quarter 2021 net sales of $730.8 million grew 26.0%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.48,revenues,up,West Pharmaceutical Services Inc.: Full-year 2021 net sales of $2.832 billion grew 31.9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2021 reported-diluted EPS of $1.93,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 reported-diluted EPS of $8.67,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2021 adjusted-diluted EPS of $2.04,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2021 adjusted-diluted EPS of $8.58,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Organic sales declined by 2.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,"West Pharmaceutical Services Inc.: In the full-year 2021, net sales grew by 3.2% to $514.7 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.72,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $253.4 million, compared with $174.4 million in 2020",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2022 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2022 net sales are expected to be in a range of $3.050 billion to $3.075 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 reported-diluted EPS is expected to be in a range of $9.20 to $9.35,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected to be $380 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2021 Results
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.98 $1.33,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Twelve Months Ended December 31, December 31, Net Sales",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2022-02-17,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2022-02-17,11:04:53,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $9.20,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $9.20-EPS $9.35 >WST
WST,2022-02-17,11:19:43,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Sees 2022 Sales Growth,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Sees 2022 Sales Growth
WST,2022-02-17,20:19:29,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services, Inc. CEO Eric Green on Q4 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q4 2021 Results -- Earnings Call Transcript >WST"
WST,2022-02-17,20:19:29,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West-pharmaceutical-services-inc-wst-ceo-eric-green-on-q4-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q4 2021 Results -- Earnings Call Transcript >WST"
WST,2022-02-23,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a second-quarter 2022 dividend of $0.18,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Dividend
WST,2022-02-23,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on May 4, 2022",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Dividend
WST,2022-02-23,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a second-quarter 2022 dividend of $0.18,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Dividend
WST,2022-02-23,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on May 4, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Dividend
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Names President,PRESS-RELEASE,PR Newswire,West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,-0.43,labor-issues,,Zenner Retires from West Board,PRESS-RELEASE,PR Newswire,West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services Inc.: the Company's Board of Directors, effective as of West's next Annual Shareholders' Meeting",PRESS-RELEASE,PR Newswire,West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Names President,NEWS-FLASH,Dow Jones Newswires,West Names President And CEO Eric M. Green As Chair Of The Board >WST
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Names President and CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Names President,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,-0.43,labor-issues,,Zenner Retires from West Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-02-28,21:30:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services Inc.: the Company's Board of Directors, effective as of West's next Annual Shareholders' Meeting",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Names President and CEO Eric M. Green as Chair of the Board
WST,2022-03-09,11:00:06,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2022-03-09,11:01:47,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2022-03-16,15:17:28,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Lai Sells 8,016 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"VP Lai Sells 8,016 Of West Pharmaceutical Services >WST"
WST,2022-04-01,21:54:41,BF79F5,West Pharmaceutical Services Inc.,100,0.38,credit,,West Pharmaceutical Services Amends Credit Facility,RNS-SEC8K,Dow Jones Newswires,"West Pharmaceutical Services Amends Credit Facility, Including Increase From $300M to $500M >WST"
WST,2022-04-07,13:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.49,partnerships,,"Systems collaborates with West Pharmaceutical Services, Inc. to",PRESS-RELEASE,PR Newswire,"Pneuma Systems collaborates with West Pharmaceutical Services, Inc. to improve the patient experience"
WST,2022-04-07,13:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.49,partnerships,,"Systems collaborates with West Pharmaceutical Services, Inc. to",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Pneuma Systems collaborates with West Pharmaceutical Services, Inc. to improve the patient experience"
WST,2022-04-07,13:01:58,BF79F5,West Pharmaceutical Services Inc.,100,0.49,partnerships,,"Systems Collaborates With West Pharmaceutical Services, Inc. to",NEWS-FLASH,Dow Jones Newswires,"Pneuma Systems Collaborates With West Pharmaceutical Services, Inc. to Improve the Patient Experience"
WST,2022-04-14,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2022 Conference Call,PRESS-RELEASE,PR Newswire,West to Host First-Quarter 2022 Conference Call
WST,2022-04-14,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2022 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host First-Quarter 2022 Conference Call
WST,2022-04-14,13:08:59,BF79F5,West Pharmaceutical Services Inc.,100,0.44,labor-issues,,West Pharmaceutical CEO Eric Green Received Total Compensation of $9.47M,NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical CEO Eric Green Received Total Compensation of $9.47M in 2021, Up From $7.64M in 2020"
WST,2022-04-21,08:15:30,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 1Q 2022 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 1Q 2022 (WST)"
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2022",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales of $720.0 million grew 7.4%,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.29,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2022 financial guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2022 financial guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is raising full-year 2022 financial guidance of,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a third-quarter 2022 dividend of $0.18,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on August 3, 2022",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: growing demand for our high-value products,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,"West Pharmaceutical Services Inc.: our full-year 2022 net sales guidance, raising",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Net sales declined by 6.6% to $118.7 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $65.8 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 390,000 shares for $147.1 million",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected to be $380 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, 2022 2021 Net sales $720.0",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2022 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.34 $2.04,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, Net Sales",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2022 Results and -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q EPS $2.29,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q EPS $2.29 >WST
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 1Q Sales $720M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Sales $720M >WST
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Adj EPS $2.30,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Adj EPS $2.30 >WST
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Net $173.8M,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Net $173.8M >WST
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales of $720.0 million grew 7.4%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.29,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharmaceutical Services Inc.: The Company is reaffirming full-year 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is raising full-year 2022 financial guidance of,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a third-quarter 2022 dividend of $0.18,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on August 3, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.51,products-services,increase,West Pharmaceutical Services Inc.: growing demand for our high-value products,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,"West Pharmaceutical Services Inc.: our full-year 2022 net sales guidance, raising",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Net sales declined by 6.6% to $118.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $65.8 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 390,000 shares for $147.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected to be $380 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, 2022 2021 Net sales $720.0",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.34 $2.04,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended March 31, Net Sales",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 -2-
WST,2022-04-28,10:00:11,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2022 -2-
WST,2022-04-28,10:06:53,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharma Backs FY Sales $3.05B-$3.075B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Backs FY Sales $3.05B-$3.075B >WST
WST,2022-04-28,10:07:08,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharma Raises FY View To Adj EPS $9.30,NEWS-FLASH,Dow Jones Newswires,West Pharma Raises FY View To Adj EPS $9.30-Adj EPS $9.45 >WST
WST,2022-04-28,10:07:20,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharma Declares Dividend of 18,NEWS-FLASH,Dow Jones Newswires,West Pharma Declares Dividend of 18c >WST
WST,2022-04-28,20:07:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services, Inc. CEO Eric Green on Q1 2022 Earnings Call",NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc. CEO Eric Green on Q1 2022 Earnings Call Transcript >WST"
WST,2022-04-29,09:01:12,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2022-04-29,09:01:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.82,price-targets,downgrade,West Pharma Price Target Cut to $400.00/Share From $475.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $400.00/Share From $475.00 by Keybanc
WST,2022-05-03,20:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2022-05-03,20:30:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2022-05-06,15:31:38,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Winters Surrenders 10 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Winters Surrenders 10 Of West Pharmaceutical Services >WST
WST,2022-05-12,20:30:05,BF79F5,West Pharmaceutical Services Inc.,99,0.53,labor-issues,,West Pharmaceutical Services Inc.: The Company also announced the hiring of Kathy dePadua as Vice President and Chief,PRESS-RELEASE,PR Newswire,West Announces Executive Leadership Appointments
WST,2022-05-12,20:30:06,BF79F5,West Pharmaceutical Services Inc.,99,0.53,labor-issues,,West Announces Executive Leadership Appointments,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Executive Leadership Appointments
WST,2022-05-12,20:48:01,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Pharma Names CFO Bernard J. Birkett to Newly Combined Position of Chief,NEWS-FLASH,Dow Jones Newswires,West Pharma Names CFO Bernard J. Birkett to Newly Combined Position of Chief Fincl and Operations Officer >WST
WST,2022-05-12,20:48:58,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,Appointed Chief Comml Officer >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Names Cindy Reiss-Clark Has Been Appointed Chief Comml Officer >WST
WST,2022-06-13,10:00:06,BF79F5,West Pharmaceutical Services Inc.,99,0.49,partnerships,,West has partnered with Daikyo in,PRESS-RELEASE,PR Newswire,West Introduces Daikyo Crystal Zenith(R) 2.25mL Insert Needle Syringe System at BIO International Convention
WST,2022-06-23,14:13:48,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Cfo Birkett Surrenders 946 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,CFO Birkett Surrenders 946 Of West Pharmaceutical Services >WST
WST,2022-07-14,21:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2022 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Second-Quarter 2022 Conference Call
WST,2022-07-14,21:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2022 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Second-Quarter 2022 Conference Call
WST,2022-07-21,08:27:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 2Q 2022 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 2Q 2022 (WST)"
WST,2022-07-27,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,PRESS-RELEASE,PR Newswire,West Elects New Director to the Board
WST,2022-07-27,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Elects New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Elects New Director to the Board
WST,2022-07-27,10:00:29,BF79F5,West Pharmaceutical Services Inc.,100,0.47,labor-issues,,West Pharma Names Stephen Lockhart to Board,NEWS-FLASH,Dow Jones Newswires,West Pharma Names Stephen Lockhart to Board >WST
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.32,earnings,,West Announces Second-Quarter 2022 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.1,revenues,,West Pharmaceutical Services Inc.: Net sales of $771.3 million grew 6.6%,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.48,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: The Company is updating full-year 2022 net sales guidance to a range of $2.950 billion to $2.975 billion,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: The Company is updating full-year 2022 adjusted-diluted EPS guidance to a new range of $9.00 to $9.15,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.68,revenues,down,West Pharmaceutical Services Inc.: Segment sales declined,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.3,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $131.9 million, an increase of 18.2%",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 476,667 shares for $175.7 million",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2022 Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For second-half 2022, our EPS guidance",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected to be $380 million,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2022 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 321.5,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.53 $2.53,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Six Months Ended June 30, June 30, Net Sales",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2022 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -3-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2022 Results -3-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 2Q Sales $771.3M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Sales $771.3M >WST
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q EPS $2.48,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q EPS $2.48 >WST
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Adj EPS $2.47,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Adj EPS $2.47 >WST
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Net $188.5M,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Net $188.5M >WST
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.32,earnings,,West Pharmaceutical Services Inc.: We delivered excellent second-quarter results,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.1,revenues,,West Pharmaceutical Services Inc.: Net sales of $771.3 million grew 6.6%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: The Company is updating full-year 2022 net sales guidance to a range of $2.950 billion to $2.975 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: The Company is updating full-year 2022 adjusted-diluted EPS guidance to a new range of $9.00 to $9.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.68,revenues,down,West Pharmaceutical Services Inc.: Segment sales declined,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.3,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $131.9 million, an increase of 18.2%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 476,667 shares for $175.7 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2022 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For second-half 2022, our EPS guidance",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected to be $380 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 Results
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.53 $2.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,"West Pharmaceutical Services Inc.: Three Months Ended Six Months Ended June 30, June 30, Net Sales",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 -2-
WST,2022-07-28,10:00:13,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2022 -3-
WST,2022-07-28,10:06:49,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.95B-$2.975B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.95B-$2.975B >WST
WST,2022-07-28,10:07:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $9,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $9-Adj EPS $9.15 >WST
WST,2022-07-28,18:26:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services, Inc.'s CEO Eric Green on Q2 2022 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc.'s CEO Eric Green on Q2 2022 Results -- Earnings Call Transcript >WST"
WST,2022-07-28,18:26:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West-pharmaceutical-services-inc-s-wst-ceo-eric-green-on-q2-2022-results-earnings,NEWS-FLASH,Dow Jones Newswires,"West Pharmaceutical Services, Inc.'s CEO Eric Green on Q2 2022 Results -- Earnings Call Transcript >WST"
WST,2022-08-03,16:26:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Officer Abraham Sells 5,374 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"Officer Abraham Sells 5,374 Of West Pharmaceutical Services >WST"
WST,2022-08-03,19:25:28,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Coo Birkett Sells 14,174 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"COO Birkett Sells 14,174 Of West Pharmaceutical Services >WST"
WST,2022-08-11,10:00:05,BF79F5,West Pharmaceutical Services Inc.,99,0.22,acquisitions-mergers,,West Pharmaceutical Services Inc.: West's investment in Latch Medical advances our,PRESS-RELEASE,PR Newswire,"West Makes Minority Investment in Dublin-Based Latch Medical, a Developer of Vaccine and Biologics Delivery Platforms"
WST,2022-08-11,10:00:24,BF79F5,West Pharmaceutical Services Inc.,99,0.22,acquisitions-mergers,,West Pharmaceutical Services Inc.: West's investment in Latch Medical advances our,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Makes Minority Investment in Dublin-Based Latch Medical, a Developer of Vaccine and Biologics Delivery Platforms"
WST,2022-09-08,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2022-09-08,10:02:40,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2022-10-13,10:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2022 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Third-Quarter 2022 Conference Call
WST,2022-10-13,10:00:25,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2022 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Third-Quarter 2022 Conference Call
WST,2022-10-21,07:43:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 3Q 2022 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 3Q 2022 (WST)"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q EPS $1.59,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q EPS $1.59 >WST
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2022",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Net sales of $686.9 million declined 2.8%,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.59,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2022 dividend of $0.19,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on November 16, 2022",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.13,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $189.7 million, an increase of 7.2%",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 563,334 shares for $202.9 million",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2022 Financial Guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2022 net sales are expected to be in the range of $2.830 billion to $2.840 billion,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 adjusted-diluted EPS is expected to be in the range of $8.15 to $8.20,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For the fourth-quarter 2022, our EPS guidance",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $8.15,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $8.15-Adj EPS $8.20 >WST
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Adj EPS $2.03,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Adj EPS $2.03 >WST
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.83B-$2.84B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.83B-$2.84B >WST
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2022 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -2-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $686.9,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -2-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 268.0,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -2-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.62 $2.37,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -2-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Reported Operating Profit,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -2-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 3Q Sales $686.9M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Sales $686.9M >WST
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2022 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -3-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -3-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -3-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2022 Results, -3-"
WST,2022-10-27,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Net $120.6M,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Net $120.6M >WST
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Announces Third-Quarter 2022 Results, Updates Full-Year 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Net sales of $686.9 million declined 2.8%,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.59,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2022 dividend of $0.19,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on November 16, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,-0.13,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $189.7 million, an increase of 7.2%",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 563,334 shares for $202.9 million",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2022 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2022 net sales are expected to be in the range of $2.830 billion to $2.840 billion,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 adjusted-diluted EPS is expected to be in the range of $8.15 to $8.20,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For the fourth-quarter 2022, our EPS guidance",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2022 capital spending is expected,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend"
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,97,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $686.9,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -2-
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,97,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 268.0,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -2-
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,97,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.62 $2.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -2-
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,97,0.6,earnings,positive,West Pharmaceutical Services Inc.: Reported Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -2-
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -3-
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -3-
WST,2022-10-27,10:00:27,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2022 -3-
WST,2022-10-27,10:08:25,BF79F5,West Pharmaceutical Services Inc.,100,0.38,dividends,up,West Pharma Raises Dividend to 19c Vs. 18c,NEWS-FLASH,Dow Jones Newswires,West Pharma Raises Dividend to 19c Vs. 18c >WST
WST,2022-10-28,09:02:23,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2022-10-28,09:02:23,BF79F5,West Pharmaceutical Services Inc.,100,-0.8,price-targets,downgrade,West Pharma Price Target Cut to $350.00/Share From $400.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $350.00/Share From $400.00 by Keybanc
WST,2022-10-28,11:12:53,BF79F5,West Pharmaceutical Services Inc.,100,-0.58,analyst-ratings,negative,West Pharma Cut to Neutral From Buy,NEWS-FLASH,Dow Jones Newswires,West Pharma Cut to Neutral From Buy by B of A Securities
WST,2022-10-28,11:12:53,BF79F5,West Pharmaceutical Services Inc.,100,-0.86,price-targets,downgrade,West Pharma Price Target Cut to $250.00/Share From $385.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $250.00/Share From $385.00 by B of A Securities
WST,2022-11-01,19:00:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Winters Surrenders 47 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Winters Surrenders 47 Of West Pharmaceutical Services >WST
WST,2022-11-04,20:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,"West Pharmaceutical Services Inc.: The Company will also present at the Stephens Annual Investment Conference in Nashville, TN on Thursday",PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2022-11-04,20:37:31,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,"West Pharmaceutical Services Inc.: The Company will also present at the Stephens Annual Investment Conference in Nashville, TN on Thursday",PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2022-11-30,14:07:18,BF79F5,West Pharmaceutical Services Inc.,100,0.01,analyst-ratings,neutral,West Pharma Initiated at Neutral by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Neutral by UBS
WST,2022-11-30,14:07:18,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $250.00/Share by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $250.00/Share by UBS
WST,2022-12-02,10:03:59,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2022-12-02,10:03:59,BF79F5,West Pharmaceutical Services Inc.,100,-0.8,price-targets,downgrade,West Pharma Price Target Cut to $315.00/Share From $350.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $315.00/Share From $350.00 by Keybanc
WST,2022-12-02,11:04:30,BF79F5,West Pharmaceutical Services Inc.,100,-0.8,price-targets,downgrade,West Pharmaceutical Services stock price target cut to $315 from $350 at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW West Pharmaceutical Services stock price target cut to $315 from $350 at KeyBanc Capital
WST,2022-12-06,23:09:41,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Ceo Green Registers 44,000 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"CEO Green Registers 44,000 Of West Pharmaceutical Services >WST"
WST,2022-12-08,13:39:30,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Ceo Green Sells 44,000 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"CEO Green Sells 44,000 Of West Pharmaceutical Services >WST"
WST,2022-12-13,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a first-quarter 2023 dividend of $0.19,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference
WST,2022-12-13,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on February 1, 2023",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference
WST,2022-12-13,11:00:36,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: the Company's Board of Directors has approved a first-quarter 2023 dividend of $0.19,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference
WST,2022-12-13,11:00:36,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on February 1, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference
WST,2022-12-14,10:09:04,BF79F5,West Pharmaceutical Services Inc.,100,0.01,analyst-ratings,neutral,West Pharma Initiated at Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Hold by Deutsche Bank
WST,2022-12-14,10:09:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $250.00/Share by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $250.00/Share by Deutsche Bank
WST,2023-01-05,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2023-01-05,11:02:18,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2023-01-21,09:10:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 4Q 2022 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 4Q 2022 (WST)"
WST,2023-01-31,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.52,products-services,,West Announces Three New Product,PRESS-RELEASE,PR Newswire,West Announces Three New Product Innovations at Pharmapack Europe
WST,2023-01-31,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West's participation in this year's conference,PRESS-RELEASE,PR Newswire,West Announces Three New Product Innovations at Pharmapack Europe
WST,2023-01-31,11:00:53,BF79F5,West Pharmaceutical Services Inc.,100,0.52,products-services,,West Announces Three New Product,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Three New Product Innovations at Pharmapack Europe
WST,2023-01-31,11:00:53,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West's participation in this year's conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Three New Product Innovations at Pharmapack Europe
WST,2023-02-02,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2022 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
WST,2023-02-02,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2022 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
WST,2023-02-02,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West will also participate in the Barclays Global Healthcare Conference,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
WST,2023-02-02,11:04:29,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2022 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
WST,2023-02-02,11:04:29,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2022 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
WST,2023-02-02,11:04:29,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West will also participate in the Barclays Global Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
WST,2023-02-08,13:30:06,BF79F5,West Pharmaceutical Services Inc.,99,0.39,products-services,,West announced its agreement with Corning,PRESS-RELEASE,PR Newswire,West Expands Corning Collaboration and Launches First Product
WST,2023-02-08,13:30:06,BF79F5,West Pharmaceutical Services Inc.,99,0.49,partnerships,,Corning Inc.: our collaboration with West to,PRESS-RELEASE,PR Newswire,West Expands Corning Collaboration and Launches First Product
WST,2023-02-08,13:30:06,BF79F5,West Pharmaceutical Services Inc.,99,0.39,products-services,,West announced its agreement with Corning,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Expands Corning Collaboration and Launches First Product
WST,2023-02-08,13:30:06,BF79F5,West Pharmaceutical Services Inc.,99,0.49,partnerships,,Corning Inc.: our collaboration with West to,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Expands Corning Collaboration and Launches First Product
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 4Q Sales $708.7M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Sales $708.7M >WST
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q EPS $1.36,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q EPS $1.36 >WST
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Adj EPS $1.77,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Adj EPS $1.77 >WST
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2022",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2022",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Fourth-quarter 2022 net sales of $708.7 million declined 3.0%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.04,revenues,,"West Pharmaceutical Services Inc.: In the full-year 2022, net sales declined by 6.7%",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2022 reported-diluted EPS of $1.36,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 reported-diluted EPS of $7.73,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2022 adjusted-diluted EPS of $1.77,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 adjusted-diluted EPS of $8.58,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharmaceutical Services Inc.: The Board of Directors approved a share repurchase program,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,-0.51,products-services,decrease,West Pharmaceutical Services Inc.: Though pandemic-related product demand is declining,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.66,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $284.6 million, compared with $253.4 million in 2021",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.22,acquisitions-mergers,,"West Pharmaceutical Services Inc.: we purchased 563,334 shares of our",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2023 net sales are expected to be in a range of $2.935 billion to $2.960 billion,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.25 to $7.40,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending is expected to be $350 million,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Net $103M,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Net $103M >WST
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $708.7,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -2-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 262.1,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -2-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.38 $1.98,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -2-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Reported Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -2-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: The twelve-month charge,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -3-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -3-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -3-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -3-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -3-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Fourth-quarter 2022 net sales of $708.7 million declined 3.0%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.04,revenues,,"West Pharmaceutical Services Inc.: In the full-year 2022, net sales declined by 6.7%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2022 reported-diluted EPS of $1.36,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 reported-diluted EPS of $7.73,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2022 adjusted-diluted EPS of $1.77,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 adjusted-diluted EPS of $8.58,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharmaceutical Services Inc.: The Board of Directors approved a share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,-0.51,products-services,decrease,West Pharmaceutical Services Inc.: Though pandemic-related product demand is declining,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.66,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $284.6 million, compared with $253.4 million in 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.22,acquisitions-mergers,,"West Pharmaceutical Services Inc.: we purchased 563,334 shares of our",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2023 net sales are expected to be in a range of $2.935 billion to $2.960 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.25 to $7.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending is expected to be $350 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $708.7,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 262.1,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.38 $1.98,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Reported Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: The twelve-month charge,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2023-02-16,11:06:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees 2023 Sales $2.935B-$2.96B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees 2023 Sales $2.935B-$2.96B >WST
WST,2023-02-16,11:06:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees 2023 Adj EPS $7.25,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees 2023 Adj EPS $7.25-Adj EPS $7.40 >WST
WST,2023-02-16,11:06:36,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharma Board Approves Buyback of Up to $1 Billion in Stock,NEWS-FLASH,Dow Jones Newswires,West Pharma Board Approves Buyback of Up to $1 Billion in Stock >WST
WST,2023-02-16,16:06:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: the company reported stronger fourth-quarter results,FULL-ARTICLE,Dow Jones Newswires,"West Pharmaceutical Shares Rise on Above-Consensus 4Q Results, Outlook"
WST,2023-02-17,10:01:55,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2023-02-17,10:01:55,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $375.00/Share From $315.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $375.00/Share From $315.00 by Keybanc
WST,2023-02-24,14:14:11,BF79F5,West Pharmaceutical Services Inc.,100,0.8,price-targets,upgrade,West Pharmaceutical Services stock price target raised to $324 from $250 at UBS,NEWS-FLASH,MarketWatch,MW West Pharmaceutical Services stock price target raised to $324 from $250 at UBS
WST,2023-03-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces Second-Quarter 2023 Dividend,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Dividend
WST,2023-03-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on May 3, 2023",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Dividend
WST,2023-03-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces Second-Quarter 2023 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Dividend
WST,2023-03-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on May 3, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Dividend
WST,2023-03-08,20:43:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Ceo Green Registers 44,000 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"CEO Green Registers 44,000 Of West Pharmaceutical Services >WST"
WST,2023-03-09,21:45:06,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Ceo Green Sells 44,000 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"CEO Green Sells 44,000 Of West Pharmaceutical Services >WST"
WST,2023-03-22,20:44:20,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Abraham Sells 1,500 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"VP Abraham Sells 1,500 Of West Pharmaceutical Services >WST"
WST,2023-03-28,20:29:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,"Ceo Green Gifts 2,700 Of West Pharmaceutical Services >WST",FULL-ARTICLE,Dow Jones Newswires,"CEO Green Gifts 2,700 Of West Pharmaceutical Services >WST"
WST,2023-04-11,00:30:00,BF79F5,West Pharmaceutical Services Inc.,99,0.44,products-services,,West Pharmaceutical Services Inc.: we entered the market in 2008,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING Schnitzer West Expands Its Ownership Team
WST,2023-04-11,11:01:44,BF79F5,West Pharmaceutical Services Inc.,100,0.94,analyst-ratings,positive,West Pharma Raised to Overweight From Equal-Weight by Stephens,NEWS-FLASH,Dow Jones Newswires,West Pharma Raised to Overweight From Equal-Weight by Stephens & Co.
WST,2023-04-11,11:01:44,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $400.00/Share From $330.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $400.00/Share From $330.00 by Stephens & Co.
WST,2023-04-13,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2023 Conference Call,PRESS-RELEASE,PR Newswire,West to Host First-Quarter 2023 Conference Call
WST,2023-04-13,10:00:23,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host First-Quarter 2023 Conference Call
WST,2023-04-21,07:14:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 1Q 2023 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 1Q 2023 (WST)"
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 1Q Sales $716.6M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Sales $716.6M >WST
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Adj EPS $1.98,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Adj EPS $1.98 >WST
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $7.50,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $7.50-Adj EPS $7.65 >WST
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q EPS $1.85,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q EPS $1.85 >WST
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Net $140M,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Net $140M >WST
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2023",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Net sales of $716.6 million declined 0.5%,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales increased by 12.5% to $133.5 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.85,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 net sales guidance to be a new range of $2.965 billion to $2.990 billion,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 financial guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $82.1 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 183,360 shares for $60.1 million",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.50 to $7.65,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $716.6,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 271.3,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.88 $2.34,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -3-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: increased adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -3-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -3-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Net sales of $716.6 million declined 0.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales increased by 12.5% to $133.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.85,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 net sales guidance to be a new range of $2.965 billion to $2.990 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $82.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 183,360 shares for $60.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.50 to $7.65,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $716.6,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 271.3,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.88 $2.34,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,97,0.0,earnings,,West Pharmaceutical Services Inc.: increased adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -3-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,97,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -3-
WST,2023-04-27,10:34:29,BF79F5,West Pharmaceutical Services Inc.,100,-0.38,earnings,down,West Pharmaceutical Services Inc.'s first-quarter earnings fell 19%,FULL-ARTICLE,Dow Jones Newswires,West Pharma 1Q Net Down on Lower Covid-19 Product Sales
WST,2023-05-02,00:09:33,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Dir Hofmann Registers 1,212 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"Dir Hofmann Registers 1,212 Of West Pharmaceutical Services >WST"
WST,2023-05-02,17:54:42,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Favorite Sells 13,012 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"VP Favorite Sells 13,012 Of West Pharmaceutical Services >WST"
WST,2023-05-02,18:06:05,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Abraham Sells 8,020 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Abraham Sells 8,020 Of West Pharmaceutical Services >WST"
WST,2023-05-02,18:07:22,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Dir Hofmann Sells 1,212 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Hofmann Sells 1,212 Of West Pharmaceutical Services >WST"
WST,2023-05-04,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2023-05-04,10:12:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2023-05-09,19:43:44,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Winters Surrenders 10 Of West Pharmaceutical Services >WST,TABULAR-MATERIAL,Dow Jones Newswires,VP Winters Surrenders 10 Of West Pharmaceutical Services >WST
WST,2023-05-09,21:12:37,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Ceo Green Registers 44,000 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"CEO Green Registers 44,000 Of West Pharmaceutical Services >WST"
WST,2023-05-11,17:54:52,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,"Ceo Green Acquires 6,000 Of West Pharmaceutical Services >WST",FULL-ARTICLE,Dow Jones Newswires,"CEO Green Acquires 6,000 Of West Pharmaceutical Services >WST"
WST,2023-05-24,10:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2023-05-24,10:00:24,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2023-05-31,20:39:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,Vp Winters Sells 872 Of West Pharmaceutical Services,TABULAR-MATERIAL,Dow Jones Newswires,VP Winters Sells 872 Of West Pharmaceutical Services >WST
WST,2023-05-31,20:40:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Treas Witherspoon Sells 1,000 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"Treas Witherspoon Sells 1,000 Of West Pharmaceutical Services >WST"
WST,2023-06-16,11:23:24,BF79F5,West Pharmaceutical Services Inc.,100,0.94,analyst-ratings,positive,West Pharma Raised to Buy From Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,West Pharma Raised to Buy From Neutral by B of A Securities
WST,2023-06-16,11:23:24,BF79F5,West Pharmaceutical Services Inc.,100,0.48,price-targets,upgrade,West Pharma Price Target Raised to $405.00/Share From $390.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $405.00/Share From $390.00 by B of A Securities
WST,2023-07-13,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2023 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Second-Quarter 2023 Conference Call
WST,2023-07-13,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Second-Quarter 2023 Conference Call
WST,2023-07-17,16:09:41,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Stephens & Co.
WST,2023-07-17,16:09:41,BF79F5,West Pharmaceutical Services Inc.,100,0.58,price-targets,upgrade,West Pharma Price Target Raised to $420.00/Share From $400.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $420.00/Share From $400.00 by Stephens & Co.
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q EPS $2.06,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q EPS $2.06 >WST
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Second-Quarter 2023 Conference Call,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharmaceutical Services Inc.: Net sales of $753.8 million declined 2.3%,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,-0.34,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.06, compared to $2.48 in the same period last year",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 net sales guidance to be a new range of $2.970 billion to $2.995 billion,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,-0.32,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $157.5 million, an increase of 19.4%",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 676,070 shares for $233.5 million",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2023 Updated Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.65 to $7.80,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -2-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $753.8,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -2-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 291.4,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -2-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.08 $2.53,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -2-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -2-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -3-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -3-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -3-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -3-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 2Q Sales $753.8M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Sales $753.8M >WST
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Adj EPS $2.11,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Adj EPS $2.11 >WST
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Net $155.1M,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Net $155.1M >WST
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Second-Quarter 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharmaceutical Services Inc.: Net sales of $753.8 million declined 2.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,-0.34,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.06, compared to $2.48 in the same period last year",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 net sales guidance to be a new range of $2.970 billion to $2.995 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,-0.32,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $157.5 million, an increase of 19.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 676,070 shares for $233.5 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2023 Updated Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.65 to $7.80,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,96,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $753.8,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -2-
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,96,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 291.4,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -2-
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,96,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.08 $2.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -2-
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,96,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -2-
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -3-
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -3-
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -3-
WST,2023-07-27,10:08:39,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharma Raises 2023 View To Sales $2.97B-$2.995B,NEWS-FLASH,Dow Jones Newswires,West Pharma Raises 2023 View To Sales $2.97B-$2.995B >WST
WST,2023-07-27,10:08:59,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Had Seen 2023 Sales $2.965B-$2.99B,NEWS-FLASH,Dow Jones Newswires,West Pharma Had Seen 2023 Sales $2.965B-$2.99B >WST
WST,2023-07-27,10:09:27,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharma Raises 2023 View To Adj EPS $7.65,NEWS-FLASH,Dow Jones Newswires,West Pharma Raises 2023 View To Adj EPS $7.65-Adj EPS $7.80 >WST
WST,2023-07-27,10:09:40,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Had Seen 2023 Adjusted EPS $7.50-$7.65,NEWS-FLASH,Dow Jones Newswires,West Pharma Had Seen 2023 Adjusted EPS $7.50-$7.65 >WST
WST,2023-07-27,10:16:46,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,above-expectations,West Pharmaceutical Services' profit beat estimates in the second quarter,FULL-ARTICLE,Dow Jones Newswires,West Pharma Profit Beats Estimates Despite Lower Covid-19 Sales
WST,2023-07-27,10:16:46,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: the company to raise its full-year guidance,FULL-ARTICLE,Dow Jones Newswires,West Pharma Profit Beats Estimates Despite Lower Covid-19 Sales
WST,2023-07-27,10:16:46,BF79F5,West Pharmaceutical Services Inc.,100,-0.38,revenues,,West Pharmaceutical Services Inc.: the company saw lower revenue,FULL-ARTICLE,Dow Jones Newswires,West Pharma Profit Beats Estimates Despite Lower Covid-19 Sales
WST,2023-07-27,10:23:43,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharma raised its full-year guidance,FULL-ARTICLE,Dow Jones Newswires,West Pharma Lifts Profit Guidance on Stable Demand
WST,2023-07-27,10:23:43,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West reported second-quarter profit,FULL-ARTICLE,Dow Jones Newswires,West Pharma Lifts Profit Guidance on Stable Demand
WST,2023-07-28,09:13:59,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2023-07-28,09:13:59,BF79F5,West Pharmaceutical Services Inc.,100,0.42,price-targets,upgrade,West Pharma Price Target Raised to $385.00/Share From $375.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $385.00/Share From $375.00 by Keybanc
WST,2023-08-02,20:30:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2023-08-02,20:30:35,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2023-08-08,19:50:19,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Coo Birkett Sells 22,334 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"COO Birkett Sells 22,334 Of West Pharmaceutical Services >WST"
WST,2023-08-08,22:03:28,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Ceo Green Registers 44,000 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"CEO Green Registers 44,000 Of West Pharmaceutical Services >WST"
WST,2023-08-10,18:53:14,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Ceo Green Sells 44,000 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Green Sells 44,000 Of West Pharmaceutical Services >WST"
WST,2023-08-10,20:32:34,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Abraham Sells 8,160 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Abraham Sells 8,160 Of West Pharmaceutical Services >WST"
WST,2023-08-11,20:53:53,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Treas Witherspoon Sells 1,680 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"Treas Witherspoon Sells 1,680 Of West Pharmaceutical Services >WST"
WST,2023-08-15,18:51:52,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Lai Sells 21,101 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Lai Sells 21,101 Of West Pharmaceutical Services >WST"
WST,2023-08-19,07:53:52,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 2Q 2023 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 2Q 2023 (WST)"
WST,2023-08-21,08:22:37,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2023-08-21,08:22:37,BF79F5,West Pharmaceutical Services Inc.,100,0.7,price-targets,upgrade,West Pharma Price Target Raised to $415.00/Share From $385.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $415.00/Share From $385.00 by Keybanc
WST,2023-08-24,23:26:33,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Reiss-Clark Sells 3,477 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Reiss-Clark Sells 3,477 Of West Pharmaceutical Services >WST"
WST,2023-08-30,08:19:34,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2023-08-30,08:19:34,BF79F5,West Pharmaceutical Services Inc.,100,0.62,price-targets,upgrade,West Pharma Price Target Raised to $440.00/Share From $415.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $440.00/Share From $415.00 by Keybanc
WST,2023-09-01,19:47:35,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Favorite Sells 2,000 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Favorite Sells 2,000 Of West Pharmaceutical Services >WST"
WST,2023-09-07,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2023-09-07,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2023-10-12,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2023 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Third-Quarter 2023 Conference Call
WST,2023-10-12,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Third-Quarter 2023 Conference Call
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Adj EPS $2.16,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Adj EPS $2.16 >WST
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.95B-$2.96B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.95B-$2.96B >WST
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $7.95,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $7.95-Adj EPS $8.00 >WST
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q EPS $2.14,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q EPS $2.14 >WST
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Net $161.3M,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Net $161.3M >WST
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Third-Quarter 2023 Conference Call,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2023",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales of $747.4 million grew 8.8%,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.14,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Company is updating full-year 2023 net sales,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2023 dividend of $0.20,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2023 Updated Financial Guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,-0.42,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $253.3 million, an increase of 33.5%",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 753,399 shares for $261.3 million",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 net sales guidance to be a new range of $2.950 billion to $2.960 billion,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.95 to $8.00,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For the fourth-quarter 2023, our EPS guidance",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 3Q Sales $747.4M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Sales $747.4M >WST
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -2-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $747.4,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -2-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 288.3,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -2-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.17 $1.62,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -2-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -2-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -3-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -3-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -3-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -3-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -4-"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Third-Quarter 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales of $747.4 million grew 8.8%,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.14,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Company is updating full-year 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2023 dividend of $0.20,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2023 Updated Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,-0.42,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $253.3 million, an increase of 33.5%",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 753,399 shares for $261.3 million",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 net sales guidance to be a new range of $2.950 billion to $2.960 billion,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.95 to $8.00,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For the fourth-quarter 2023, our EPS guidance",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $747.4,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -2-
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 288.3,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -2-
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.17 $1.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -2-
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -2-
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -3-
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -3-
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -3-
WST,2023-10-26,10:05:39,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 3Q Sales $747.4M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Sales $747.4M >WST
WST,2023-10-26,10:05:44,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q EPS $2.14,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q EPS $2.14 >WST
WST,2023-10-26,10:16:01,BF79F5,West Pharmaceutical Services Inc.,100,0.64,earnings,up,West Pharma Services 3Q Net Up on,FULL-ARTICLE,Dow Jones Newswires,West Pharma Services 3Q Net Up on Higher Sales
WST,2023-10-26,10:16:01,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West posted earnings of $2.16 a share,FULL-ARTICLE,Dow Jones Newswires,West Pharma Services 3Q Net Up on Higher Sales
WST,2023-10-26,10:16:01,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West's board of directors approved an increase in its quarterly dividend to 20 cents,FULL-ARTICLE,Dow Jones Newswires,West Pharma Services 3Q Net Up on Higher Sales
WST,2023-10-26,10:34:40,BF79F5,West Pharmaceutical Services Inc.,100,-0.75,revenues,down,West Pharma now expects 2023 sales between $2.95 billion,FULL-ARTICLE,Dow Jones Newswires,"West Pharma Cuts 2023 Sales View, Boosts Adjusted Earnings View, as Ordering Trends Change"
WST,2023-10-26,10:34:40,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharma reiterated its projection for 2023,FULL-ARTICLE,Dow Jones Newswires,"West Pharma Cuts 2023 Sales View, Boosts Adjusted Earnings View, as Ordering Trends Change"
WST,2023-10-27,15:42:42,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Stephens & Co.
WST,2023-10-27,15:42:42,BF79F5,West Pharmaceutical Services Inc.,100,-0.68,price-targets,downgrade,West Pharma Price Target Cut to $390.00/Share From $420.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $390.00/Share From $420.00 by Stephens & Co.
WST,2023-11-01,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2023-11-01,10:00:19,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2023-11-02,17:39:25,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Treas Witherspoon Sells 1,190 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"Treas Witherspoon Sells 1,190 Of West Pharmaceutical Services >WST"
WST,2023-11-19,08:38:58,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 3Q 2023 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 3Q 2023 (WST)"
WST,2023-11-30,21:12:09,BF79F5,West Pharmaceutical Services Inc.,100,0.34,products-services,,Exxon to Supply Butyl Polymers to West,RNS-SEC8K,Dow Jones Newswires,West Pharmaceutical Services: Exxon to Supply Butyl Polymers to West
WST,2023-12-06,00:34:55,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Winters Sells 1,013 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Winters Sells 1,013 Of West Pharmaceutical Services >WST"
WST,2023-12-06,11:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2024 Dividend,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Dividend
WST,2023-12-06,11:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2024 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Dividend
WST,2023-12-08,20:08:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,"Chmn Green Gifts 9,800 Of West Pharmaceutical Services >WST",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Green Gifts 9,800 Of West Pharmaceutical Services >WST"
WST,2023-12-13,21:37:50,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Favorite Gifts 584 Of West Pharmaceutical Services >WST,TABULAR-MATERIAL,Dow Jones Newswires,VP Favorite Gifts 584 Of West Pharmaceutical Services >WST
WST,2023-12-14,21:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.47,labor-issues,,West Pharmaceutical Services Inc.: Appoint Browning West co-founder Peter Lee to the Board,PRESS-RELEASE,Business Wire,Browning West Issues Letter to Gildan -2-
WST,2023-12-14,21:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted EPS,PRESS-RELEASE,Business Wire,Browning West Issues Letter to Gildan -2-
WST,2023-12-21,17:57:42,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Winters Sells 1,013 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Winters Sells 1,013 Of West Pharmaceutical Services >WST-Amended"
WST,2023-01-05,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2023-01-05,11:02:18,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2023-01-21,09:10:27,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 4Q 2022 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 4Q 2022 (WST)"
WST,2023-01-31,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.52,products-services,,West Announces Three New Product,PRESS-RELEASE,PR Newswire,West Announces Three New Product Innovations at Pharmapack Europe
WST,2023-01-31,11:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West's participation in this year's conference,PRESS-RELEASE,PR Newswire,West Announces Three New Product Innovations at Pharmapack Europe
WST,2023-01-31,11:00:53,BF79F5,West Pharmaceutical Services Inc.,100,0.52,products-services,,West Announces Three New Product,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Three New Product Innovations at Pharmapack Europe
WST,2023-01-31,11:00:53,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West's participation in this year's conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Three New Product Innovations at Pharmapack Europe
WST,2023-02-02,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2022 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
WST,2023-02-02,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2022 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
WST,2023-02-02,11:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West will also participate in the Barclays Global Healthcare Conference,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
WST,2023-02-02,11:04:29,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2022 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
WST,2023-02-02,11:04:29,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2022 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
WST,2023-02-02,11:04:29,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West will also participate in the Barclays Global Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
WST,2023-02-08,13:30:06,BF79F5,West Pharmaceutical Services Inc.,99,0.39,products-services,,West announced its agreement with Corning,PRESS-RELEASE,PR Newswire,West Expands Corning Collaboration and Launches First Product
WST,2023-02-08,13:30:06,BF79F5,West Pharmaceutical Services Inc.,99,0.49,partnerships,,Corning Inc.: our collaboration with West to,PRESS-RELEASE,PR Newswire,West Expands Corning Collaboration and Launches First Product
WST,2023-02-08,13:30:06,BF79F5,West Pharmaceutical Services Inc.,99,0.39,products-services,,West announced its agreement with Corning,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Expands Corning Collaboration and Launches First Product
WST,2023-02-08,13:30:06,BF79F5,West Pharmaceutical Services Inc.,99,0.49,partnerships,,Corning Inc.: our collaboration with West to,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Expands Corning Collaboration and Launches First Product
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 4Q Sales $708.7M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Sales $708.7M >WST
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q EPS $1.36,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q EPS $1.36 >WST
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Adj EPS $1.77,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Adj EPS $1.77 >WST
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2022",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2022",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Fourth-quarter 2022 net sales of $708.7 million declined 3.0%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.04,revenues,,"West Pharmaceutical Services Inc.: In the full-year 2022, net sales declined by 6.7%",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2022 reported-diluted EPS of $1.36,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 reported-diluted EPS of $7.73,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2022 adjusted-diluted EPS of $1.77,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 adjusted-diluted EPS of $8.58,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharmaceutical Services Inc.: The Board of Directors approved a share repurchase program,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,-0.51,products-services,decrease,West Pharmaceutical Services Inc.: Though pandemic-related product demand is declining,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.66,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $284.6 million, compared with $253.4 million in 2021",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.22,acquisitions-mergers,,"West Pharmaceutical Services Inc.: we purchased 563,334 shares of our",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2023 net sales are expected to be in a range of $2.935 billion to $2.960 billion,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.25 to $7.40,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending is expected to be $350 million,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Net $103M,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Net $103M >WST
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $708.7,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -2-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 262.1,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -2-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.38 $1.98,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -2-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Reported Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -2-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: The twelve-month charge,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -3-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -3-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -3-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -3-
WST,2023-02-16,11:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2022 -3-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Fourth-quarter 2022 net sales of $708.7 million declined 3.0%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.04,revenues,,"West Pharmaceutical Services Inc.: In the full-year 2022, net sales declined by 6.7%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2022 reported-diluted EPS of $1.36,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 reported-diluted EPS of $7.73,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2022 adjusted-diluted EPS of $1.77,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2022 adjusted-diluted EPS of $8.58,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharmaceutical Services Inc.: The Board of Directors approved a share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,-0.51,products-services,decrease,West Pharmaceutical Services Inc.: Though pandemic-related product demand is declining,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.66,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $284.6 million, compared with $253.4 million in 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.22,acquisitions-mergers,,"West Pharmaceutical Services Inc.: we purchased 563,334 shares of our",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Full-year 2023 net sales are expected to be in a range of $2.935 billion to $2.960 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.25 to $7.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending is expected to be $350 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2022 Results
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $708.7,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 262.1,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.38 $1.98,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Reported Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: The twelve-month charge,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2023-02-16,11:00:15,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2023-02-16,11:06:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees 2023 Sales $2.935B-$2.96B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees 2023 Sales $2.935B-$2.96B >WST
WST,2023-02-16,11:06:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees 2023 Adj EPS $7.25,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees 2023 Adj EPS $7.25-Adj EPS $7.40 >WST
WST,2023-02-16,11:06:36,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,approved,West Pharma Board Approves Buyback of Up to $1 Billion in Stock,NEWS-FLASH,Dow Jones Newswires,West Pharma Board Approves Buyback of Up to $1 Billion in Stock >WST
WST,2023-02-16,16:06:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: the company reported stronger fourth-quarter results,FULL-ARTICLE,Dow Jones Newswires,"West Pharmaceutical Shares Rise on Above-Consensus 4Q Results, Outlook"
WST,2023-02-17,10:01:55,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2023-02-17,10:01:55,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $375.00/Share From $315.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $375.00/Share From $315.00 by Keybanc
WST,2023-02-24,14:14:11,BF79F5,West Pharmaceutical Services Inc.,100,0.8,price-targets,upgrade,West Pharmaceutical Services stock price target raised to $324 from $250 at UBS,NEWS-FLASH,MarketWatch,MW West Pharmaceutical Services stock price target raised to $324 from $250 at UBS
WST,2023-03-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces Second-Quarter 2023 Dividend,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Dividend
WST,2023-03-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on May 3, 2023",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Dividend
WST,2023-03-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces Second-Quarter 2023 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Dividend
WST,2023-03-03,11:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,"West Pharmaceutical Services Inc.: The dividend will be paid on May 3, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Dividend
WST,2023-03-08,20:43:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Ceo Green Registers 44,000 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"CEO Green Registers 44,000 Of West Pharmaceutical Services >WST"
WST,2023-03-09,21:45:06,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Ceo Green Sells 44,000 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"CEO Green Sells 44,000 Of West Pharmaceutical Services >WST"
WST,2023-03-22,20:44:20,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Abraham Sells 1,500 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"VP Abraham Sells 1,500 Of West Pharmaceutical Services >WST"
WST,2023-03-28,20:29:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,"Ceo Green Gifts 2,700 Of West Pharmaceutical Services >WST",FULL-ARTICLE,Dow Jones Newswires,"CEO Green Gifts 2,700 Of West Pharmaceutical Services >WST"
WST,2023-04-11,00:30:00,BF79F5,West Pharmaceutical Services Inc.,99,0.44,products-services,,West Pharmaceutical Services Inc.: we entered the market in 2008,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING Schnitzer West Expands Its Ownership Team
WST,2023-04-11,11:01:44,BF79F5,West Pharmaceutical Services Inc.,100,0.94,analyst-ratings,positive,West Pharma Raised to Overweight From Equal-Weight by Stephens,NEWS-FLASH,Dow Jones Newswires,West Pharma Raised to Overweight From Equal-Weight by Stephens & Co.
WST,2023-04-11,11:01:44,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $400.00/Share From $330.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $400.00/Share From $330.00 by Stephens & Co.
WST,2023-04-13,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2023 Conference Call,PRESS-RELEASE,PR Newswire,West to Host First-Quarter 2023 Conference Call
WST,2023-04-13,10:00:23,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host First-Quarter 2023 Conference Call
WST,2023-04-21,07:14:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 1Q 2023 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 1Q 2023 (WST)"
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 1Q Sales $716.6M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Sales $716.6M >WST
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Adj EPS $1.98,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Adj EPS $1.98 >WST
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $7.50,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $7.50-Adj EPS $7.65 >WST
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q EPS $1.85,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q EPS $1.85 >WST
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Net $140M,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Net $140M >WST
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2023",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Net sales of $716.6 million declined 0.5%,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales increased by 12.5% to $133.5 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.85,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 net sales guidance to be a new range of $2.965 billion to $2.990 billion,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 financial guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $82.1 million,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 183,360 shares for $60.1 million",PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.50 to $7.65,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $716.6,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 271.3,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.88 $2.34,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -3-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: increased adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -3-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2023 Results and -3-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time today,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,-0.24,revenues,down,West Pharmaceutical Services Inc.: Net sales of $716.6 million declined 0.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales increased by 12.5% to $133.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.85,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 net sales guidance to be a new range of $2.965 billion to $2.990 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Capital expenditures in the quarter were $82.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 183,360 shares for $60.1 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.50 to $7.65,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $716.6,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 271.3,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $1.88 $2.34,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -2-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,97,0.0,earnings,,West Pharmaceutical Services Inc.: increased adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -3-
WST,2023-04-27,10:00:08,BF79F5,West Pharmaceutical Services Inc.,97,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2023 -3-
WST,2023-04-27,10:34:29,BF79F5,West Pharmaceutical Services Inc.,100,-0.38,earnings,down,West Pharmaceutical Services Inc.'s first-quarter earnings fell 19%,FULL-ARTICLE,Dow Jones Newswires,West Pharma 1Q Net Down on Lower Covid-19 Product Sales
WST,2023-05-02,00:09:33,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Dir Hofmann Registers 1,212 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"Dir Hofmann Registers 1,212 Of West Pharmaceutical Services >WST"
WST,2023-05-02,17:54:42,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Favorite Sells 13,012 Of West Pharmaceutical Services",FULL-ARTICLE,Dow Jones Newswires,"VP Favorite Sells 13,012 Of West Pharmaceutical Services >WST"
WST,2023-05-02,18:06:05,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Abraham Sells 8,020 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Abraham Sells 8,020 Of West Pharmaceutical Services >WST"
WST,2023-05-02,18:07:22,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Dir Hofmann Sells 1,212 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Hofmann Sells 1,212 Of West Pharmaceutical Services >WST"
WST,2023-05-04,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2023-05-04,10:12:41,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2023-05-09,19:43:44,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Winters Surrenders 10 Of West Pharmaceutical Services >WST,TABULAR-MATERIAL,Dow Jones Newswires,VP Winters Surrenders 10 Of West Pharmaceutical Services >WST
WST,2023-05-09,21:12:37,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Ceo Green Registers 44,000 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"CEO Green Registers 44,000 Of West Pharmaceutical Services >WST"
WST,2023-05-11,17:54:52,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,"Ceo Green Acquires 6,000 Of West Pharmaceutical Services >WST",FULL-ARTICLE,Dow Jones Newswires,"CEO Green Acquires 6,000 Of West Pharmaceutical Services >WST"
WST,2023-05-24,10:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2023-05-24,10:00:24,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2023-05-31,20:39:13,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,Vp Winters Sells 872 Of West Pharmaceutical Services,TABULAR-MATERIAL,Dow Jones Newswires,VP Winters Sells 872 Of West Pharmaceutical Services >WST
WST,2023-05-31,20:40:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Treas Witherspoon Sells 1,000 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"Treas Witherspoon Sells 1,000 Of West Pharmaceutical Services >WST"
WST,2023-06-16,11:23:24,BF79F5,West Pharmaceutical Services Inc.,100,0.94,analyst-ratings,positive,West Pharma Raised to Buy From Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,West Pharma Raised to Buy From Neutral by B of A Securities
WST,2023-06-16,11:23:24,BF79F5,West Pharmaceutical Services Inc.,100,0.48,price-targets,upgrade,West Pharma Price Target Raised to $405.00/Share From $390.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $405.00/Share From $390.00 by B of A Securities
WST,2023-07-13,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2023 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Second-Quarter 2023 Conference Call
WST,2023-07-13,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Second-Quarter 2023 Conference Call
WST,2023-07-17,16:09:41,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Stephens & Co.
WST,2023-07-17,16:09:41,BF79F5,West Pharmaceutical Services Inc.,100,0.58,price-targets,upgrade,West Pharma Price Target Raised to $420.00/Share From $400.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $420.00/Share From $400.00 by Stephens & Co.
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q EPS $2.06,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q EPS $2.06 >WST
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Second-Quarter 2023 Conference Call,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharmaceutical Services Inc.: Net sales of $753.8 million declined 2.3%,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,-0.34,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.06, compared to $2.48 in the same period last year",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 net sales guidance to be a new range of $2.970 billion to $2.995 billion,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,-0.32,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $157.5 million, an increase of 19.4%",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 676,070 shares for $233.5 million",PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2023 Updated Financial Guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.65 to $7.80,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -2-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $753.8,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -2-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 291.4,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -2-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.08 $2.53,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -2-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -2-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -3-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -3-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -3-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2023 Results -3-
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 2Q Sales $753.8M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Sales $753.8M >WST
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Adj EPS $2.11,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Adj EPS $2.11 >WST
WST,2023-07-27,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Net $155.1M,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Net $155.1M >WST
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Second-Quarter 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,unchanged,West Pharmaceutical Services Inc.: Net sales of $753.8 million declined 2.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,-0.34,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.06, compared to $2.48 in the same period last year",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 net sales guidance to be a new range of $2.970 billion to $2.995 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,-0.32,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $157.5 million, an increase of 19.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 676,070 shares for $233.5 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2023 Updated Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.65 to $7.80,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 Results
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,96,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $753.8,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -2-
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,96,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 291.4,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -2-
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,96,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.08 $2.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -2-
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,96,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -2-
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -3-
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -3-
WST,2023-07-27,10:00:35,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2023 -3-
WST,2023-07-27,10:08:39,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharma Raises 2023 View To Sales $2.97B-$2.995B,NEWS-FLASH,Dow Jones Newswires,West Pharma Raises 2023 View To Sales $2.97B-$2.995B >WST
WST,2023-07-27,10:08:59,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Had Seen 2023 Sales $2.965B-$2.99B,NEWS-FLASH,Dow Jones Newswires,West Pharma Had Seen 2023 Sales $2.965B-$2.99B >WST
WST,2023-07-27,10:09:27,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharma Raises 2023 View To Adj EPS $7.65,NEWS-FLASH,Dow Jones Newswires,West Pharma Raises 2023 View To Adj EPS $7.65-Adj EPS $7.80 >WST
WST,2023-07-27,10:09:40,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Had Seen 2023 Adjusted EPS $7.50-$7.65,NEWS-FLASH,Dow Jones Newswires,West Pharma Had Seen 2023 Adjusted EPS $7.50-$7.65 >WST
WST,2023-07-27,10:16:46,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,above-expectations,West Pharmaceutical Services' profit beat estimates in the second quarter,FULL-ARTICLE,Dow Jones Newswires,West Pharma Profit Beats Estimates Despite Lower Covid-19 Sales
WST,2023-07-27,10:16:46,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: the company to raise its full-year guidance,FULL-ARTICLE,Dow Jones Newswires,West Pharma Profit Beats Estimates Despite Lower Covid-19 Sales
WST,2023-07-27,10:16:46,BF79F5,West Pharmaceutical Services Inc.,100,-0.38,revenues,,West Pharmaceutical Services Inc.: the company saw lower revenue,FULL-ARTICLE,Dow Jones Newswires,West Pharma Profit Beats Estimates Despite Lower Covid-19 Sales
WST,2023-07-27,10:23:43,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharma raised its full-year guidance,FULL-ARTICLE,Dow Jones Newswires,West Pharma Lifts Profit Guidance on Stable Demand
WST,2023-07-27,10:23:43,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West reported second-quarter profit,FULL-ARTICLE,Dow Jones Newswires,West Pharma Lifts Profit Guidance on Stable Demand
WST,2023-07-28,09:13:59,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2023-07-28,09:13:59,BF79F5,West Pharmaceutical Services Inc.,100,0.42,price-targets,upgrade,West Pharma Price Target Raised to $385.00/Share From $375.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $385.00/Share From $375.00 by Keybanc
WST,2023-08-02,20:30:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2023-08-02,20:30:35,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2023-08-08,19:50:19,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Coo Birkett Sells 22,334 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"COO Birkett Sells 22,334 Of West Pharmaceutical Services >WST"
WST,2023-08-08,22:03:28,BF79F5,West Pharmaceutical Services Inc.,100,-0.48,insider-trading,,"Ceo Green Registers 44,000 Of West Pharmaceutical Services >WST",RNS-SEC144,Dow Jones Newswires,"CEO Green Registers 44,000 Of West Pharmaceutical Services >WST"
WST,2023-08-10,18:53:14,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Ceo Green Sells 44,000 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Green Sells 44,000 Of West Pharmaceutical Services >WST"
WST,2023-08-10,20:32:34,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Abraham Sells 8,160 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Abraham Sells 8,160 Of West Pharmaceutical Services >WST"
WST,2023-08-11,20:53:53,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Treas Witherspoon Sells 1,680 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"Treas Witherspoon Sells 1,680 Of West Pharmaceutical Services >WST"
WST,2023-08-15,18:51:52,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Lai Sells 21,101 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Lai Sells 21,101 Of West Pharmaceutical Services >WST"
WST,2023-08-19,07:53:52,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 2Q 2023 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 2Q 2023 (WST)"
WST,2023-08-21,08:22:37,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2023-08-21,08:22:37,BF79F5,West Pharmaceutical Services Inc.,100,0.7,price-targets,upgrade,West Pharma Price Target Raised to $415.00/Share From $385.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $415.00/Share From $385.00 by Keybanc
WST,2023-08-24,23:26:33,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Reiss-Clark Sells 3,477 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Reiss-Clark Sells 3,477 Of West Pharmaceutical Services >WST"
WST,2023-08-30,08:19:34,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2023-08-30,08:19:34,BF79F5,West Pharmaceutical Services Inc.,100,0.62,price-targets,upgrade,West Pharma Price Target Raised to $440.00/Share From $415.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $440.00/Share From $415.00 by Keybanc
WST,2023-09-01,19:47:35,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Favorite Sells 2,000 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Favorite Sells 2,000 Of West Pharmaceutical Services >WST"
WST,2023-09-07,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conference
WST,2023-09-07,10:00:14,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conference
WST,2023-10-12,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2023 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Third-Quarter 2023 Conference Call
WST,2023-10-12,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Third-Quarter 2023 Conference Call
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Adj EPS $2.16,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Adj EPS $2.16 >WST
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.95B-$2.96B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.95B-$2.96B >WST
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $7.95,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $7.95-Adj EPS $8.00 >WST
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q EPS $2.14,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q EPS $2.14 >WST
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Net $161.3M,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Net $161.3M >WST
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Third-Quarter 2023 Conference Call,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2023",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales of $747.4 million grew 8.8%,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.14,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Company is updating full-year 2023 net sales,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2023 dividend of $0.20,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2023 Updated Financial Guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,-0.42,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $253.3 million, an increase of 33.5%",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 753,399 shares for $261.3 million",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 net sales guidance to be a new range of $2.950 billion to $2.960 billion,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.95 to $8.00,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For the fourth-quarter 2023, our EPS guidance",PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 3Q Sales $747.4M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Sales $747.4M >WST
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -2-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $747.4,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -2-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 288.3,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -2-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.17 $1.62,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -2-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -2-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -3-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -3-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -3-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -3-"
WST,2023-10-26,10:00:11,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Third-Quarter 2023 Results,PRESS-RELEASE,PR Newswire,"West Announces Third-Quarter 2023 Results, -4-"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Announces Third-Quarter 2023 Results, Updates Full-Year 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Third-Quarter 2023 Conference Call,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales of $747.4 million grew 8.8%,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Reported-diluted EPS of $2.14,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Company is updating full-year 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a fourth-quarter 2023 dividend of $0.20,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Full-Year 2023 Updated Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,-0.42,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $253.3 million, an increase of 33.5%",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 753,399 shares for $261.3 million",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: The Company is updating full-year 2023 net sales guidance to be a new range of $2.950 billion to $2.960 billion,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2023 adjusted-diluted EPS is expected to be in a range of $7.95 to $8.00,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services Inc.: For the fourth-quarter 2023, our EPS guidance",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2023 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend"
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $747.4,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -2-
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 288.3,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -2-
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $2.17 $1.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -2-
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -2-
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -3-
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -3-
WST,2023-10-26,10:00:45,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Third-Quarter 2023 -3-
WST,2023-10-26,10:05:39,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 3Q Sales $747.4M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Sales $747.4M >WST
WST,2023-10-26,10:05:44,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q EPS $2.14,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q EPS $2.14 >WST
WST,2023-10-26,10:16:01,BF79F5,West Pharmaceutical Services Inc.,100,0.64,earnings,up,West Pharma Services 3Q Net Up on,FULL-ARTICLE,Dow Jones Newswires,West Pharma Services 3Q Net Up on Higher Sales
WST,2023-10-26,10:16:01,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West posted earnings of $2.16 a share,FULL-ARTICLE,Dow Jones Newswires,West Pharma Services 3Q Net Up on Higher Sales
WST,2023-10-26,10:16:01,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West's board of directors approved an increase in its quarterly dividend to 20 cents,FULL-ARTICLE,Dow Jones Newswires,West Pharma Services 3Q Net Up on Higher Sales
WST,2023-10-26,10:34:40,BF79F5,West Pharmaceutical Services Inc.,100,-0.75,revenues,down,West Pharma now expects 2023 sales between $2.95 billion,FULL-ARTICLE,Dow Jones Newswires,"West Pharma Cuts 2023 Sales View, Boosts Adjusted Earnings View, as Ordering Trends Change"
WST,2023-10-26,10:34:40,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,unchanged,West Pharma reiterated its projection for 2023,FULL-ARTICLE,Dow Jones Newswires,"West Pharma Cuts 2023 Sales View, Boosts Adjusted Earnings View, as Ordering Trends Change"
WST,2023-10-27,15:42:42,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Stephens & Co.
WST,2023-10-27,15:42:42,BF79F5,West Pharmaceutical Services Inc.,100,-0.68,price-targets,downgrade,West Pharma Price Target Cut to $390.00/Share From $420.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $390.00/Share From $420.00 by Stephens & Co.
WST,2023-11-01,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2023-11-01,10:00:19,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2023-11-02,17:39:25,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Treas Witherspoon Sells 1,190 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"Treas Witherspoon Sells 1,190 Of West Pharmaceutical Services >WST"
WST,2023-11-19,08:38:58,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 3Q 2023 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 3Q 2023 (WST)"
WST,2023-11-30,21:12:09,BF79F5,West Pharmaceutical Services Inc.,100,0.34,products-services,,Exxon to Supply Butyl Polymers to West,RNS-SEC8K,Dow Jones Newswires,West Pharmaceutical Services: Exxon to Supply Butyl Polymers to West
WST,2023-12-06,00:34:55,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Winters Sells 1,013 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Winters Sells 1,013 Of West Pharmaceutical Services >WST"
WST,2023-12-06,11:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2024 Dividend,PRESS-RELEASE,PR Newswire,West Announces First-Quarter 2024 Dividend
WST,2023-12-06,11:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter 2024 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2024 Dividend
WST,2023-12-08,20:08:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,"Chmn Green Gifts 9,800 Of West Pharmaceutical Services >WST",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Green Gifts 9,800 Of West Pharmaceutical Services >WST"
WST,2023-12-13,21:37:50,BF79F5,West Pharmaceutical Services Inc.,100,0.0,insider-trading,,Vp Favorite Gifts 584 Of West Pharmaceutical Services >WST,TABULAR-MATERIAL,Dow Jones Newswires,VP Favorite Gifts 584 Of West Pharmaceutical Services >WST
WST,2023-12-14,21:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.47,labor-issues,,West Pharmaceutical Services Inc.: Appoint Browning West co-founder Peter Lee to the Board,PRESS-RELEASE,Business Wire,Browning West Issues Letter to Gildan -2-
WST,2023-12-14,21:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted EPS,PRESS-RELEASE,Business Wire,Browning West Issues Letter to Gildan -2-
WST,2023-12-21,17:57:42,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,insider-trading,,"Vp Winters Sells 1,013 Of West Pharmaceutical Services",TABULAR-MATERIAL,Dow Jones Newswires,"VP Winters Sells 1,013 Of West Pharmaceutical Services >WST-Amended"
WST,2025-03-24,07:00:11,2D84F1,Insig AI PLC,99,0.65,revenues,up,Insig AI PLC: The substantial growth in revenues,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Trading Update, Equity Subscription, Funding & TVR"
WST,2025-03-24,07:00:11,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: Revenue for the third quarter,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Trading Update, Equity Subscription, Funding & TVR"
WST,2025-03-24,07:00:11,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: Revenue for the fourth quarter,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Trading Update, Equity Subscription, Funding & TVR"
WST,2025-04-29,06:00:15,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: Revenue for the fourth quarter was GBP249k,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading Update and New Client Win
WST,2025-05-06,07:00:01,2D84F1,Insig AI PLC,99,0.49,partnerships,,Insig AI PLC: our collaboration with Falcon Windsor provokes thinking and provides,PRESS-RELEASE,Business Wire,Falcon Windsor and Insig AI
WST,2025-05-06,07:00:02,2D84F1,Insig AI PLC,99,0.49,partnerships,,Insig AI PLC: our collaboration with Falcon Windsor provokes thinking and provides,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Insig AI & Falcon Windsor publish research re FTSE
WST,2025-06-24,06:05:02,2D84F1,Insig AI PLC,100,0.47,labor-issues,,Insig AI Plc Appointment of Business Development Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Appointment of Business Development Director
WST,2025-07-03,06:00:17,2D84F1,Insig AI PLC,99,-0.49,labor-issues,,Insig AI PLC: He retired as Chief Executive of Wellcome Trust,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Appointment - Strategic & Asset Allocation Adviser
WST,2025-07-30,06:00:22,2D84F1,Insig AI PLC,100,0.52,products-services,,Insig AI Plc Launch of New Website,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Launch of New Website and Corporate Brand Update
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.56,revenues,up,Insig AI PLC: Revenues for the year increased 43% to GBP0.53 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and Notice of AGM"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.52,products-services,,Insig AI PLC: Launch of automated Generative Intelligence Engine,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and Notice of AGM"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: The financial results,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and Notice of AGM"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: we are reporting an operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and Notice of AGM"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: Revenue for the first quarter was GBP0.2m,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -2-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,"Insig AI PLC: the Company for the year ended 31 March 2025 was GBP5,783,244 (31 March 2024: loss",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -3-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,92,0.61,earnings,positive,"Insig AI PLC: Gross profit 366,701",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -3-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,95,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -5-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,95,0.0,assets,,Insig AI PLC: Technology assets - 7 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -6-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,95,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -6-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,90,0.0,earnings,,Insig AI PLC: The financial performance of,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -8-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.0,revenues,,"Insig AI PLC: For the year ended 31 March 2025, future sales forecasts",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -9-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.46,equity-actions,,Insig AI PLC: Investment in Subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -9-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,94,0.0,earnings,,Insig AI PLC: Other gains/(losses,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -10-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,94,0.0,earnings,,Insig AI PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -10-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,95,0.0,equity-actions,,Insig AI PLC: Development costs in the year ended 31 March 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -11-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,95,0.46,equity-actions,,Insig AI PLC: Investments in subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -11-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: On 30 May 2024, the Group purchased 1,090 shares in ImpactScope OU for GBP123,750",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -12-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -13-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,96,0.44,labor-issues,,Insig AI PLC: Directors' remuneration,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -15-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,96,-0.49,labor-issues,,Insig AI PLC: No directors retired after the year end,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -15-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,93,0.46,equity-actions,,Insig AI PLC: Investment in subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -16-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.0,credit,,"Insig AI PLC: Loans totalling GBP760,058",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -17-"
WST,2025-10-16,06:00:16,2D84F1,Insig AI PLC,99,0.0,revenues,,"Insig AI PLC: the Company's trading update on 7 October, revenue",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading update & extended CLNs and warrant terms
WST,2025-10-16,14:51:08,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Result of AGM
WST,2025-03-24,07:00:11,2D84F1,Insig AI PLC,99,0.65,revenues,up,Insig AI PLC: The substantial growth in revenues,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Trading Update, Equity Subscription, Funding & TVR"
WST,2025-03-24,07:00:11,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: Revenue for the third quarter,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Trading Update, Equity Subscription, Funding & TVR"
WST,2025-03-24,07:00:11,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: Revenue for the fourth quarter,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Trading Update, Equity Subscription, Funding & TVR"
WST,2025-04-29,06:00:15,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: Revenue for the fourth quarter was GBP249k,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading Update and New Client Win
WST,2025-05-06,07:00:01,2D84F1,Insig AI PLC,99,0.49,partnerships,,Insig AI PLC: our collaboration with Falcon Windsor provokes thinking and provides,PRESS-RELEASE,Business Wire,Falcon Windsor and Insig AI
WST,2025-05-06,07:00:02,2D84F1,Insig AI PLC,99,0.49,partnerships,,Insig AI PLC: our collaboration with Falcon Windsor provokes thinking and provides,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Insig AI & Falcon Windsor publish research re FTSE
WST,2025-06-24,06:05:02,2D84F1,Insig AI PLC,100,0.47,labor-issues,,Insig AI Plc Appointment of Business Development Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Appointment of Business Development Director
WST,2025-07-03,06:00:17,2D84F1,Insig AI PLC,99,-0.49,labor-issues,,Insig AI PLC: He retired as Chief Executive of Wellcome Trust,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Appointment - Strategic & Asset Allocation Adviser
WST,2025-07-30,06:00:22,2D84F1,Insig AI PLC,100,0.52,products-services,,Insig AI Plc Launch of New Website,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Launch of New Website and Corporate Brand Update
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.56,revenues,up,Insig AI PLC: Revenues for the year increased 43% to GBP0.53 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and Notice of AGM"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.52,products-services,,Insig AI PLC: Launch of automated Generative Intelligence Engine,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and Notice of AGM"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.0,earnings,,Insig AI PLC: The financial results,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and Notice of AGM"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,-0.63,earnings,negative,Insig AI PLC: we are reporting an operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and Notice of AGM"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.0,revenues,,Insig AI PLC: Revenue for the first quarter was GBP0.2m,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -2-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,92,-0.65,earnings,negative,"Insig AI PLC: the Company for the year ended 31 March 2025 was GBP5,783,244 (31 March 2024: loss",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -3-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,92,0.61,earnings,positive,"Insig AI PLC: Gross profit 366,701",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -3-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,95,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -5-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,95,0.0,assets,,Insig AI PLC: Technology assets - 7 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -6-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,95,0.46,equity-actions,,Insig AI PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -6-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,90,0.0,earnings,,Insig AI PLC: The financial performance of,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -8-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.0,revenues,,"Insig AI PLC: For the year ended 31 March 2025, future sales forecasts",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -9-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.46,equity-actions,,Insig AI PLC: Investment in Subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -9-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,94,0.0,earnings,,Insig AI PLC: Other gains/(losses,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -10-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,94,0.0,earnings,,Insig AI PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -10-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,95,0.0,equity-actions,,Insig AI PLC: Development costs in the year ended 31 March 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -11-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,95,0.46,equity-actions,,Insig AI PLC: Investments in subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -11-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.62,acquisitions-mergers,,"Insig AI PLC: On 30 May 2024, the Group purchased 1,090 shares in ImpactScope OU for GBP123,750",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -12-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.38,credit,,Insig AI PLC: the Company entered into a convertible loan facility agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -13-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,96,0.44,labor-issues,,Insig AI PLC: Directors' remuneration,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -15-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,96,-0.49,labor-issues,,Insig AI PLC: No directors retired after the year end,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -15-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,93,0.46,equity-actions,,Insig AI PLC: Investment in subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -16-"
WST,2025-09-19,06:00:21,2D84F1,Insig AI PLC,99,0.0,credit,,"Insig AI PLC: Loans totalling GBP760,058",PRESS-RELEASE,LSE Regulatory News Service (RNS),"Insig AI Plc Final Results, Posting of AR&A and -17-"
WST,2025-10-16,06:00:16,2D84F1,Insig AI PLC,99,0.0,revenues,,"Insig AI PLC: the Company's trading update on 7 October, revenue",PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Trading update & extended CLNs and warrant terms
WST,2025-10-16,14:51:08,2D84F1,Insig AI PLC,99,0.0,investor-relations,,Insig AI PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Insig AI Plc Result of AGM
WST,2025-03-25,09:40:22,651C38,Vienna Insurance Group AG,100,0.16,credit-ratings,set,S&PGR Assigns 'A-' Rating To VIG,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Assigns 'A-' Rating To VIG's Prpsd Jr Subord FtF Notes
WST,2025-08-08,06:48:39,651C38,Vienna Insurance Group AG,100,0.55,acquisitions-mergers,interest,Vienna INSURANCE GROUP AG Wiener Versicherung Gruppe: VIG considers the acquisition,PRESS-RELEASE,DGAP News,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: VIG considers the acquisition of a majority stake in NUeRNBERGER Beteiligungs-AG
WST,2025-08-08,06:48:39,651C38,Vienna Insurance Group AG,100,0.55,acquisitions-mergers,interest,Vienna INSURANCE GROUP AG Wiener Versicherung Gruppe: VIG considers the acquisition,PRESS-RELEASE,Dow Jones Newswires,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: VIG considers the acquisition of a majority stake in NUeRNBERGER Beteiligungs-AG
WST,2025-08-26,10:00:00,651C38,Vienna Insurance Group AG,100,0.49,partnerships,,Camunda Partners with Kooperativa to,PRESS-RELEASE,Business Wire,Camunda Partners with Kooperativa to Automate and Orchestrate Mission Critical Insurance Business Processes
WST,2025-08-26,10:00:00,651C38,Vienna Insurance Group AG,100,0.34,products-services,,"Vienna Insurance Group, will leverage Camunda to",PRESS-RELEASE,Business Wire,Camunda Partners with Kooperativa to Automate and Orchestrate Mission Critical Insurance Business Processes
WST,2025-10-22,12:51:00,651C38,Vienna Insurance Group AG,91,0.39,products-services,,Nuernberger) and Vienna Insurance Group AG's (VIG) announcement on 16 October 2025 that they have signed an agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Places Nuernberger on Rating Watch Positive on Proposed Acquisition by VIG
WST,2025-10-23,10:07:55,651C38,Vienna Insurance Group AG,100,0.53,credit-ratings,positive,S&PGR Revises Vienna Insurance Group Outlook To Positive,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Revises Vienna Insurance Group Outlook To Positive
WST,2025-10-23,10:07:55,651C38,Vienna Insurance Group AG,100,0.55,acquisitions-mergers,,Vienna Insurance Group's Potential Acquisition Of NUERNBERGER Beteiligungs-AG Is In Line,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Revises Vienna Insurance Group Outlook To Positive
WST,2025-10-23,10:07:55,651C38,Vienna Insurance Group AG,100,0.53,credit-ratings,positive,S&PGR Revises Vienna Insurance Group Outlook To Positive,NEWS-FLASH,Dow Jones Newswires,S&PGR Revises Vienna Insurance Group Outlook To Positive
WST,2025-03-25,09:40:22,651C38,Vienna Insurance Group AG,100,0.16,credit-ratings,set,S&PGR Assigns 'A-' Rating To VIG,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Assigns 'A-' Rating To VIG's Prpsd Jr Subord FtF Notes
WST,2025-08-08,06:48:39,651C38,Vienna Insurance Group AG,100,0.55,acquisitions-mergers,interest,Vienna INSURANCE GROUP AG Wiener Versicherung Gruppe: VIG considers the acquisition,PRESS-RELEASE,DGAP News,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: VIG considers the acquisition of a majority stake in NUeRNBERGER Beteiligungs-AG
WST,2025-08-08,06:48:39,651C38,Vienna Insurance Group AG,100,0.55,acquisitions-mergers,interest,Vienna INSURANCE GROUP AG Wiener Versicherung Gruppe: VIG considers the acquisition,PRESS-RELEASE,Dow Jones Newswires,EQS-Adhoc: VIENNA INSURANCE GROUP AG Wiener Versicherung Gruppe: VIG considers the acquisition of a majority stake in NUeRNBERGER Beteiligungs-AG
WST,2025-08-26,10:00:00,651C38,Vienna Insurance Group AG,100,0.49,partnerships,,Camunda Partners with Kooperativa to,PRESS-RELEASE,Business Wire,Camunda Partners with Kooperativa to Automate and Orchestrate Mission Critical Insurance Business Processes
WST,2025-08-26,10:00:00,651C38,Vienna Insurance Group AG,100,0.34,products-services,,"Vienna Insurance Group, will leverage Camunda to",PRESS-RELEASE,Business Wire,Camunda Partners with Kooperativa to Automate and Orchestrate Mission Critical Insurance Business Processes
WST,2025-10-22,12:51:00,651C38,Vienna Insurance Group AG,91,0.39,products-services,,Nuernberger) and Vienna Insurance Group AG's (VIG) announcement on 16 October 2025 that they have signed an agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Places Nuernberger on Rating Watch Positive on Proposed Acquisition by VIG
WST,2025-10-23,10:07:55,651C38,Vienna Insurance Group AG,100,0.53,credit-ratings,positive,S&PGR Revises Vienna Insurance Group Outlook To Positive,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Revises Vienna Insurance Group Outlook To Positive
WST,2025-10-23,10:07:55,651C38,Vienna Insurance Group AG,100,0.55,acquisitions-mergers,,Vienna Insurance Group's Potential Acquisition Of NUERNBERGER Beteiligungs-AG Is In Line,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Revises Vienna Insurance Group Outlook To Positive
WST,2025-10-23,10:07:55,651C38,Vienna Insurance Group AG,100,0.53,credit-ratings,positive,S&PGR Revises Vienna Insurance Group Outlook To Positive,NEWS-FLASH,Dow Jones Newswires,S&PGR Revises Vienna Insurance Group Outlook To Positive
WST,2025-01-08,21:34:08,BF79F5,West Pharmaceutical Services Inc.,100,0.95,analyst-ratings,positive,West Pharma Initiated at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Buy by Citigroup
WST,2025-01-08,21:34:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $400.00/Share by Citigroup,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $400.00/Share by Citigroup
WST,2025-01-28,17:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter Dividend,PRESS-RELEASE,PR Newswire,West Announces First-Quarter Dividend
WST,2025-01-28,17:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter Dividend
WST,2025-01-30,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2024 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2024 Conference Call
WST,2025-01-30,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2024 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2024 Conference Call
WST,2025-01-30,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2024 Conference Call
WST,2025-01-30,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2024 Conference Call
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 4Q Sales $748.8M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Sales $748.8M >WST
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $5.97,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $5.97-EPS $6.17 >WST
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q EPS $1.78,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q EPS $1.78 >WST
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Fourth-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.02,revenues,,West Pharmaceutical Services Inc.: Fourth-quarter 2024 net sales of $748.8 million increased 2.3%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2024 reported-diluted EPS of $1.78,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: fourth-quarter 2024 adjusted-diluted EPS of $1.82,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: For Full-year 2025, the Company anticipates net sales in a range of $2.875 billion to $2.905 billion",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Full-year 2024 net sales grew by 1.1% to $558.7 million,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.13,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $377.0 million, an increase of 4.1%",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 1,583,032 shares for $560.9 million",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2025 adjusted-diluted EPS is expected to be in a range of $6.00 to $6.20,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2025 capital spending is expected to be $275 million,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $6.00,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $6.00-Adj EPS $6.20 >WST
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2022 restructuring plan,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 -3-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 -3-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 -3-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 -3-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Adj EPS $1.82,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Adj EPS $1.82 >WST
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Net $130.1M,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Net $130.1M >WST
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Fourth-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.02,revenues,,West Pharmaceutical Services Inc.: Fourth-quarter 2024 net sales of $748.8 million increased 2.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2024 reported-diluted EPS of $1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: fourth-quarter 2024 adjusted-diluted EPS of $1.82,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: For Full-year 2025, the Company anticipates net sales in a range of $2.875 billion to $2.905 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Full-year 2024 net sales grew by 1.1% to $558.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.13,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $377.0 million, an increase of 4.1%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 1,583,032 shares for $560.9 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2025 adjusted-diluted EPS is expected to be in a range of $6.00 to $6.20,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2025 capital spending is expected to be $275 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,92,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 748.8,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,92,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 273.6,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,92,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,92,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.79 $ 1.85 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2025-02-13,11:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2022 restructuring plan,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2025-02-13,11:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2025-02-13,11:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2025-02-13,11:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2025-02-13,11:04:19,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees 2025 Sales $2.875B-$2.905B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees 2025 Sales $2.875B-$2.905B >WST
WST,2025-02-13,11:04:39,BF79F5,West Pharmaceutical Services Inc.,100,0.48,revenues,up,West Pharma Sees 2025 Organic Sales Growth 2%-3%,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees 2025 Organic Sales Growth 2%-3% >WST
WST,2025-02-13,11:04:59,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharma Sees 2025 Capital Spending $275M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees 2025 Capital Spending $275M >WST
WST,2025-02-13,11:35:18,BF79F5,West Pharmaceutical Services Inc.,92,-0.67,earnings,down,West Pharmaceutical Services posted a slight decline in profit,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Services 4Q Results Clear Estimates but 2025 Guidance Comes Up Short
WST,2025-02-13,11:35:18,BF79F5,West Pharmaceutical Services Inc.,92,0.0,revenues,,"For 2025, West Pharmaceutical guided for sales between $2.88 billion",FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Services 4Q Results Clear Estimates but 2025 Guidance Comes Up Short
WST,2025-02-13,13:01:38,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: the ""Company"") issued a press release announcing its fourth-quarter and full year 2024 financial results",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2025-02-13,13:01:38,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: the ""Company"") issued a press release announcing its fourth-quarter and full year 2024 financial results",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2025-02-13,17:20:52,BF79F5,West Pharmaceutical Services Inc.,92,0.0,revenues,,West Pharmaceutical Services Inc.: The company said it expects expects 2025 net sales,FULL-ARTICLE,Dow Jones Newswires,"These Stocks Are Moving the Most Today: Trade Desk, AppLovin, Intel, Tesla, Robinhood, Deere, MGM, West Pharma, and More -- Barrons.com"
WST,2025-02-13,18:49:52,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,above-expectations,West Pharma posted better-than-expected fourth-quarter earnings,FULL-ARTICLE,MarketWatch,MW West Pharma's stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin
WST,2025-02-13,19:40:16,BF79F5,West Pharmaceutical Services Inc.,92,0.0,revenues,,West Pharmaceutical Services Inc.: The company said it expects 2025 net sales,FULL-ARTICLE,Dow Jones Newswires,"These Stocks Are Moving the Most Today: Trade Desk, AppLovin, Intel, Tesla, Robinhood, Deere, MGM, West Pharma, and More -- Barrons.com"
WST,2025-02-13,21:24:59,BF79F5,West Pharmaceutical Services Inc.,92,0.0,revenues,,West Pharmaceutical Services Inc.: The company said it expects 2025 net sales,FULL-ARTICLE,Dow Jones Newswires,"These Stocks Moved the Most Today: Trade Desk, AppLovin, Intel, Tesla, Robinhood, Deere, MGM, West Pharma, and More -- Barrons.com"
WST,2025-02-14,17:32:10,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2025-02-14,17:32:10,BF79F5,West Pharmaceutical Services Inc.,100,-0.84,price-targets,downgrade,West Pharma Price Target Cut to $325.00/Share From $470.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $325.00/Share From $470.00 by Keybanc
WST,2025-02-20,21:30:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces Second-Quarter Dividend,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter Dividend
WST,2025-02-20,21:30:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces Second-Quarter Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter Dividend
WST,2025-02-21,02:10:48,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Treas Witherspoon Acquires 42 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,Treas Witherspoon Acquires 42 Of West Pharmaceutical Services >WST
WST,2025-02-21,02:11:01,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Vp Winters Acquires 54 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Winters Acquires 54 Of West Pharmaceutical Services >WST
WST,2025-02-21,02:12:49,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,"Chmn Green Acquires 1,761 Of West Pharmaceutical Services >WST",FULL-ARTICLE,Dow Jones Newswires,"Chmn Green Acquires 1,761 Of West Pharmaceutical Services >WST"
WST,2025-02-21,02:13:20,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Vp Favorite Acquires 162 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Favorite Acquires 162 Of West Pharmaceutical Services >WST
WST,2025-02-21,02:14:47,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Vp MacKay Acquires 153 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP MacKay Acquires 153 Of West Pharmaceutical Services >WST
WST,2025-02-21,02:19:08,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Vp Reiss-Clark Acquires 163 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Reiss-Clark Acquires 163 Of West Pharmaceutical Services >WST
WST,2025-02-21,02:47:02,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Cfo Birkett Acquires 631 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,CFO Birkett Acquires 631 Of West Pharmaceutical Services >WST
WST,2025-02-21,20:30:59,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates"
WST,2025-02-22,08:08:52,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 4Q 2024 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 4Q 2024 (WST)"
WST,2025-02-24,12:31:17,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights"
WST,2025-02-25,12:32:56,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights"
WST,2025-02-26,12:49:08,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - WST"
WST,2025-02-27,12:31:57,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST)"
WST,2025-02-28,12:47:09,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights"
WST,2025-03-03,12:33:01,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Regarding an Ongoing Investigation"
WST,2025-03-04,12:26:07,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc.(WST)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky"
WST,2025-03-05,11:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2025-03-05,11:01:42,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2025-03-06,12:25:37,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - WST"
WST,2025-03-11,11:31:26,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky"
WST,2025-03-11,20:08:58,BF79F5,West Pharmaceutical Services Inc.,97,-0.57,labor-issues,,"West Pharmaceutical Services Inc.: Senior Vice President and Chief Commercial Officer, has departed the Company",RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-03-11,21:07:23,BF79F5,West Pharmaceutical Services Inc.,100,-0.57,labor-issues,,West Pharmaceutical Services Chief Commercial Officer Cindy Reiss-Clark Leaves Company,RNS-SEC8K,Dow Jones Newswires,West Pharmaceutical Services Chief Commercial Officer Cindy Reiss-Clark Leaves Company
WST,2025-03-12,11:31:36,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - WST"
WST,2025-03-13,11:31:18,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders that Lost Money on West Pharmaceutical Services, Inc. (WST) Should Contact Levi & Korsinsky About Securities Fraud Investigation - WST"
WST,2025-03-14,11:32:37,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST)"
WST,2025-03-17,11:27:08,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Shareholder Rights Advocates at Levi & Korsinsky Investigate West Pharmaceutical Services, Inc. (WST) Regarding Possible Securities Fraud Violations"
WST,2025-03-18,09:19:43,BF79F5,West Pharmaceutical Services Inc.,100,0.95,analyst-ratings,positive,West Pharma Initiated at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Outperform by Evercore ISI Group
WST,2025-03-18,09:19:43,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $275.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $275.00/Share by Evercore ISI Group
WST,2025-03-18,11:27:06,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates"
WST,2025-03-19,11:26:35,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- WST"
WST,2025-03-20,11:27:33,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - WST"
WST,2025-03-21,11:31:10,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds Shareholders of an Investigation into West Pharmaceutical Services, Inc. (WST) Regarding Potential Securities Fraud Allegations"
WST,2025-03-24,11:27:12,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - WST"
WST,2025-03-25,11:26:36,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - WST"
WST,2025-03-26,11:31:43,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights"
WST,2025-03-27,11:27:33,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment"
WST,2025-03-28,11:34:09,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST"
WST,2025-03-31,11:26:09,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment"
WST,2025-04-01,11:31:38,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders that Lost Money on West Pharmaceutical Services, Inc. (WST) Should Contact Levi & Korsinsky About Securities Fraud Investigation - WST"
WST,2025-04-02,11:27:06,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - WST"
WST,2025-04-03,11:31:36,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"ATTENTION WST SHAREHOLDERS: Investors who Lost Money on West Pharmaceutical Services, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation"
WST,2025-04-04,11:26:38,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST"
WST,2025-04-07,11:32:10,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST"
WST,2025-04-08,11:26:42,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Regarding an Ongoing Investigation"
WST,2025-04-09,11:27:36,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Investors who lost money on West Pharmaceutical Services, Inc. should contact Levi & Korsinsky about an ongoing investigation - WST"
WST,2025-04-10,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2025 Conference Call,PRESS-RELEASE,PR Newswire,West to Host First-Quarter 2025 Conference Call
WST,2025-04-10,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2025 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host First-Quarter 2025 Conference Call
WST,2025-04-10,11:27:35,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders that lost money on West Pharmaceutical Services, Inc.(WST) should contact Levi & Korsinsky about Securities Fraud Investigation - WST"
WST,2025-04-11,11:26:39,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of West Pharmaceutical Services, Inc. Shareholders Who Lost Money"
WST,2025-04-14,11:26:05,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment"
WST,2025-04-14,20:09:37,BF79F5,West Pharmaceutical Services Inc.,99,0.53,labor-issues,,West Pharmaceutical Services Inc.: named executive officer of the Company,RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-04-14,20:09:37,BF79F5,West Pharmaceutical Services Inc.,99,0.39,products-services,,West Pharmaceutical Services Inc.: Ms. Reiss-Clark and the Company have reached an agreement on,RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-04-14,20:09:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"West Pharmaceutical Services Inc.: In exchange for these benefits, Ms. Reiss-Clark released all potential claims against the Company",RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-04-14,20:09:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,West Pharmaceutical Services Inc.: not to pursue any litigation against the Company,RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-04-14,20:09:37,BF79F5,West Pharmaceutical Services Inc.,99,0.49,partnerships,,West Pharmaceutical Services Inc.: agreed to cooperate with the Company as,RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-04-15,11:27:36,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Being Investigated on Behalf of West Pharmaceutical Services, Inc. Investors. Contact Levi & Korsinsky For Details."
WST,2025-04-16,11:33:06,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"An Investigation Has Commenced on Behalf of West Pharmaceutical Services, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your WST Losses"
WST,2025-04-17,11:27:11,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates"
WST,2025-04-18,11:26:11,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST)"
WST,2025-04-21,11:33:36,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by West Pharmaceutical Services, Inc."
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.95B-$2.98B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.95B-$2.98B >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2025",PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: First-Quarter 2025 Conference Call,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales of $698.0 million increased 0.4%,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,-0.4,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.23, compared to $1.55 in the same period last year",PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is increasing its full year 2025 net sales guidance,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a third-quarter 2025 dividend of $0.21,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our first quarter guidance,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.34,equity-actions,down,"West Pharmaceutical Services Inc.: Capital expenditures were $71.3 million, a decrease of 21.3%",PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 550,281 shares for $133.5 million",PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Our updated adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2025 capital spending guidance,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 1Q Sales $698M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Sales $698M >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 698.0,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 231.9,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.24 $ 1.57,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: the Company recorded charges of $17.8 million,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2025 restructuring plan,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $5.86,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $5.86-EPS $6.06 >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -3-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -3-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q EPS $1.23,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q EPS $1.23 >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $6.15,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $6.15-Adj EPS $6.35 >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Adj EPS $1.45,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Adj EPS $1.45 >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Net $89.8M,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Net $89.8M >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: First-Quarter 2025 Conference Call,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales of $698.0 million increased 0.4%,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,-0.4,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.23, compared to $1.55 in the same period last year",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is increasing its full year 2025 net sales guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a third-quarter 2025 dividend of $0.21,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our first quarter guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.34,equity-actions,down,"West Pharmaceutical Services Inc.: Capital expenditures were $71.3 million, a decrease of 21.3%",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 550,281 shares for $133.5 million",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Our updated adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2025 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 698.0,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 231.9,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.24 $ 1.57,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: the Company recorded charges of $17.8 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2025 restructuring plan,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -3-
WST,2025-04-24,10:10:02,BF79F5,West Pharmaceutical Services Inc.,99,0.53,labor-issues,,West Pharmaceutical Services Inc.: Mr. Birkett joined West as Senior Vice President,PRESS-RELEASE,PR Newswire,West Announces Leadership Changes
WST,2025-04-24,10:10:02,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: First-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Announces Leadership Changes
WST,2025-04-24,10:10:02,BF79F5,West Pharmaceutical Services Inc.,99,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call at 9:00 a.m. Eastern Time,PRESS-RELEASE,PR Newswire,West Announces Leadership Changes
WST,2025-04-24,10:10:02,BF79F5,West Pharmaceutical Services Inc.,99,0.53,labor-issues,,West Pharmaceutical Services Inc.: Mr. Birkett joined West as Senior Vice President,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Leadership Changes
WST,2025-04-24,10:10:02,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: First-Quarter 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Leadership Changes
WST,2025-04-24,10:10:02,BF79F5,West Pharmaceutical Services Inc.,99,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call at 9:00 a.m. Eastern Time,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Leadership Changes
WST,2025-04-24,10:10:58,BF79F5,West Pharmaceutical Services Inc.,100,-0.57,labor-issues,,West Pharma CFO Bernard Birkett to Step Down From,NEWS-FLASH,Dow Jones Newswires,West Pharma CFO Bernard Birkett to Step Down From His Current Position >WST
WST,2025-04-24,10:28:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,labor-issues,,West Pharmaceutical Chief Financial Officer Bernard Birkett to Retire,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Chief Financial Officer Bernard Birkett to Retire
WST,2025-04-24,10:28:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,labor-issues,,"West Pharmaceutical Services' top finance executive, Bernard Birkett, plans to retire",FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Chief Financial Officer Bernard Birkett to Retire
WST,2025-04-24,11:27:09,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Investors who lost money on West Pharmaceutical Services, Inc. should contact Levi & Korsinsky about an ongoing investigation - WST"
WST,2025-04-24,11:47:40,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: West Pharmaceutical Services, Inc. (the ""Company"") issued a press release announcing its first-quarter 2025 financial results.",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2025-04-24,11:56:58,BF79F5,West Pharmaceutical Services Inc.,99,-0.49,labor-issues,,"West Pharmaceutical Services Inc.: West Pharmaceutical Services, Inc. (the ""Company"") of his intention to retire as Senior Vice President & Chief Financial Officer",RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-04-25,11:31:06,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"An Investigation Has Commenced on Behalf of West Pharmaceutical Services, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your WST Losses"
WST,2025-04-28,11:25:48,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"ATTENTION West Pharmaceutical Services, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights"
WST,2025-04-29,11:32:09,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - WST"
WST,2025-04-30,11:32:40,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Regarding an Ongoing Investigation"
WST,2025-05-01,11:31:39,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST"
WST,2025-05-02,11:31:08,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"An Investigation Has Commenced on Behalf of West Pharmaceutical Services, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your WST Losses"
WST,2025-05-05,11:22:11,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- WST"
WST,2025-05-05,22:30:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Business Wire,"Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. and Certain of Its Executives"
WST,2025-05-06,11:31:09,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders that Lost Money on West Pharmaceutical Services, Inc.(WST) Should Contact Levi & Korsinsky About Securities Fraud Investigation - WST"
WST,2025-05-06,12:15:46,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by West Pharmaceutical Services, Inc"
WST,2025-05-06,16:01:33,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-06,16:16:04,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-06,18:10:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Business Wire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-06,22:08:04,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,PR Newswire,"WST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead the West Pharmaceutical Class Action Lawsuit"
WST,2025-05-06,22:30:45,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST"
WST,2025-05-06,22:35:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-06,22:35:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-06,23:01:41,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline"
WST,2025-05-07,00:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,GlobeNewswire,"Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-07,00:32:37,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST"
WST,2025-05-07,09:55:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,Business Wire,"WST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-07,11:02:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-07,11:17:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders that lost money on West Pharmaceutical Services, Inc.(WST) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More"
WST,2025-05-07,12:02:35,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-07,12:02:35,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-07,12:16:43,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline"
WST,2025-05-07,13:02:51,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies Shareholders of West Pharmaceutical Services, Inc. (WST) of a Class Action Lawsuit and an Upcoming Deadline"
WST,2025-05-07,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-07,20:30:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,"West Pharmaceutical Services Inc.: It will also present at the William Blair 45(th) Annual Growth Stock Conference on Thursday, June 5, 2025 at 10:40 AM",PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2025-05-07,20:30:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,"West Pharmaceutical Services Inc.: It will also present at the William Blair 45(th) Annual Growth Stock Conference on Thursday, June 5, 2025 at 10:40 AM",PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2025-05-07,20:33:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders"
WST,2025-05-07,22:02:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky"
WST,2025-05-08,01:30:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Securities Fraud Investigation Into West Pharmaceutical Services, Inc. (WST) Announced -- Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz"
WST,2025-05-08,01:30:00,BF79F5,West Pharmaceutical Services Inc.,99,0.62,acquisitions-mergers,,West Pharmaceutical Services Inc.: If you purchased West,PRESS-RELEASE,Business Wire,"Securities Fraud Investigation Into West Pharmaceutical Services, Inc. (WST) Announced -- Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz"
WST,2025-05-08,11:02:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-08,11:31:38,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc. (WST) Shareholders"
WST,2025-05-08,12:02:30,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-08,12:02:30,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-08,12:16:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Contact Levi & Korsinsky by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-08,13:25:14,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"WST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-08,13:45:43,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders that lost money on West Pharmaceutical Services, Inc. (WST) should contact Levi & Korsinsky about pending Class Action - WST"
WST,2025-05-08,18:04:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money -- Contact Law Offices of Howard G. Smith About Securities Fraud Investigation"
WST,2025-05-08,18:04:00,BF79F5,West Pharmaceutical Services Inc.,99,0.62,acquisitions-mergers,,West Pharmaceutical Services Inc.: If you purchased West,PRESS-RELEASE,Business Wire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money -- Contact Law Offices of Howard G. Smith About Securities Fraud Investigation"
WST,2025-05-08,19:23:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-08,19:46:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST"
WST,2025-05-08,20:00:34,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-08,20:31:39,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders of West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST"
WST,2025-05-08,21:47:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Securities Fraud Investigation Into West Pharmaceutical Services, Inc. (WST) Announced -- Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm"
WST,2025-05-08,23:16:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies Shareholders of West Pharmaceutical Services, Inc.(WST) of a Class Action Lawsuit and an Upcoming Deadline"
WST,2025-05-09,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West Pharmaceutical",PRESS-RELEASE,GlobeNewswire,"WEST PHARMACEUTICAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. and Encourages Investors to Contact the Firm"
WST,2025-05-09,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"WEST PHARMACEUTICAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. and Encourages Investors to Contact the Firm"
WST,2025-05-09,01:21:09,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - July 7, 2025 Deadline to Join - Contact Levi & Korsinsky"
WST,2025-05-09,11:01:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-09,11:32:36,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST"
WST,2025-05-09,14:32:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-09,14:32:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-09,14:57:07,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST"
WST,2025-05-09,20:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-09,20:31:39,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders of West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST"
WST,2025-05-10,02:07:24,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-10,12:03:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-10,12:03:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-10,22:22:38,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Class Action: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST"
WST,2025-05-11,11:03:14,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-11,11:30:16,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST"
WST,2025-05-11,16:50:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,Business Wire,"WST INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-12,09:05:03,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,PR Newswire,"WST INVESTOR NOTICE: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-12,09:30:47,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders That Lost Money on West Pharmaceutical Services, Inc. (WST) Should Contact Levi & Korsinsky about pending Class Action - WST"
WST,2025-05-12,09:45:05,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST"
WST,2025-05-12,09:45:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST"
WST,2025-05-12,11:03:16,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-12,11:31:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST"
WST,2025-05-12,16:00:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.6,legal,,"West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud",PRESS-RELEASE,Business Wire,"Law Offices of Howard G. Smith Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-12,16:00:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Law Offices of Howard G. Smith Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-12,16:00:00,BF79F5,West Pharmaceutical Services Inc.,100,0.62,acquisitions-mergers,,West Pharmaceutical Services Inc.: If you purchased West,PRESS-RELEASE,Business Wire,"Law Offices of Howard G. Smith Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-12,18:05:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-12,18:05:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-12,18:31:09,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Seeking Recovery for Investors - Contact Levi & Korsinsky"
WST,2025-05-13,00:20:28,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-13,00:45:42,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies Shareholders of West Pharmaceutical Services, Inc. (WST) of a Class Action Lawsuit and an Upcoming Deadline"
WST,2025-05-13,01:16:36,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST"
WST,2025-05-13,09:45:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,Levi & Korsinsky to Join Class Action Suit Against WST,PRESS-RELEASE,PR Newswire,"July 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against WST"
WST,2025-05-13,11:02:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-13,11:26:39,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - WST"
WST,2025-05-13,13:01:33,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"(PMZN) INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-13,13:01:33,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"(PMZN) INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-13,13:16:06,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST"
WST,2025-05-13,16:00:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.6,legal,,"West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud",PRESS-RELEASE,Business Wire,"Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-13,16:00:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-13,20:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-13,21:33:34,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST"
WST,2025-05-14,11:02:43,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-14,11:16:47,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-14,13:03:53,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-14,13:03:53,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-14,13:16:12,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline"
WST,2025-05-14,16:09:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.6,legal,,"West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud",PRESS-RELEASE,Business Wire,"Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-14,16:09:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-14,16:09:00,BF79F5,West Pharmaceutical Services Inc.,100,0.62,acquisitions-mergers,,West Pharmaceutical Services Inc.: If you purchased West,PRESS-RELEASE,Business Wire,"Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-14,20:00:34,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-14,20:31:12,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-14,21:30:45,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit"
WST,2025-05-14,21:45:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-14,22:46:32,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Contact Levi & Korsinsky by July 7, 2025 to Join Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-15,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Avis Budget, Civitas, Open Lending, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-05-15,01:21:19,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-15,11:02:16,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-15,11:16:47,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-15,14:40:29,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-15,15:02:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-15,16:00:01,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Deadline Approaching: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith"
WST,2025-05-15,16:34:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline"
WST,2025-05-16,11:03:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-16,11:17:43,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-05-16,13:04:38,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-16,13:04:38,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-16,13:20:40,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-05-16,14:32:10,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-05-16,15:11:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"WST INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In WST To Contact Him Directly To Discuss Their Options"
WST,2025-05-16,15:31:17,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-05-16,17:09:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-05-16,23:00:24,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR DEADLINE: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-17,22:08:45,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-05-18,11:03:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-18,11:16:08,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-05-18,14:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-18,14:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-18,14:33:11,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-18,20:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-18,20:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-18,20:26:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-05-19,02:31:16,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-05-19,08:55:04,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,PR Newswire,"WST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit"
WST,2025-05-19,09:19:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-05-19,11:02:10,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-19,11:16:36,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-19,12:16:34,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-19,15:46:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-19,15:46:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-19,16:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-05-19,16:18:42,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-19,22:01:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-05-20,11:02:10,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-20,11:17:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-20,11:31:38,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-20,13:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-20,13:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-20,13:31:49,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky to Join Class Action Before July 7, 2025"
WST,2025-05-20,13:50:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"WST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit"
WST,2025-05-20,14:17:17,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-05-20,14:38:30,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-20,15:01:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-20,16:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-05-20,16:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-05-20,16:01:12,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-20,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-20,20:00:31,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-20,20:31:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed: West Pharmaceutical Services, Inc. (WST) - Join by July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-21,07:08:06,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 1Q 2025 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 1Q 2025 (WST)"
WST,2025-05-21,11:02:07,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-21,11:16:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-21,13:04:33,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-21,13:04:33,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-21,13:31:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-22,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance Health, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-05-22,01:46:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-22,09:15:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-22,11:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-22,11:16:34,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-22,15:00:59,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR NOTICE: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit"
WST,2025-05-22,15:29:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-22,15:30:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors Urged to Contact Levi & Korsinsky for Information Before July 7, 2025 - West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-22,23:45:47,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-05-23,11:01:53,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-23,11:19:17,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-23,13:50:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-05-23,14:01:19,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-05-23,16:30:49,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-23,17:01:17,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-05-24,13:05:44,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-24,13:05:44,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-24,22:08:53,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline"
WST,2025-05-25,11:04:23,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-25,11:33:17,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-25,12:32:23,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-25,12:40:14,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-05-25,15:27:16,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors Urged to Contact Levi & Korsinsky for Information Before July 7, 2025 - West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-25,16:14:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-05-26,11:02:18,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-26,11:16:16,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-26,14:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-26,14:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-26,18:01:24,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-05-26,20:00:31,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-26,20:30:56,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-05-27,11:02:50,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-27,11:31:50,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky to Join Class Action Before July 7, 2025"
WST,2025-05-27,14:45:44,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-27,14:45:44,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-27,15:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-27,16:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-05-27,16:21:14,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-27,16:32:53,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-27,17:47:20,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-27,19:25:45,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-05-27,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-27,20:31:45,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed: West Pharmaceutical Services, Inc. (WST) - Join by July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-28,11:02:18,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-28,11:16:47,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders of West Pharmaceutical Services, Inc. (WST): Protect Your Rights Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-28,13:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-28,13:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-28,15:06:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-05-28,15:25:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-05-28,16:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-05-28,16:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-05-28,19:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-28,22:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-29,11:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-29,11:30:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-05-29,13:55:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-05-29,22:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-05-30,00:30:02,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-05-30,02:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-30,04:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline"
WST,2025-05-30,06:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-30,08:45:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-05-30,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!"
WST,2025-05-30,13:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-05-30,13:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-05-30,14:30:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-30,14:45:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-05-30,15:25:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-05-30,16:34:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,GlobeNewswire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - July 7, 2025 Deadline to Join -- Contact Levi & Korsinsky"
WST,2025-05-30,17:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-30,18:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-30,21:30:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-05-31,22:08:47,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-06-01,11:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST Shareholders Have Opportunity to Lead West Pharmaceutical Services, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!"
WST,2025-06-01,11:30:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-01,12:10:27,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-01,12:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-01,13:45:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) -Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-01,14:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-01,14:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-01,14:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-01,17:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-01,20:00:31,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-01,21:07:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-02,11:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST Stockholders Have Opportunity to Lead West Pharmaceutical Services, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!"
WST,2025-06-02,11:25:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-02,15:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-06-02,16:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-06-02,16:20:58,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-02,16:20:58,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-02,16:25:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors Urged to Contact Levi & Korsinsky for Information Before July 7, 2025 - West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-02,17:15:18,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-02,17:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-02,23:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders of West Pharmaceutical Services, Inc. (WST): Protect Your Rights Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-03,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Avis Budget, Civitas, Open Lending, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-06-03,02:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-03,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of West Pharmaceutical Services, Inc. to Contact the Firm Today!"
WST,2025-06-03,11:30:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline"
WST,2025-06-03,13:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-03,13:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-03,13:30:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-03,16:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-03,16:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-03,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-03,20:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-04,11:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of West Pharmaceutical Services, Inc. to Contact the Firm Today!"
WST,2025-06-04,11:20:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-04,13:55:26,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-04,14:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders of West Pharmaceutical Services, Inc. (WST): Protect Your Rights Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-04,16:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-04,16:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-04,16:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action - Contact Levi & Korsinsky"
WST,2025-06-04,16:58:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,GlobeNewswire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations -- Investors Should Contact The Gross Law Firm for More Information -- WST"
WST,2025-06-05,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of West Pharmaceutical Services, Inc. to Contact the Firm Today!"
WST,2025-06-05,11:25:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Investors - Lead Plaintiff Deadline on July 7, 2025"
WST,2025-06-05,13:00:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-05,13:00:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-05,13:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-05,19:00:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-06-05,21:47:25,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-05,22:05:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-06-06,00:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Investors - Lead Plaintiff Deadline on July 7, 2025"
WST,2025-06-06,11:00:07,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-06,11:30:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action - Contact Levi & Korsinsky"
WST,2025-06-06,13:41:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-06,14:59:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-06,14:59:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-06,16:15:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-06,20:00:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-06,20:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline"
WST,2025-06-06,22:25:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders of West Pharmaceutical Services, Inc. (WST): Protect Your Rights Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-07,14:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"(PR) INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-07,14:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"(PR) INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-07,22:11:23,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-08,11:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-08,12:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-08,12:04:25,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-08,13:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-06-08,17:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-06-09,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-09,11:30:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-09,14:44:25,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-09,15:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-09,16:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-06-09,16:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors Urged to Contact Levi & Korsinsky for Information Before July 7, 2025 - West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-09,16:30:05,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-06-09,19:15:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-10,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Civitas, Open Lending, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-06-10,01:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-10,11:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-10,11:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-10,13:01:35,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-10,13:01:35,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-10,14:11:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-10,14:35:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-06-10,15:30:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-10,16:30:02,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Reminds Investors of July 7, 2025"
WST,2025-06-10,19:00:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-06-10,20:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-10,20:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-11,11:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-11,11:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Contact Levi & Korsinsky by July 7, 2025 to Join Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-11,14:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-11,14:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-11,14:30:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-06-11,19:50:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-11,19:50:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-11,21:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-12,11:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-12,11:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-06-12,13:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-12,13:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-12,20:01:13,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-12,20:40:47,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-12,21:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Investors - Lead Plaintiff Deadline on July 7, 2025"
WST,2025-06-12,22:21:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-12,22:35:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-13,00:15:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-06-13,11:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-13,11:30:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline"
WST,2025-06-13,15:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-13,15:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-13,16:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-13,16:30:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-06-13,17:20:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,GlobeNewswire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights -- WST"
WST,2025-06-13,18:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-13,21:45:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-14,12:22:23,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-14,22:55:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-06-15,11:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-15,11:45:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-15,14:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-15,14:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-15,14:33:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-15,15:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-15,21:27:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action - Contact Levi & Korsinsky"
WST,2025-06-16,11:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-16,11:30:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline"
WST,2025-06-16,13:59:25,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-16,14:05:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Contact Levi & Korsinsky by July 7, 2025 to Join Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-16,16:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-06-16,16:21:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-16,16:21:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-16,16:45:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-06-16,22:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-06-17,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-06-17,01:55:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action - Contact Levi & Korsinsky"
WST,2025-06-17,11:00:07,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-17,11:20:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Reminds Investors of July 7, 2025"
WST,2025-06-17,14:00:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-17,14:00:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-17,16:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-17,16:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-17,17:04:25,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-17,17:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-06-17,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-18,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-18,11:13:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-18,14:10:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-18,14:56:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-18,14:56:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-18,20:00:51,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-18,23:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-19,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-20,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-20,13:00:04,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST"
WST,2025-06-20,14:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-20,14:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-20,15:45:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"Faruqi & Faruqi Reminds West Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST"
WST,2025-06-20,16:05:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-20,17:45:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-06-20,18:35:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-06-20,22:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-21,12:44:26,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-21,22:12:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-22,11:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-22,11:20:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-06-22,13:13:29,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-06-22,14:00:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-22,14:00:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-22,14:20:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed: West Pharmaceutical Services, Inc. (WST) - Join by July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-22,23:55:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-23,11:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-23,11:16:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-23,13:00:05,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST"
WST,2025-06-23,13:49:24,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-23,14:32:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-23,14:50:45,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-23,14:50:45,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-23,15:10:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-23,16:47:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-23,18:05:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-06-23,22:45:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-24,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-06-24,01:35:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-24,11:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-24,11:40:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-24,13:32:25,BF79F5,West Pharmaceutical Services Inc.,100,0.01,analyst-ratings,neutral,West Pharma Initiated at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Equal-Weight by Barclays
WST,2025-06-24,13:32:25,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $245.00/Share by Barclays,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $245.00/Share by Barclays
WST,2025-06-24,14:00:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-24,14:00:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-24,15:04:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-24,15:05:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-06-24,17:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-06-24,17:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-24,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-24,20:00:45,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-24,21:15:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-24,23:35:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-25,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-25,11:32:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline"
WST,2025-06-25,13:40:26,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-25,14:07:06,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-06-25,14:20:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-25,14:20:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-25,14:37:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-25,17:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-25,17:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-25,22:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-26,11:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-26,11:45:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-26,14:00:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-26,14:00:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-26,14:32:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-06-26,17:15:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-06-26,23:27:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-06-26,23:45:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-27,11:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!"
WST,2025-06-27,11:30:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-06-27,14:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-27,14:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-27,14:47:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-27,15:42:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-27,17:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-27,21:50:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-28,12:40:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-06-28,14:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"(PMZN) INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-28,14:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"(PMZN) INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-29,02:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Contact Levi & Korsinsky by July 7, 2025 to Join Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-29,11:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST Shareholders Have Opportunity to Lead West Pharmaceutical Services, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!"
WST,2025-06-29,11:40:24,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-29,13:50:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed: West Pharmaceutical Services, Inc. (WST) - Join by July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-29,14:46:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-30,00:17:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-06-30,11:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST Stockholders Have Opportunity to Lead West Pharmaceutical Services, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!"
WST,2025-06-30,11:17:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-30,15:52:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-30,15:52:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-30,16:52:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-30,17:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-06-30,17:05:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-30,20:00:47,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-30,21:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-30,22:41:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-30,23:41:17,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-07-01,01:00:01,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-07-01,02:12:14,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-01,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of West Pharmaceutical Services, Inc. to Contact the Firm Today!"
WST,2025-07-01,11:42:44,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-07-01,14:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-01,14:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-01,14:44:20,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-07-01,15:51:24,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-01,15:58:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-07-01,15:58:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-07-01,16:57:26,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-07-01,18:12:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-01,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-07-01,21:30:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-01,22:45:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-02,11:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of West Pharmaceutical Services, Inc. to Contact the Firm Today!"
WST,2025-07-02,11:33:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-02,14:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-02,14:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-02,15:12:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action - Contact Levi & Korsinsky"
WST,2025-07-02,16:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-07-02,16:00:01,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Deadline Soon: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit"
WST,2025-07-02,16:40:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-07-02,20:07:06,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST"
WST,2025-07-02,21:15:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-07-03,11:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of West Pharmaceutical Services, Inc. to Contact the Firm Today!"
WST,2025-07-03,11:20:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky to Join Class Action Before July 7, 2025"
WST,2025-07-03,12:15:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-07-03,14:13:42,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-07-03,14:13:42,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-07-03,14:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Investors - Lead Plaintiff Deadline on July 7, 2025"
WST,2025-07-03,17:47:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-07-03,18:45:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-04,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"FINAL WST DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds West Pharmaceutical Services, Inc. Investors to Join the Class Action Lawsuit"
WST,2025-07-04,11:20:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline"
WST,2025-07-04,13:17:25,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Faruqi & Faruqi Reminds West Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST"
WST,2025-07-04,14:10:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Reminds Investors of July 7, 2025"
WST,2025-07-06,11:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"FINAL REMINDER WST DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts West Pharmaceutical Services, Inc. Investors to Participate in the Class Action Lawsuit"
WST,2025-07-06,11:35:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-06,12:25:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-07-06,14:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-06,14:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-06,14:40:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-07-06,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-07-06,21:10:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-07,06:50:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-07,13:00:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,PR Newswire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Seeking Recovery for Investors - Contact The Gross Law Firm"
WST,2025-07-07,13:00:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Seeking Recovery for Investors - Contact The Gross Law Firm"
WST,2025-07-07,14:30:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Reminds Investors of July 7, 2025"
WST,2025-07-07,17:06:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Business Wire,"FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceuticals"
WST,2025-07-07,18:45:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-07,18:45:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-07,20:41:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,GlobeNewswire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations -- Investors Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights -- WST"
WST,2025-07-07,20:52:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-07-07,21:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-07-07,21:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-07-07,22:35:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-07-07,23:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-07-07,23:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-07-07,23:35:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-08,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2025 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Second-Quarter 2025 Conference Call
WST,2025-07-08,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2025 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Second-Quarter 2025 Conference Call
WST,2025-07-09,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc. (NYSE:WST)",PRESS-RELEASE,GlobeNewswire,"WEST ALERT: Bragar Eagel & Squire, P.C. is Investigating West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm"
WST,2025-07-21,10:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Pharma Names Robert McMahon as New Chief Fincl Officer >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Names Robert McMahon as New Chief Fincl Officer >WST
WST,2025-07-21,10:21:09,BF79F5,West Pharmaceutical Services Inc.,94,0.53,labor-issues,,"West Pharmaceutical Services has hired Robert McMahon as its new chief financial officer, effective Aug. 4",FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Names Robert McMahon Chief Financial Officer
WST,2025-07-21,20:17:57,BF79F5,West Pharmaceutical Services Inc.,99,0.53,labor-issues,,"West Pharmaceutical Services Inc.: the ""Company"") announced the appointment of Robert McMahon as Senior Vice President & Chief Financial Officer",RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 2Q Sales $766.5M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Sales $766.5M >WST
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $3.04B-$3.06B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $3.04B-$3.06B >WST
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2025",PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Second-Quarter 2025 Conference Call,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales of $766.5 million increased 9.2%,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.4,earnings,up,"West Pharmaceutical Services Inc.: Diluted EPS of $1.82, compared to $1.51",PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Adjusted-diluted EPS of $1.84,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Updates full-year 2025 net sales,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announces that its Board of Directors has approved a fourth-quarter 2025 dividend of $0.22,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.36,equity-actions,down,"West Pharmaceutical Services Inc.: Capital expenditures were $146.5 million, a decrease of 23.2%",PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 552,593 shares for $134.0 million",PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is increasing its full-year 2025 net sales guidance,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Our updated adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2025 capital spending guidance,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $6.65,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $6.65-Adj EPS $6.85 >WST
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 766.5,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 273.9,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.82 $ 1.52 $,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Adj EPS $1.84,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Adj EPS $1.84 >WST
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: the Company recorded charges of $1.6 million,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2025 restructuring plan,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q EPS $1.82,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q EPS $1.82 >WST
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Net $131.8M,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Net $131.8M >WST
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Second-Quarter 2025 Conference Call,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales of $766.5 million increased 9.2%,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.4,earnings,up,"West Pharmaceutical Services Inc.: Diluted EPS of $1.82, compared to $1.51",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Adjusted-diluted EPS of $1.84,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Updates full-year 2025 net sales,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announces that its Board of Directors has approved a fourth-quarter 2025 dividend of $0.22,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.36,equity-actions,down,"West Pharmaceutical Services Inc.: Capital expenditures were $146.5 million, a decrease of 23.2%",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 552,593 shares for $134.0 million",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is increasing its full-year 2025 net sales guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Our updated adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2025 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 766.5,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 273.9,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.82 $ 1.52 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: the Company recorded charges of $1.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2025 restructuring plan,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -3-
WST,2025-07-24,10:02:19,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Previous FY Sales Guidance,NEWS-FLASH,Dow Jones Newswires,West Pharma Previous FY Sales Guidance Was $2.945B to $2.975B >WST
WST,2025-07-24,10:03:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma: Previous FY Adj EPS Guidance Was $6,NEWS-FLASH,Dow Jones Newswires,West Pharma: Previous FY Adj EPS Guidance Was $6.15$6.35 >WST
WST,2025-07-24,10:40:38,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Boosts Outlook After,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Boosts Outlook After Beating 2Q Expectations
WST,2025-07-24,10:40:38,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,above-expectations,West Pharmaceutical Services logged higher-than-expected profit,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Boosts Outlook After Beating 2Q Expectations
WST,2025-07-24,10:40:38,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: The company raised its sales outlook,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Boosts Outlook After Beating 2Q Expectations
WST,2025-07-24,11:18:01,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: the ""Company"") issued a press release announcing its second-quarter 2025 financial results",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2025-07-24,11:36:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: The company reported adjusted earnings of $1.84 a share for the second quarter,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Stock Surges After Earnings. GLP-1s Play a Role. -- Barrons.com
WST,2025-07-24,14:04:06,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharma earned $1.84 per share,FULL-ARTICLE,Dow Jones Newswires,"West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings -- IBD"
WST,2025-07-24,14:04:06,BF79F5,West Pharmaceutical Services Inc.,99,0.48,revenues,up,West Pharmaceutical expects sales to rise 3% to 3.75%,FULL-ARTICLE,Dow Jones Newswires,"West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings -- IBD"
WST,2025-07-24,14:15:36,BF79F5,West Pharmaceutical Services Inc.,93,0.61,earnings,positive,West Pharmaceutical Services Inc.: The company reported adjusted earnings of $1.84 a share for the second quarter,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Stock On Track for Best Day Ever After Earnings -- Barrons.com
WST,2025-07-24,20:31:36,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharma earned $1.84 per share,FULL-ARTICLE,Dow Jones Newswires,"West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings -- IBD"
WST,2025-07-24,20:31:36,BF79F5,West Pharmaceutical Services Inc.,99,0.48,revenues,up,West Pharmaceutical expects sales to rise 3% to 3.75%,FULL-ARTICLE,Dow Jones Newswires,"West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings -- IBD"
WST,2025-07-25,14:16:37,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Outperform by Evercore ISI Group
WST,2025-07-25,14:16:37,BF79F5,West Pharmaceutical Services Inc.,100,0.8,price-targets,upgrade,West Pharma Price Target Raised to $350.00/Share From $275.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $350.00/Share From $275.00 by Evercore ISI Group
WST,2025-07-25,16:15:57,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Buy by UBS
WST,2025-07-25,16:15:57,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $320.00/Share From $285.00 by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $320.00/Share From $285.00 by UBS
WST,2025-08-21,07:08:32,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 2Q 2025 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 2Q 2025 (WST)"
WST,2025-08-21,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences in September 2025,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences in September 2025
WST,2025-08-21,10:05:46,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences in September 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences in September 2025
WST,2025-09-15,13:51:45,BF79F5,West Pharmaceutical Services Inc.,100,0.95,analyst-ratings,positive,West Pharma Initiated at Buy by Rothschild & Co,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Buy by Rothschild & Co
WST,2025-09-15,13:51:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $311.00/Share by Rothschild & Co,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $311.00/Share by Rothschild & Co
WST,2025-10-02,13:27:54,BF79F5,West Pharmaceutical Services Inc.,100,0.0,analyst-ratings,neutral,West Pharma Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Equal-Weight by Barclays
WST,2025-10-02,13:27:54,BF79F5,West Pharmaceutical Services Inc.,100,0.62,price-targets,upgrade,West Pharma Price Target Raised to $275.00/Share From $260.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $275.00/Share From $260.00 by Barclays
WST,2025-10-08,19:27:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc. (NYSE:WST)",PRESS-RELEASE,GlobeNewswire,"WEST PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm"
WST,2025-10-09,10:00:52,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2025 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Third-Quarter 2025 Conference Call
WST,2025-10-09,10:00:56,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2025 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Third-Quarter 2025 Conference Call
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Reports Third-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Increases Full-Year 2025 Revenue,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.4,earnings,up,"West Pharmaceutical Services Inc.: Diluted EPS of $1.92, compared to $1.85",PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Adjusted-diluted EPS of $1.96,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: Full-year 2025 net sales guidance increased to a range of $3.060 billion to $3.070 billion,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2025 adjusted-diluted EPS guidance increased to a range of $7.06 to $7.11,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: we are again increasing our full-year guidance,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: HVP Delivery Devices net sales of $99.1 million,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.36,equity-actions,down,"West Pharmaceutical Services Inc.: Capital expenditures were $209.8 million, a decrease of 22.9%",PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 552,593 shares for $134.0 million",PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,unchanged,West Pharmaceutical Services Inc.: Capital spending guidance is unchanged,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Fourth-Quarter 2025 Financial Guidance,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Third-Quarter 2025 Conference Call,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Reports Third-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -2-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 804.6,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -2-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 294.3,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -2-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -2-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.94 $ 1.87 $,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -2-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Reports Third-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -3-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: the Company recorded charges of $2.5 million,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -3-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2025 restructuring plan,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -3-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2022 restructuring plan,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -3-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Reported Net Sales,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -3-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Reports Third-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -4-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Reported Net Sales,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -4-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -4-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -4-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,assets,,"West Pharmaceutical Services Inc.: Total Assets $ 4,105.8 $ 3,643.4",PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -4-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Reports Third-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -5-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: Dividend,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -5-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q EPS $1.92,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q EPS $1.92 >WST
WST,2025-10-23,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $7.06,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $7.06-Adj EPS $7.11 >WST
WST,2025-10-23,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Adj EPS $1.96,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Adj EPS $1.96 >WST
WST,2025-10-23,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Net $140M,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Net $140M >WST
WST,2025-10-23,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $3.06B-$3.07B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $3.06B-$3.07B >WST
WST,2025-10-23,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 3Q Sales $804.6M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Sales $804.6M >WST
WST,2025-10-23,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $6.75,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $6.75-EPS $6.80 >WST
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Reports Third-Quarter 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Increases Full-Year 2025 Revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.4,earnings,up,"West Pharmaceutical Services Inc.: Diluted EPS of $1.92, compared to $1.85",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Adjusted-diluted EPS of $1.96,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: Full-year 2025 net sales guidance increased to a range of $3.060 billion to $3.070 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2025 adjusted-diluted EPS guidance increased to a range of $7.06 to $7.11,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: we are again increasing our full-year guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: HVP Delivery Devices net sales of $99.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.36,equity-actions,down,"West Pharmaceutical Services Inc.: Capital expenditures were $209.8 million, a decrease of 22.9%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 552,593 shares for $134.0 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,unchanged,West Pharmaceutical Services Inc.: Capital spending guidance is unchanged,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Fourth-Quarter 2025 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Third-Quarter 2025 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 804.6,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -2-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 294.3,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -2-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -2-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.94 $ 1.87 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -2-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: the Company recorded charges of $2.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -3-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2025 restructuring plan,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -3-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2022 restructuring plan,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -3-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Reported Net Sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -3-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,98,0.0,revenues,,West Pharmaceutical Services Inc.: Reported Net Sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -4-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,98,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -4-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,98,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -4-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,98,0.0,assets,,"West Pharmaceutical Services Inc.: Total Assets $ 4,105.8 $ 3,643.4",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -4-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,92,0.0,dividends,,West Pharmaceutical Services Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -5-
WST,2025-10-23,10:52:50,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Lifts Outlook as 3Q Profit,FULL-ARTICLE,Dow Jones Newswires,"West Pharmaceutical Lifts Outlook as 3Q Profit, Sales Rise"
WST,2025-10-23,11:15:31,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: West Pharmaceutical Services, Inc. (the ""Company"") issued a press release announcing its third-quarter 2025 financial results.",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2025-10-23,18:04:05,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Outperform by Evercore ISI Group
WST,2025-10-23,18:04:05,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $390.00/Share From $350.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $390.00/Share From $350.00 by Evercore ISI Group
WST,2025-10-24,10:00:01,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2025-10-24,10:09:56,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2025-10-24,12:43:36,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2025-10-24,12:43:37,BF79F5,West Pharmaceutical Services Inc.,100,0.68,price-targets,upgrade,West Pharma Price Target Raised to $350.00/Share From $325.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $350.00/Share From $325.00 by Keybanc
WST,2025-10-24,15:15:47,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Buy by UBS
WST,2025-10-24,15:15:47,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $355.00/Share From $320.00 by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $355.00/Share From $320.00 by UBS
WST,2025-10-27,16:35:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,analyst-ratings,neutral,West Pharma Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Equal-Weight by Barclays
WST,2025-10-27,16:35:13,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $325.00/Share From $275.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $325.00/Share From $275.00 by Barclays
WST,2025-10-29,13:10:08,BF79F5,West Pharmaceutical Services Inc.,100,0.95,analyst-ratings,positive,West Pharma Initiated at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Buy by TD Cowen
WST,2025-10-29,13:10:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $350.00/Share by TD Cowen,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $350.00/Share by TD Cowen
WST,2025-01-08,21:34:08,BF79F5,West Pharmaceutical Services Inc.,100,0.95,analyst-ratings,positive,West Pharma Initiated at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Buy by Citigroup
WST,2025-01-08,21:34:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $400.00/Share by Citigroup,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $400.00/Share by Citigroup
WST,2025-01-28,17:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter Dividend,PRESS-RELEASE,PR Newswire,West Announces First-Quarter Dividend
WST,2025-01-28,17:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces First-Quarter Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter Dividend
WST,2025-01-30,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2024 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2024 Conference Call
WST,2025-01-30,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2024 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Fourth-Quarter and Full-Year 2024 Conference Call
WST,2025-01-30,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2024 Conference Call
WST,2025-01-30,11:00:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Fourth-Quarter and Full-Year 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Fourth-Quarter and Full-Year 2024 Conference Call
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 4Q Sales $748.8M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Sales $748.8M >WST
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $5.97,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $5.97-EPS $6.17 >WST
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q EPS $1.78,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q EPS $1.78 >WST
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Fourth-Quarter 2024 Conference Call,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.02,revenues,,West Pharmaceutical Services Inc.: Fourth-quarter 2024 net sales of $748.8 million increased 2.3%,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2024 reported-diluted EPS of $1.78,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: fourth-quarter 2024 adjusted-diluted EPS of $1.82,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: For Full-year 2025, the Company anticipates net sales in a range of $2.875 billion to $2.905 billion",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Full-year 2024 net sales grew by 1.1% to $558.7 million,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.13,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $377.0 million, an increase of 4.1%",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 1,583,032 shares for $560.9 million",PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2025 adjusted-diluted EPS is expected to be in a range of $6.00 to $6.20,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2025 capital spending is expected to be $275 million,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $6.00,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $6.00-Adj EPS $6.20 >WST
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2022 restructuring plan,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 -3-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 -3-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 -3-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Fourth-Quarter and Full-Year 2024 -3-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Adj EPS $1.82,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Adj EPS $1.82 >WST
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 4Q Net $130.1M,NEWS-FLASH,Dow Jones Newswires,West Pharma 4Q Net $130.1M >WST
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Fourth-Quarter 2024 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.02,revenues,,West Pharmaceutical Services Inc.: Fourth-quarter 2024 net sales of $748.8 million increased 2.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Fourth-quarter 2024 reported-diluted EPS of $1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: fourth-quarter 2024 adjusted-diluted EPS of $1.82,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,"West Pharmaceutical Services Inc.: For Full-year 2025, the Company anticipates net sales in a range of $2.875 billion to $2.905 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.04,revenues,,West Pharmaceutical Services Inc.: Full-year 2024 net sales grew by 1.1% to $558.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.13,equity-actions,up,"West Pharmaceutical Services Inc.: Capital expenditures were $377.0 million, an increase of 4.1%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 1,583,032 shares for $560.9 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2025 adjusted-diluted EPS is expected to be in a range of $6.00 to $6.20,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2025 capital spending is expected to be $275 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and Full-Year 2024 Results
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,92,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 748.8,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,92,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 273.6,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,92,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2025-02-13,11:00:07,BF79F5,West Pharmaceutical Services Inc.,92,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.79 $ 1.85 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -2-
WST,2025-02-13,11:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2022 restructuring plan,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2025-02-13,11:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.65,revenues,up,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2025-02-13,11:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2025-02-13,11:00:08,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Fourth-Quarter and -3-
WST,2025-02-13,11:04:19,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees 2025 Sales $2.875B-$2.905B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees 2025 Sales $2.875B-$2.905B >WST
WST,2025-02-13,11:04:39,BF79F5,West Pharmaceutical Services Inc.,100,0.48,revenues,up,West Pharma Sees 2025 Organic Sales Growth 2%-3%,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees 2025 Organic Sales Growth 2%-3% >WST
WST,2025-02-13,11:04:59,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharma Sees 2025 Capital Spending $275M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees 2025 Capital Spending $275M >WST
WST,2025-02-13,11:35:18,BF79F5,West Pharmaceutical Services Inc.,92,-0.67,earnings,down,West Pharmaceutical Services posted a slight decline in profit,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Services 4Q Results Clear Estimates but 2025 Guidance Comes Up Short
WST,2025-02-13,11:35:18,BF79F5,West Pharmaceutical Services Inc.,92,0.0,revenues,,"For 2025, West Pharmaceutical guided for sales between $2.88 billion",FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Services 4Q Results Clear Estimates but 2025 Guidance Comes Up Short
WST,2025-02-13,13:01:38,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: the ""Company"") issued a press release announcing its fourth-quarter and full year 2024 financial results",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2025-02-13,13:01:38,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: the ""Company"") issued a press release announcing its fourth-quarter and full year 2024 financial results",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2025-02-13,17:20:52,BF79F5,West Pharmaceutical Services Inc.,92,0.0,revenues,,West Pharmaceutical Services Inc.: The company said it expects expects 2025 net sales,FULL-ARTICLE,Dow Jones Newswires,"These Stocks Are Moving the Most Today: Trade Desk, AppLovin, Intel, Tesla, Robinhood, Deere, MGM, West Pharma, and More -- Barrons.com"
WST,2025-02-13,18:49:52,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,above-expectations,West Pharma posted better-than-expected fourth-quarter earnings,FULL-ARTICLE,MarketWatch,MW West Pharma's stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin
WST,2025-02-13,19:40:16,BF79F5,West Pharmaceutical Services Inc.,92,0.0,revenues,,West Pharmaceutical Services Inc.: The company said it expects 2025 net sales,FULL-ARTICLE,Dow Jones Newswires,"These Stocks Are Moving the Most Today: Trade Desk, AppLovin, Intel, Tesla, Robinhood, Deere, MGM, West Pharma, and More -- Barrons.com"
WST,2025-02-13,21:24:59,BF79F5,West Pharmaceutical Services Inc.,92,0.0,revenues,,West Pharmaceutical Services Inc.: The company said it expects 2025 net sales,FULL-ARTICLE,Dow Jones Newswires,"These Stocks Moved the Most Today: Trade Desk, AppLovin, Intel, Tesla, Robinhood, Deere, MGM, West Pharma, and More -- Barrons.com"
WST,2025-02-14,17:32:10,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2025-02-14,17:32:10,BF79F5,West Pharmaceutical Services Inc.,100,-0.84,price-targets,downgrade,West Pharma Price Target Cut to $325.00/Share From $470.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Cut to $325.00/Share From $470.00 by Keybanc
WST,2025-02-20,21:30:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces Second-Quarter Dividend,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter Dividend
WST,2025-02-20,21:30:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Announces Second-Quarter Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter Dividend
WST,2025-02-21,02:10:48,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Treas Witherspoon Acquires 42 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,Treas Witherspoon Acquires 42 Of West Pharmaceutical Services >WST
WST,2025-02-21,02:11:01,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Vp Winters Acquires 54 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Winters Acquires 54 Of West Pharmaceutical Services >WST
WST,2025-02-21,02:12:49,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,"Chmn Green Acquires 1,761 Of West Pharmaceutical Services >WST",FULL-ARTICLE,Dow Jones Newswires,"Chmn Green Acquires 1,761 Of West Pharmaceutical Services >WST"
WST,2025-02-21,02:13:20,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Vp Favorite Acquires 162 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Favorite Acquires 162 Of West Pharmaceutical Services >WST
WST,2025-02-21,02:14:47,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Vp MacKay Acquires 153 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP MacKay Acquires 153 Of West Pharmaceutical Services >WST
WST,2025-02-21,02:19:08,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Vp Reiss-Clark Acquires 163 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,VP Reiss-Clark Acquires 163 Of West Pharmaceutical Services >WST
WST,2025-02-21,02:47:02,BF79F5,West Pharmaceutical Services Inc.,100,0.52,insider-trading,,Cfo Birkett Acquires 631 Of West Pharmaceutical Services >WST,FULL-ARTICLE,Dow Jones Newswires,CFO Birkett Acquires 631 Of West Pharmaceutical Services >WST
WST,2025-02-21,20:30:59,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates"
WST,2025-02-22,08:08:52,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 4Q 2024 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 4Q 2024 (WST)"
WST,2025-02-24,12:31:17,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights"
WST,2025-02-25,12:32:56,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights"
WST,2025-02-26,12:49:08,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - WST"
WST,2025-02-27,12:31:57,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST)"
WST,2025-02-28,12:47:09,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights"
WST,2025-03-03,12:33:01,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Regarding an Ongoing Investigation"
WST,2025-03-04,12:26:07,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc.(WST)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky"
WST,2025-03-05,11:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2025-03-05,11:01:42,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2025-03-06,12:25:37,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - WST"
WST,2025-03-11,11:31:26,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky"
WST,2025-03-11,20:08:58,BF79F5,West Pharmaceutical Services Inc.,97,-0.57,labor-issues,,"West Pharmaceutical Services Inc.: Senior Vice President and Chief Commercial Officer, has departed the Company",RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-03-11,21:07:23,BF79F5,West Pharmaceutical Services Inc.,100,-0.57,labor-issues,,West Pharmaceutical Services Chief Commercial Officer Cindy Reiss-Clark Leaves Company,RNS-SEC8K,Dow Jones Newswires,West Pharmaceutical Services Chief Commercial Officer Cindy Reiss-Clark Leaves Company
WST,2025-03-12,11:31:36,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - WST"
WST,2025-03-13,11:31:18,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders that Lost Money on West Pharmaceutical Services, Inc. (WST) Should Contact Levi & Korsinsky About Securities Fraud Investigation - WST"
WST,2025-03-14,11:32:37,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST)"
WST,2025-03-17,11:27:08,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Shareholder Rights Advocates at Levi & Korsinsky Investigate West Pharmaceutical Services, Inc. (WST) Regarding Possible Securities Fraud Violations"
WST,2025-03-18,09:19:43,BF79F5,West Pharmaceutical Services Inc.,100,0.95,analyst-ratings,positive,West Pharma Initiated at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Outperform by Evercore ISI Group
WST,2025-03-18,09:19:43,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $275.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $275.00/Share by Evercore ISI Group
WST,2025-03-18,11:27:06,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates"
WST,2025-03-19,11:26:35,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- WST"
WST,2025-03-20,11:27:33,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - WST"
WST,2025-03-21,11:31:10,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds Shareholders of an Investigation into West Pharmaceutical Services, Inc. (WST) Regarding Potential Securities Fraud Allegations"
WST,2025-03-24,11:27:12,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - WST"
WST,2025-03-25,11:26:36,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - WST"
WST,2025-03-26,11:31:43,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights"
WST,2025-03-27,11:27:33,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment"
WST,2025-03-28,11:34:09,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST"
WST,2025-03-31,11:26:09,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment"
WST,2025-04-01,11:31:38,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders that Lost Money on West Pharmaceutical Services, Inc. (WST) Should Contact Levi & Korsinsky About Securities Fraud Investigation - WST"
WST,2025-04-02,11:27:06,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - WST"
WST,2025-04-03,11:31:36,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"ATTENTION WST SHAREHOLDERS: Investors who Lost Money on West Pharmaceutical Services, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation"
WST,2025-04-04,11:26:38,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST"
WST,2025-04-07,11:32:10,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST"
WST,2025-04-08,11:26:42,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Regarding an Ongoing Investigation"
WST,2025-04-09,11:27:36,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Investors who lost money on West Pharmaceutical Services, Inc. should contact Levi & Korsinsky about an ongoing investigation - WST"
WST,2025-04-10,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2025 Conference Call,PRESS-RELEASE,PR Newswire,West to Host First-Quarter 2025 Conference Call
WST,2025-04-10,10:00:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host First-Quarter 2025 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host First-Quarter 2025 Conference Call
WST,2025-04-10,11:27:35,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders that lost money on West Pharmaceutical Services, Inc.(WST) should contact Levi & Korsinsky about Securities Fraud Investigation - WST"
WST,2025-04-11,11:26:39,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of West Pharmaceutical Services, Inc. Shareholders Who Lost Money"
WST,2025-04-14,11:26:05,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment"
WST,2025-04-14,20:09:37,BF79F5,West Pharmaceutical Services Inc.,99,0.53,labor-issues,,West Pharmaceutical Services Inc.: named executive officer of the Company,RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-04-14,20:09:37,BF79F5,West Pharmaceutical Services Inc.,99,0.39,products-services,,West Pharmaceutical Services Inc.: Ms. Reiss-Clark and the Company have reached an agreement on,RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-04-14,20:09:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"West Pharmaceutical Services Inc.: In exchange for these benefits, Ms. Reiss-Clark released all potential claims against the Company",RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-04-14,20:09:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,West Pharmaceutical Services Inc.: not to pursue any litigation against the Company,RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-04-14,20:09:37,BF79F5,West Pharmaceutical Services Inc.,99,0.49,partnerships,,West Pharmaceutical Services Inc.: agreed to cooperate with the Company as,RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-04-15,11:27:36,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Being Investigated on Behalf of West Pharmaceutical Services, Inc. Investors. Contact Levi & Korsinsky For Details."
WST,2025-04-16,11:33:06,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"An Investigation Has Commenced on Behalf of West Pharmaceutical Services, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your WST Losses"
WST,2025-04-17,11:27:11,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates"
WST,2025-04-18,11:26:11,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST)"
WST,2025-04-21,11:33:36,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by West Pharmaceutical Services, Inc."
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $2.95B-$2.98B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $2.95B-$2.98B >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2025",PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: First-Quarter 2025 Conference Call,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales of $698.0 million increased 0.4%,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,-0.4,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.23, compared to $1.55 in the same period last year",PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is increasing its full year 2025 net sales guidance,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a third-quarter 2025 dividend of $0.21,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our first quarter guidance,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.34,equity-actions,down,"West Pharmaceutical Services Inc.: Capital expenditures were $71.3 million, a decrease of 21.3%",PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 550,281 shares for $133.5 million",PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Our updated adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2025 capital spending guidance,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 1Q Sales $698M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Sales $698M >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 698.0,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 231.9,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.24 $ 1.57,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: the Company recorded charges of $17.8 million,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2025 restructuring plan,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -2-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $5.86,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $5.86-EPS $6.06 >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces First-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -3-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,"West Announces First-Quarter 2025 Results, -3-"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q EPS $1.23,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q EPS $1.23 >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $6.15,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $6.15-Adj EPS $6.35 >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Adj EPS $1.45,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Adj EPS $1.45 >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 1Q Net $89.8M,NEWS-FLASH,Dow Jones Newswires,West Pharma 1Q Net $89.8M >WST
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: First-Quarter 2025 Conference Call,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales of $698.0 million increased 0.4%,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,-0.4,earnings,down,"West Pharmaceutical Services Inc.: Reported-diluted EPS of $1.23, compared to $1.55 in the same period last year",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is increasing its full year 2025 net sales guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announced that its Board of Directors has approved a third-quarter 2025 dividend of $0.21,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our first quarter guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.34,equity-actions,down,"West Pharmaceutical Services Inc.: Capital expenditures were $71.3 million, a decrease of 21.3%",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 550,281 shares for $133.5 million",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Our updated adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2025 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend"
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 698.0,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 231.9,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.24 $ 1.57,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: the Company recorded charges of $17.8 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2025 restructuring plan,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -2-
WST,2025-04-24,10:00:10,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces First-Quarter 2025 -3-
WST,2025-04-24,10:10:02,BF79F5,West Pharmaceutical Services Inc.,99,0.53,labor-issues,,West Pharmaceutical Services Inc.: Mr. Birkett joined West as Senior Vice President,PRESS-RELEASE,PR Newswire,West Announces Leadership Changes
WST,2025-04-24,10:10:02,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: First-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Announces Leadership Changes
WST,2025-04-24,10:10:02,BF79F5,West Pharmaceutical Services Inc.,99,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call at 9:00 a.m. Eastern Time,PRESS-RELEASE,PR Newswire,West Announces Leadership Changes
WST,2025-04-24,10:10:02,BF79F5,West Pharmaceutical Services Inc.,99,0.53,labor-issues,,West Pharmaceutical Services Inc.: Mr. Birkett joined West as Senior Vice President,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Leadership Changes
WST,2025-04-24,10:10:02,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: First-Quarter 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Leadership Changes
WST,2025-04-24,10:10:02,BF79F5,West Pharmaceutical Services Inc.,99,0.0,investor-relations,,West Pharmaceutical Services Inc.: The Company will host a conference call at 9:00 a.m. Eastern Time,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Leadership Changes
WST,2025-04-24,10:10:58,BF79F5,West Pharmaceutical Services Inc.,100,-0.57,labor-issues,,West Pharma CFO Bernard Birkett to Step Down From,NEWS-FLASH,Dow Jones Newswires,West Pharma CFO Bernard Birkett to Step Down From His Current Position >WST
WST,2025-04-24,10:28:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,labor-issues,,West Pharmaceutical Chief Financial Officer Bernard Birkett to Retire,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Chief Financial Officer Bernard Birkett to Retire
WST,2025-04-24,10:28:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.49,labor-issues,,"West Pharmaceutical Services' top finance executive, Bernard Birkett, plans to retire",FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Chief Financial Officer Bernard Birkett to Retire
WST,2025-04-24,11:27:09,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Investors who lost money on West Pharmaceutical Services, Inc. should contact Levi & Korsinsky about an ongoing investigation - WST"
WST,2025-04-24,11:47:40,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: West Pharmaceutical Services, Inc. (the ""Company"") issued a press release announcing its first-quarter 2025 financial results.",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2025-04-24,11:56:58,BF79F5,West Pharmaceutical Services Inc.,99,-0.49,labor-issues,,"West Pharmaceutical Services Inc.: West Pharmaceutical Services, Inc. (the ""Company"") of his intention to retire as Senior Vice President & Chief Financial Officer",RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-04-25,11:31:06,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"An Investigation Has Commenced on Behalf of West Pharmaceutical Services, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your WST Losses"
WST,2025-04-28,11:25:48,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"ATTENTION West Pharmaceutical Services, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights"
WST,2025-04-29,11:32:09,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - WST"
WST,2025-04-30,11:32:40,BF79F5,West Pharmaceutical Services Inc.,96,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Regarding an Ongoing Investigation"
WST,2025-05-01,11:31:39,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST"
WST,2025-05-02,11:31:08,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"An Investigation Has Commenced on Behalf of West Pharmaceutical Services, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your WST Losses"
WST,2025-05-05,11:22:11,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- WST"
WST,2025-05-05,22:30:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Business Wire,"Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. and Certain of Its Executives"
WST,2025-05-06,11:31:09,BF79F5,West Pharmaceutical Services Inc.,98,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders that Lost Money on West Pharmaceutical Services, Inc.(WST) Should Contact Levi & Korsinsky About Securities Fraud Investigation - WST"
WST,2025-05-06,12:15:46,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by West Pharmaceutical Services, Inc"
WST,2025-05-06,16:01:33,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-06,16:16:04,BF79F5,West Pharmaceutical Services Inc.,97,0.32,earnings,,West reported positive 4Q 2024 financial results,PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-06,18:10:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Business Wire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-06,22:08:04,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,PR Newswire,"WST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead the West Pharmaceutical Class Action Lawsuit"
WST,2025-05-06,22:30:45,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST"
WST,2025-05-06,22:35:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-06,22:35:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-06,23:01:41,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline"
WST,2025-05-07,00:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,GlobeNewswire,"Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-07,00:32:37,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST"
WST,2025-05-07,09:55:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,Business Wire,"WST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-07,11:02:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-07,11:17:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders that lost money on West Pharmaceutical Services, Inc.(WST) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More"
WST,2025-05-07,12:02:35,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-07,12:02:35,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-07,12:16:43,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline"
WST,2025-05-07,13:02:51,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies Shareholders of West Pharmaceutical Services, Inc. (WST) of a Class Action Lawsuit and an Upcoming Deadline"
WST,2025-05-07,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-07,20:30:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,"West Pharmaceutical Services Inc.: It will also present at the William Blair 45(th) Annual Growth Stock Conference on Thursday, June 5, 2025 at 10:40 AM",PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2025-05-07,20:30:05,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,"West Pharmaceutical Services Inc.: It will also present at the William Blair 45(th) Annual Growth Stock Conference on Thursday, June 5, 2025 at 10:40 AM",PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2025-05-07,20:33:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders"
WST,2025-05-07,22:02:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky"
WST,2025-05-08,01:30:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Securities Fraud Investigation Into West Pharmaceutical Services, Inc. (WST) Announced -- Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz"
WST,2025-05-08,01:30:00,BF79F5,West Pharmaceutical Services Inc.,99,0.62,acquisitions-mergers,,West Pharmaceutical Services Inc.: If you purchased West,PRESS-RELEASE,Business Wire,"Securities Fraud Investigation Into West Pharmaceutical Services, Inc. (WST) Announced -- Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz"
WST,2025-05-08,11:02:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-08,11:31:38,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc. (WST) Shareholders"
WST,2025-05-08,12:02:30,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-08,12:02:30,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-08,12:16:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Contact Levi & Korsinsky by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-08,13:25:14,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"WST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-08,13:45:43,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders that lost money on West Pharmaceutical Services, Inc. (WST) should contact Levi & Korsinsky about pending Class Action - WST"
WST,2025-05-08,18:04:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money -- Contact Law Offices of Howard G. Smith About Securities Fraud Investigation"
WST,2025-05-08,18:04:00,BF79F5,West Pharmaceutical Services Inc.,99,0.62,acquisitions-mergers,,West Pharmaceutical Services Inc.: If you purchased West,PRESS-RELEASE,Business Wire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money -- Contact Law Offices of Howard G. Smith About Securities Fraud Investigation"
WST,2025-05-08,19:23:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-08,19:46:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST"
WST,2025-05-08,20:00:34,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-08,20:31:39,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders of West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST"
WST,2025-05-08,21:47:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Securities Fraud Investigation Into West Pharmaceutical Services, Inc. (WST) Announced -- Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm"
WST,2025-05-08,23:16:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies Shareholders of West Pharmaceutical Services, Inc.(WST) of a Class Action Lawsuit and an Upcoming Deadline"
WST,2025-05-09,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West Pharmaceutical",PRESS-RELEASE,GlobeNewswire,"WEST PHARMACEUTICAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. and Encourages Investors to Contact the Firm"
WST,2025-05-09,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"WEST PHARMACEUTICAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. and Encourages Investors to Contact the Firm"
WST,2025-05-09,01:21:09,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - July 7, 2025 Deadline to Join - Contact Levi & Korsinsky"
WST,2025-05-09,11:01:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-09,11:32:36,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST"
WST,2025-05-09,14:32:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-09,14:32:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-09,14:57:07,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST"
WST,2025-05-09,20:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-09,20:31:39,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders of West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST"
WST,2025-05-10,02:07:24,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-10,12:03:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-10,12:03:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-10,22:22:38,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Class Action: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST"
WST,2025-05-11,11:03:14,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-11,11:30:16,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST"
WST,2025-05-11,16:50:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,Business Wire,"WST INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-12,09:05:03,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,PR Newswire,"WST INVESTOR NOTICE: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-12,09:30:47,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders That Lost Money on West Pharmaceutical Services, Inc. (WST) Should Contact Levi & Korsinsky about pending Class Action - WST"
WST,2025-05-12,09:45:05,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST"
WST,2025-05-12,09:45:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST"
WST,2025-05-12,11:03:16,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-12,11:31:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST"
WST,2025-05-12,16:00:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.6,legal,,"West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud",PRESS-RELEASE,Business Wire,"Law Offices of Howard G. Smith Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-12,16:00:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Law Offices of Howard G. Smith Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-12,16:00:00,BF79F5,West Pharmaceutical Services Inc.,100,0.62,acquisitions-mergers,,West Pharmaceutical Services Inc.: If you purchased West,PRESS-RELEASE,Business Wire,"Law Offices of Howard G. Smith Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-12,18:05:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-12,18:05:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-12,18:31:09,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Seeking Recovery for Investors - Contact Levi & Korsinsky"
WST,2025-05-13,00:20:28,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-13,00:45:42,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies Shareholders of West Pharmaceutical Services, Inc. (WST) of a Class Action Lawsuit and an Upcoming Deadline"
WST,2025-05-13,01:16:36,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST"
WST,2025-05-13,09:45:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,Levi & Korsinsky to Join Class Action Suit Against WST,PRESS-RELEASE,PR Newswire,"July 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against WST"
WST,2025-05-13,11:02:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-13,11:26:39,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - WST"
WST,2025-05-13,13:01:33,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"(PMZN) INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-13,13:01:33,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"(PMZN) INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-13,13:16:06,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST"
WST,2025-05-13,16:00:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.6,legal,,"West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud",PRESS-RELEASE,Business Wire,"Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-13,16:00:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-13,20:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-13,21:33:34,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST"
WST,2025-05-14,11:02:43,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-14,11:16:47,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-14,13:03:53,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-14,13:03:53,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-14,13:16:12,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline"
WST,2025-05-14,16:09:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.6,legal,,"West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud",PRESS-RELEASE,Business Wire,"Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-14,16:09:00,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-14,16:09:00,BF79F5,West Pharmaceutical Services Inc.,100,0.62,acquisitions-mergers,,West Pharmaceutical Services Inc.: If you purchased West,PRESS-RELEASE,Business Wire,"Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action"
WST,2025-05-14,20:00:34,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-14,20:31:12,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-14,21:30:45,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit"
WST,2025-05-14,21:45:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-14,22:46:32,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Contact Levi & Korsinsky by July 7, 2025 to Join Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-15,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Avis Budget, Civitas, Open Lending, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-05-15,01:21:19,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-15,11:02:16,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-15,11:16:47,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-15,14:40:29,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-15,15:02:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-15,16:00:01,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Deadline Approaching: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith"
WST,2025-05-15,16:34:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline"
WST,2025-05-16,11:03:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-16,11:17:43,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-05-16,13:04:38,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-16,13:04:38,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-16,13:20:40,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-05-16,14:32:10,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-05-16,15:11:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"WST INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In WST To Contact Him Directly To Discuss Their Options"
WST,2025-05-16,15:31:17,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-05-16,17:09:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-05-16,23:00:24,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR DEADLINE: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-17,22:08:45,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-05-18,11:03:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-18,11:16:08,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-05-18,14:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-18,14:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-18,14:33:11,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-18,20:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-18,20:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-18,20:26:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-05-19,02:31:16,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-05-19,08:55:04,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,PR Newswire,"WST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit"
WST,2025-05-19,09:19:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-05-19,11:02:10,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-19,11:16:36,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-19,12:16:34,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-19,15:46:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-19,15:46:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-19,16:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-05-19,16:18:42,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-19,22:01:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-05-20,11:02:10,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-20,11:17:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-20,11:31:38,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-20,13:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-20,13:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-20,13:31:49,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky to Join Class Action Before July 7, 2025"
WST,2025-05-20,13:50:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"WST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit"
WST,2025-05-20,14:17:17,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-05-20,14:38:30,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-20,15:01:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-20,16:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-05-20,16:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-05-20,16:01:12,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-20,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-20,20:00:31,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-20,20:31:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed: West Pharmaceutical Services, Inc. (WST) - Join by July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-21,07:08:06,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 1Q 2025 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 1Q 2025 (WST)"
WST,2025-05-21,11:02:07,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-21,11:16:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-21,13:04:33,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-21,13:04:33,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-21,13:31:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-22,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance Health, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-05-22,01:46:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-22,09:15:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-22,11:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-22,11:16:34,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-22,15:00:59,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR NOTICE: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit"
WST,2025-05-22,15:29:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-22,15:30:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors Urged to Contact Levi & Korsinsky for Information Before July 7, 2025 - West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-22,23:45:47,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-05-23,11:01:53,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-23,11:19:17,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-23,13:50:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-05-23,14:01:19,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-05-23,16:30:49,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-23,17:01:17,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-05-24,13:05:44,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-24,13:05:44,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-24,22:08:53,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline"
WST,2025-05-25,11:04:23,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-25,11:33:17,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-25,12:32:23,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-25,12:40:14,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-05-25,15:27:16,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors Urged to Contact Levi & Korsinsky for Information Before July 7, 2025 - West Pharmaceutical Services, Inc. (WST)"
WST,2025-05-25,16:14:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-05-26,11:02:18,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-26,11:16:16,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-26,14:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-26,14:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-26,18:01:24,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-05-26,20:00:31,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-26,20:30:56,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-05-27,11:02:50,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-27,11:31:50,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky to Join Class Action Before July 7, 2025"
WST,2025-05-27,14:45:44,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-27,14:45:44,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-27,15:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-27,16:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-05-27,16:21:14,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-05-27,16:32:53,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-05-27,17:47:20,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-27,19:25:45,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-05-27,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-05-27,20:31:45,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed: West Pharmaceutical Services, Inc. (WST) - Join by July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-28,11:02:18,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-28,11:16:47,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders of West Pharmaceutical Services, Inc. (WST): Protect Your Rights Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-28,13:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-28,13:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-05-28,15:06:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-05-28,15:25:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-05-28,16:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-05-28,16:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-05-28,19:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-28,22:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-29,11:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-05-29,11:30:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-05-29,13:55:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-05-29,22:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-05-30,00:30:02,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-05-30,02:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-30,04:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline"
WST,2025-05-30,06:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-30,08:45:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-05-30,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!"
WST,2025-05-30,13:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-05-30,13:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-05-30,14:30:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-05-30,14:45:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-05-30,15:25:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-05-30,16:34:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,GlobeNewswire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - July 7, 2025 Deadline to Join -- Contact Levi & Korsinsky"
WST,2025-05-30,17:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-30,18:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-05-30,21:30:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-05-31,22:08:47,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-06-01,11:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST Shareholders Have Opportunity to Lead West Pharmaceutical Services, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!"
WST,2025-06-01,11:30:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-01,12:10:27,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-01,12:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-01,13:45:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) -Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-01,14:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-01,14:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-01,14:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-01,17:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-01,20:00:31,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-01,21:07:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-02,11:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST Stockholders Have Opportunity to Lead West Pharmaceutical Services, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!"
WST,2025-06-02,11:25:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-02,15:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-06-02,16:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-06-02,16:20:58,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-02,16:20:58,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-02,16:25:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors Urged to Contact Levi & Korsinsky for Information Before July 7, 2025 - West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-02,17:15:18,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-02,17:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-02,23:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders of West Pharmaceutical Services, Inc. (WST): Protect Your Rights Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-03,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Avis Budget, Civitas, Open Lending, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-06-03,02:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-03,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of West Pharmaceutical Services, Inc. to Contact the Firm Today!"
WST,2025-06-03,11:30:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline"
WST,2025-06-03,13:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-03,13:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-03,13:30:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-03,16:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-03,16:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-03,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-03,20:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-04,11:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of West Pharmaceutical Services, Inc. to Contact the Firm Today!"
WST,2025-06-04,11:20:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-04,13:55:26,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-04,14:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders of West Pharmaceutical Services, Inc. (WST): Protect Your Rights Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-04,16:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-04,16:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-04,16:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action - Contact Levi & Korsinsky"
WST,2025-06-04,16:58:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,GlobeNewswire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations -- Investors Should Contact The Gross Law Firm for More Information -- WST"
WST,2025-06-05,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of West Pharmaceutical Services, Inc. to Contact the Firm Today!"
WST,2025-06-05,11:25:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Investors - Lead Plaintiff Deadline on July 7, 2025"
WST,2025-06-05,13:00:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-05,13:00:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-05,13:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-05,19:00:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-06-05,21:47:25,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-05,22:05:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-06-06,00:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Investors - Lead Plaintiff Deadline on July 7, 2025"
WST,2025-06-06,11:00:07,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-06,11:30:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action - Contact Levi & Korsinsky"
WST,2025-06-06,13:41:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-06,14:59:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-06,14:59:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-06,16:15:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-06,20:00:37,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-06,20:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline"
WST,2025-06-06,22:25:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Shareholders of West Pharmaceutical Services, Inc. (WST): Protect Your Rights Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-07,14:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"(PR) INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-07,14:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"(PR) INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-07,22:11:23,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-08,11:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-08,12:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-08,12:04:25,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-08,13:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-06-08,17:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-06-09,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-09,11:30:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-09,14:44:25,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-09,15:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-09,16:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-06-09,16:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors Urged to Contact Levi & Korsinsky for Information Before July 7, 2025 - West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-09,16:30:05,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-06-09,19:15:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-10,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Civitas, Open Lending, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-06-10,01:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-10,11:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-10,11:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-10,13:01:35,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-10,13:01:35,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-10,14:11:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-10,14:35:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-06-10,15:30:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-10,16:30:02,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Reminds Investors of July 7, 2025"
WST,2025-06-10,19:00:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-06-10,20:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-10,20:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-11,11:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-11,11:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Contact Levi & Korsinsky by July 7, 2025 to Join Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-11,14:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-11,14:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-11,14:30:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-06-11,19:50:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-11,19:50:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-11,21:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-12,11:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-12,11:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-06-12,13:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-12,13:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-12,20:01:13,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-12,20:40:47,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-12,21:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Investors - Lead Plaintiff Deadline on July 7, 2025"
WST,2025-06-12,22:21:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-12,22:35:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-13,00:15:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-06-13,11:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-13,11:30:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline"
WST,2025-06-13,15:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-13,15:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-13,16:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-13,16:30:03,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-06-13,17:20:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,GlobeNewswire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights -- WST"
WST,2025-06-13,18:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-13,21:45:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-14,12:22:23,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-14,22:55:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-06-15,11:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-15,11:45:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-15,14:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-15,14:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-15,14:33:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-15,15:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-15,21:27:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action - Contact Levi & Korsinsky"
WST,2025-06-16,11:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-16,11:30:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline"
WST,2025-06-16,13:59:25,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-16,14:05:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Contact Levi & Korsinsky by July 7, 2025 to Join Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-16,16:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-06-16,16:21:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-16,16:21:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-16,16:45:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-06-16,22:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-06-17,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-06-17,01:55:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action - Contact Levi & Korsinsky"
WST,2025-06-17,11:00:07,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-17,11:20:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Reminds Investors of July 7, 2025"
WST,2025-06-17,14:00:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-17,14:00:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-17,16:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-17,16:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-17,17:04:25,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-17,17:30:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-06-17,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-18,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-18,11:13:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-18,14:10:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-18,14:56:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-18,14:56:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-18,20:00:51,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-18,23:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-19,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-20,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-20,13:00:04,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST"
WST,2025-06-20,14:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-20,14:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-20,15:45:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"Faruqi & Faruqi Reminds West Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST"
WST,2025-06-20,16:05:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-20,17:45:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-06-20,18:35:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky"
WST,2025-06-20,22:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-21,12:44:26,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-21,22:12:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-22,11:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-22,11:20:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-06-22,13:13:29,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-06-22,14:00:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-22,14:00:08,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-22,14:20:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed: West Pharmaceutical Services, Inc. (WST) - Join by July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-22,23:55:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-23,11:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-23,11:16:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-23,13:00:05,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST"
WST,2025-06-23,13:49:24,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-23,14:32:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-23,14:50:45,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-23,14:50:45,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-23,15:10:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-23,16:47:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-23,18:05:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-06-23,22:45:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-24,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-06-24,01:35:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-24,11:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-24,11:40:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-24,13:32:25,BF79F5,West Pharmaceutical Services Inc.,100,0.01,analyst-ratings,neutral,West Pharma Initiated at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Equal-Weight by Barclays
WST,2025-06-24,13:32:25,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $245.00/Share by Barclays,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $245.00/Share by Barclays
WST,2025-06-24,14:00:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-24,14:00:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-24,15:04:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-24,15:05:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-06-24,17:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-06-24,17:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-24,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-24,20:00:45,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-24,21:15:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-24,23:35:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-25,11:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-25,11:32:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline"
WST,2025-06-25,13:40:26,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-25,14:07:06,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-06-25,14:20:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-25,14:20:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-25,14:37:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-25,17:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-25,17:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-06-25,22:15:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-26,11:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!"
WST,2025-06-26,11:45:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-26,14:00:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-26,14:00:11,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-06-26,14:32:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-06-26,17:15:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025"
WST,2025-06-26,23:27:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-06-26,23:45:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-27,11:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!"
WST,2025-06-27,11:30:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-06-27,14:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-27,14:00:05,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-27,14:47:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline"
WST,2025-06-27,15:42:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-27,17:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-27,21:50:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-28,12:40:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-06-28,14:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"(PMZN) INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-28,14:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"(PMZN) INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-29,02:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Contact Levi & Korsinsky by July 7, 2025 to Join Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-29,11:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST Shareholders Have Opportunity to Lead West Pharmaceutical Services, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!"
WST,2025-06-29,11:40:24,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-29,13:50:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed: West Pharmaceutical Services, Inc. (WST) - Join by July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-29,14:46:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-30,00:17:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-06-30,11:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST Stockholders Have Opportunity to Lead West Pharmaceutical Services, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!"
WST,2025-06-30,11:17:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-06-30,15:52:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-30,15:52:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-06-30,16:52:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-06-30,17:00:00,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,GlobeNewswire,"Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit"
WST,2025-06-30,17:05:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-06-30,20:00:47,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-06-30,21:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky"
WST,2025-06-30,22:41:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025"
WST,2025-06-30,23:41:17,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-07-01,01:00:01,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical issued its 2025 revenue,PRESS-RELEASE,GlobeNewswire,"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm"
WST,2025-07-01,02:12:14,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-01,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of West Pharmaceutical Services, Inc. to Contact the Firm Today!"
WST,2025-07-01,11:42:44,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline"
WST,2025-07-01,14:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-01,14:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-01,14:44:20,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)"
WST,2025-07-01,15:51:24,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-01,15:58:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-07-01,15:58:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.64,legal,,"Securities fraud class action lawsuit against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"
WST,2025-07-01,16:57:26,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP"
WST,2025-07-01,18:12:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-01,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-07-01,21:30:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-01,22:45:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-02,11:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of West Pharmaceutical Services, Inc. to Contact the Firm Today!"
WST,2025-07-02,11:33:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-02,14:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-02,14:00:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-02,15:12:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action - Contact Levi & Korsinsky"
WST,2025-07-02,16:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-07-02,16:00:01,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West issued disappointing revenue and earnings forecasts for 2025,PRESS-RELEASE,Business Wire,"Deadline Soon: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit"
WST,2025-07-02,16:40:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-07-02,20:07:06,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST"
WST,2025-07-02,21:15:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-07-03,11:00:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of West Pharmaceutical Services, Inc. to Contact the Firm Today!"
WST,2025-07-03,11:20:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky to Join Class Action Before July 7, 2025"
WST,2025-07-03,12:15:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,PR Newswire,"SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-07-03,14:13:42,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-07-03,14:13:42,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-07-03,14:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Investors - Lead Plaintiff Deadline on July 7, 2025"
WST,2025-07-03,17:47:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action"
WST,2025-07-03,18:45:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-04,11:00:03,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"FINAL WST DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds West Pharmaceutical Services, Inc. Investors to Join the Class Action Lawsuit"
WST,2025-07-04,11:20:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline"
WST,2025-07-04,13:17:25,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Faruqi & Faruqi Reminds West Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST"
WST,2025-07-04,14:10:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Reminds Investors of July 7, 2025"
WST,2025-07-06,11:00:04,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"FINAL REMINDER WST DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts West Pharmaceutical Services, Inc. Investors to Participate in the Class Action Lawsuit"
WST,2025-07-06,11:35:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-06,12:25:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services"
WST,2025-07-06,14:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-06,14:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,GlobeNewswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-06,14:40:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025"
WST,2025-07-06,20:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,GlobeNewswire,"WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit"
WST,2025-07-06,21:10:02,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-07,06:50:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-07,13:00:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,PR Newswire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Seeking Recovery for Investors - Contact The Gross Law Firm"
WST,2025-07-07,13:00:07,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Seeking Recovery for Investors - Contact The Gross Law Firm"
WST,2025-07-07,14:30:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.64,legal,,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Reminds Investors of July 7, 2025"
WST,2025-07-07,17:06:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc.",PRESS-RELEASE,Business Wire,"FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceuticals"
WST,2025-07-07,18:45:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-07,18:45:06,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,PR Newswire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST"
WST,2025-07-07,20:41:00,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations",PRESS-RELEASE,GlobeNewswire,"West Pharmaceutical Services, Inc. Sued for Securities Law Violations -- Investors Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights -- WST"
WST,2025-07-07,20:52:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders"
WST,2025-07-07,21:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-07-07,21:30:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-07-07,22:35:01,BF79F5,West Pharmaceutical Services Inc.,100,-0.52,legal,,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST)",PRESS-RELEASE,DJ Global Press Release Wire,"Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today"
WST,2025-07-07,23:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Class action lawsuit has been filed against West Pharmaceutical Services, Inc. (""West",PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-07-07,23:00:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.34,revenues,,West issued weak 2025 revenue,PRESS-RELEASE,DJ Global Press Release Wire,"INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit And Upcoming Deadlines - WST"
WST,2025-07-07,23:35:01,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Lawsuit was filed against West Pharmaceutical Services, Inc.",PRESS-RELEASE,DJ Global Press Release Wire,"West Pharmaceutical Services, Inc. (WST) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before July 7, 2025"
WST,2025-07-08,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2025 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Second-Quarter 2025 Conference Call
WST,2025-07-08,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Second-Quarter 2025 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Second-Quarter 2025 Conference Call
WST,2025-07-09,01:00:00,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc. (NYSE:WST)",PRESS-RELEASE,GlobeNewswire,"WEST ALERT: Bragar Eagel & Squire, P.C. is Investigating West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm"
WST,2025-07-21,10:00:41,BF79F5,West Pharmaceutical Services Inc.,100,0.53,labor-issues,,West Pharma Names Robert McMahon as New Chief Fincl Officer >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Names Robert McMahon as New Chief Fincl Officer >WST
WST,2025-07-21,10:21:09,BF79F5,West Pharmaceutical Services Inc.,94,0.53,labor-issues,,"West Pharmaceutical Services has hired Robert McMahon as its new chief financial officer, effective Aug. 4",FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Names Robert McMahon Chief Financial Officer
WST,2025-07-21,20:17:57,BF79F5,West Pharmaceutical Services Inc.,99,0.53,labor-issues,,"West Pharmaceutical Services Inc.: the ""Company"") announced the appointment of Robert McMahon as Senior Vice President & Chief Financial Officer",RNS-SEC8K,Dow Jones Newswires,"West Pharma Files 8K - Director, Officer or Compensation Filing >WST"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 2Q Sales $766.5M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Sales $766.5M >WST
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $3.04B-$3.06B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $3.04B-$3.06B >WST
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2025",PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Second-Quarter 2025 Conference Call,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales of $766.5 million increased 9.2%,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.4,earnings,up,"West Pharmaceutical Services Inc.: Diluted EPS of $1.82, compared to $1.51",PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Adjusted-diluted EPS of $1.84,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Updates full-year 2025 net sales,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announces that its Board of Directors has approved a fourth-quarter 2025 dividend of $0.22,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.36,equity-actions,down,"West Pharmaceutical Services Inc.: Capital expenditures were $146.5 million, a decrease of 23.2%",PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 552,593 shares for $134.0 million",PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is increasing its full-year 2025 net sales guidance,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Our updated adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2025 capital spending guidance,PRESS-RELEASE,PR Newswire,"West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $6.65,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $6.65-Adj EPS $6.85 >WST
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 766.5,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 273.9,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.82 $ 1.52 $,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Adj EPS $1.84,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Adj EPS $1.84 >WST
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Announces Second-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: the Company recorded charges of $1.6 million,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2025 restructuring plan,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Announces Second-Quarter 2025 Results and -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q EPS $1.82,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q EPS $1.82 >WST
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 2Q Net $131.8M,NEWS-FLASH,Dow Jones Newswires,West Pharma 2Q Net $131.8M >WST
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,"West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Second-Quarter 2025 Conference Call,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Net sales of $766.5 million increased 9.2%,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.4,earnings,up,"West Pharmaceutical Services Inc.: Diluted EPS of $1.82, compared to $1.51",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Adjusted-diluted EPS of $1.84,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Updates full-year 2025 net sales,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: The Company also announces that its Board of Directors has approved a fourth-quarter 2025 dividend of $0.22,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.36,equity-actions,down,"West Pharmaceutical Services Inc.: Capital expenditures were $146.5 million, a decrease of 23.2%",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 552,593 shares for $134.0 million",PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: The Company is increasing its full-year 2025 net sales guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Our updated adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,,West Pharmaceutical Services Inc.: Full-year 2025 capital spending guidance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance"
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 766.5,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 273.9,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.82 $ 1.52 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -2-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: the Company recorded charges of $1.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2025 restructuring plan,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Reported net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -3-
WST,2025-07-24,10:00:12,BF79F5,West Pharmaceutical Services Inc.,99,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Announces Second-Quarter 2025 -3-
WST,2025-07-24,10:02:19,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Previous FY Sales Guidance,NEWS-FLASH,Dow Jones Newswires,West Pharma Previous FY Sales Guidance Was $2.945B to $2.975B >WST
WST,2025-07-24,10:03:15,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma: Previous FY Adj EPS Guidance Was $6,NEWS-FLASH,Dow Jones Newswires,West Pharma: Previous FY Adj EPS Guidance Was $6.15$6.35 >WST
WST,2025-07-24,10:40:38,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Boosts Outlook After,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Boosts Outlook After Beating 2Q Expectations
WST,2025-07-24,10:40:38,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,above-expectations,West Pharmaceutical Services logged higher-than-expected profit,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Boosts Outlook After Beating 2Q Expectations
WST,2025-07-24,10:40:38,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: The company raised its sales outlook,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Boosts Outlook After Beating 2Q Expectations
WST,2025-07-24,11:18:01,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: the ""Company"") issued a press release announcing its second-quarter 2025 financial results",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2025-07-24,11:36:10,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: The company reported adjusted earnings of $1.84 a share for the second quarter,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Stock Surges After Earnings. GLP-1s Play a Role. -- Barrons.com
WST,2025-07-24,14:04:06,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharma earned $1.84 per share,FULL-ARTICLE,Dow Jones Newswires,"West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings -- IBD"
WST,2025-07-24,14:04:06,BF79F5,West Pharmaceutical Services Inc.,99,0.48,revenues,up,West Pharmaceutical expects sales to rise 3% to 3.75%,FULL-ARTICLE,Dow Jones Newswires,"West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings -- IBD"
WST,2025-07-24,14:15:36,BF79F5,West Pharmaceutical Services Inc.,93,0.61,earnings,positive,West Pharmaceutical Services Inc.: The company reported adjusted earnings of $1.84 a share for the second quarter,FULL-ARTICLE,Dow Jones Newswires,West Pharmaceutical Stock On Track for Best Day Ever After Earnings -- Barrons.com
WST,2025-07-24,20:31:36,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharma earned $1.84 per share,FULL-ARTICLE,Dow Jones Newswires,"West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings -- IBD"
WST,2025-07-24,20:31:36,BF79F5,West Pharmaceutical Services Inc.,99,0.48,revenues,up,West Pharmaceutical expects sales to rise 3% to 3.75%,FULL-ARTICLE,Dow Jones Newswires,"West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings -- IBD"
WST,2025-07-25,14:16:37,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Outperform by Evercore ISI Group
WST,2025-07-25,14:16:37,BF79F5,West Pharmaceutical Services Inc.,100,0.8,price-targets,upgrade,West Pharma Price Target Raised to $350.00/Share From $275.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $350.00/Share From $275.00 by Evercore ISI Group
WST,2025-07-25,16:15:57,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Buy by UBS
WST,2025-07-25,16:15:57,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $320.00/Share From $285.00 by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $320.00/Share From $285.00 by UBS
WST,2025-08-21,07:08:32,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,"West Pharmaceutical Services , Inst Holders, 2Q 2025 (WST)",RNS-SEC13F,Dow Jones Newswires,"West Pharmaceutical Services , Inst Holders, 2Q 2025 (WST)"
WST,2025-08-21,10:00:04,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences in September 2025,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences in September 2025
WST,2025-08-21,10:05:46,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences in September 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences in September 2025
WST,2025-09-15,13:51:45,BF79F5,West Pharmaceutical Services Inc.,100,0.95,analyst-ratings,positive,West Pharma Initiated at Buy by Rothschild & Co,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Buy by Rothschild & Co
WST,2025-09-15,13:51:45,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $311.00/Share by Rothschild & Co,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $311.00/Share by Rothschild & Co
WST,2025-10-02,13:27:54,BF79F5,West Pharmaceutical Services Inc.,100,0.0,analyst-ratings,neutral,West Pharma Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Equal-Weight by Barclays
WST,2025-10-02,13:27:54,BF79F5,West Pharmaceutical Services Inc.,100,0.62,price-targets,upgrade,West Pharma Price Target Raised to $275.00/Share From $260.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $275.00/Share From $260.00 by Barclays
WST,2025-10-08,19:27:15,BF79F5,West Pharmaceutical Services Inc.,99,-0.52,legal,,"Firm, is investigating potential claims against West Pharmaceutical Services, Inc. (NYSE:WST)",PRESS-RELEASE,GlobeNewswire,"WEST PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm"
WST,2025-10-09,10:00:52,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2025 Conference Call,PRESS-RELEASE,PR Newswire,West to Host Third-Quarter 2025 Conference Call
WST,2025-10-09,10:00:56,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West to Host Third-Quarter 2025 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Host Third-Quarter 2025 Conference Call
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Reports Third-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Increases Full-Year 2025 Revenue,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.4,earnings,up,"West Pharmaceutical Services Inc.: Diluted EPS of $1.92, compared to $1.85",PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Adjusted-diluted EPS of $1.96,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: Full-year 2025 net sales guidance increased to a range of $3.060 billion to $3.070 billion,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2025 adjusted-diluted EPS guidance increased to a range of $7.06 to $7.11,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: we are again increasing our full-year guidance,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: HVP Delivery Devices net sales of $99.1 million,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.36,equity-actions,down,"West Pharmaceutical Services Inc.: Capital expenditures were $209.8 million, a decrease of 22.9%",PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 552,593 shares for $134.0 million",PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,unchanged,West Pharmaceutical Services Inc.: Capital spending guidance is unchanged,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Fourth-Quarter 2025 Financial Guidance,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Third-Quarter 2025 Conference Call,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Reports Third-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -2-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 804.6,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -2-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 294.3,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -2-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -2-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.94 $ 1.87 $,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -2-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Reports Third-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -3-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: the Company recorded charges of $2.5 million,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -3-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2025 restructuring plan,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -3-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2022 restructuring plan,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -3-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Reported Net Sales,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -3-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Reports Third-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -4-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: Reported Net Sales,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -4-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -4-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -4-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,assets,,"West Pharmaceutical Services Inc.: Total Assets $ 4,105.8 $ 3,643.4",PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -4-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Reports Third-Quarter 2025 Results,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -5-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.0,dividends,,West Pharmaceutical Services Inc.: Dividend,PRESS-RELEASE,PR Newswire,West Reports Third-Quarter 2025 Results -5-
WST,2025-10-23,10:00:02,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q EPS $1.92,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q EPS $1.92 >WST
WST,2025-10-23,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY Adj EPS $7.06,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Adj EPS $7.06-Adj EPS $7.11 >WST
WST,2025-10-23,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Adj EPS $1.96,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Adj EPS $1.96 >WST
WST,2025-10-23,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharma 3Q Net $140M,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Net $140M >WST
WST,2025-10-23,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma Sees FY Sales $3.06B-$3.07B >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY Sales $3.06B-$3.07B >WST
WST,2025-10-23,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharma 3Q Sales $804.6M >WST,NEWS-FLASH,Dow Jones Newswires,West Pharma 3Q Sales $804.6M >WST
WST,2025-10-23,10:00:03,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharma Sees FY EPS $6.75,NEWS-FLASH,Dow Jones Newswires,West Pharma Sees FY EPS $6.75-EPS $6.80 >WST
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Reports Third-Quarter 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.41,revenues,up,West Pharmaceutical Services Inc.: Increases Full-Year 2025 Revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.4,earnings,up,"West Pharmaceutical Services Inc.: Diluted EPS of $1.92, compared to $1.85",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Adjusted-diluted EPS of $1.96,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.72,revenues,up,West Pharmaceutical Services Inc.: Full-year 2025 net sales guidance increased to a range of $3.060 billion to $3.070 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.61,earnings,positive,West Pharmaceutical Services Inc.: Full-year 2025 adjusted-diluted EPS guidance increased to a range of $7.06 to $7.11,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Services Inc.: we are again increasing our full-year guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,revenues,,West Pharmaceutical Services Inc.: HVP Delivery Devices net sales of $99.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.36,equity-actions,down,"West Pharmaceutical Services Inc.: Capital expenditures were $209.8 million, a decrease of 22.9%",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.59,equity-actions,,"West Pharmaceutical Services Inc.: the Company repurchased 552,593 shares for $134.0 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Adjusted-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,equity-actions,unchanged,West Pharmaceutical Services Inc.: Capital spending guidance is unchanged,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,earnings,,West Pharmaceutical Services Inc.: Fourth-Quarter 2025 Financial Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,100,0.0,investor-relations,,West Pharmaceutical Services Inc.: Third-Quarter 2025 Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 Results
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Net sales $ 804.6,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -2-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Gross profit 294.3,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -2-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.6,earnings,positive,West Pharmaceutical Services Inc.: Adjusted Operating Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -2-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.61,earnings,positive,West Pharmaceutical Services Inc.: Net income per share: Basic $ 1.94 $ 1.87 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -2-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,-0.45,equity-actions,charge,West Pharmaceutical Services Inc.: the Company recorded charges of $2.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -3-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2025 restructuring plan,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -3-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.47,equity-actions,,West Pharmaceutical Services Inc.: the Company's 2022 restructuring plan,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -3-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,99,0.0,revenues,,West Pharmaceutical Services Inc.: Reported Net Sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -3-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,98,0.0,revenues,,West Pharmaceutical Services Inc.: Reported Net Sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -4-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,98,0.0,earnings,,West Pharmaceutical Services Inc.: Reported-diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -4-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,98,0.0,earnings,,West Pharmaceutical Services Inc.: our full-year EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -4-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,98,0.0,assets,,"West Pharmaceutical Services Inc.: Total Assets $ 4,105.8 $ 3,643.4",PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -4-
WST,2025-10-23,10:00:09,BF79F5,West Pharmaceutical Services Inc.,92,0.0,dividends,,West Pharmaceutical Services Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: West Reports Third-Quarter 2025 -5-
WST,2025-10-23,10:52:50,BF79F5,West Pharmaceutical Services Inc.,100,0.7,earnings,up,West Pharmaceutical Lifts Outlook as 3Q Profit,FULL-ARTICLE,Dow Jones Newswires,"West Pharmaceutical Lifts Outlook as 3Q Profit, Sales Rise"
WST,2025-10-23,11:15:31,BF79F5,West Pharmaceutical Services Inc.,94,0.0,earnings,,"West Pharmaceutical Services Inc.: West Pharmaceutical Services, Inc. (the ""Company"") issued a press release announcing its third-quarter 2025 financial results.",RNS-SEC8K,Dow Jones Newswires,West Pharma Files 8K - Operations And Financial Condition >WST
WST,2025-10-23,18:04:05,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Outperform by Evercore ISI Group
WST,2025-10-23,18:04:05,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $390.00/Share From $350.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $390.00/Share From $350.00 by Evercore ISI Group
WST,2025-10-24,10:00:01,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,West to Participate in Upcoming Investor Conferences
WST,2025-10-24,10:09:56,BF79F5,West Pharmaceutical Services Inc.,100,0.0,marketing,,West to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: West to Participate in Upcoming Investor Conferences
WST,2025-10-24,12:43:36,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Overweight by Keybanc
WST,2025-10-24,12:43:37,BF79F5,West Pharmaceutical Services Inc.,100,0.68,price-targets,upgrade,West Pharma Price Target Raised to $350.00/Share From $325.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $350.00/Share From $325.00 by Keybanc
WST,2025-10-24,15:15:47,BF79F5,West Pharmaceutical Services Inc.,100,0.34,analyst-ratings,neutral,West Pharma Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Buy by UBS
WST,2025-10-24,15:15:47,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $355.00/Share From $320.00 by UBS,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $355.00/Share From $320.00 by UBS
WST,2025-10-27,16:35:13,BF79F5,West Pharmaceutical Services Inc.,100,0.0,analyst-ratings,neutral,West Pharma Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,West Pharma Is Maintained at Equal-Weight by Barclays
WST,2025-10-27,16:35:13,BF79F5,West Pharmaceutical Services Inc.,100,0.78,price-targets,upgrade,West Pharma Price Target Raised to $325.00/Share From $275.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Raised to $325.00/Share From $275.00 by Barclays
WST,2025-10-29,13:10:08,BF79F5,West Pharmaceutical Services Inc.,100,0.95,analyst-ratings,positive,West Pharma Initiated at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,West Pharma Initiated at Buy by TD Cowen
WST,2025-10-29,13:10:08,BF79F5,West Pharmaceutical Services Inc.,100,0.0,price-targets,set,West Pharma Price Target Announced at $350.00/Share by TD Cowen,NEWS-FLASH,Dow Jones Newswires,West Pharma Price Target Announced at $350.00/Share by TD Cowen
